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I N T R O D U C T I O N 

I N T R O D U C T I O N 
The multiannual research and training programme of the 
European Economic Community in the field of Biotechnology 
(BAP : Biotechnology Action Programme) was adopted by Council 
on 12 March 1985 for the period 1985 to 1989. The programme, 
inherently precompetitive, is oriented towards medium and long 
term objectives essential for the strategic strength of 
European industry and European agriculture. It deals with two 
essential tasks, namely : 
- the establishment of a supportive infrastructure for 
biotechnology research and development in Europe ; 
- the elimination, through research and through training, 
of bottlenecks which prevent the exploitation by 
industry and agriculture of the materials and methods 
originating from modern biology. 
The programme extends over five years, with a total budget 
allocation of 55 Mio ECU. 
The adoption by Council on 29 June 19 88 of a programme 
revision further increased it resources by 20 Mio ECU and 
reinforced, without widening the range of activities in 
progress, some of its present weakest aspects, in particular 
the incomplete participation of Portugal and Spain who joined 
the Community after the expiration date of the calls for 
proposals. 
The present progress report was prepared after the programme 
had been running for two and a half years. It outlines the 
preliminary results obtained by mid-1988 from transnational 
cost-shared research contracts between the Commission and 
associated public or private institutions from different 
Member States. 
******* 
IMPLEMENTATION 
From a total of 1,357 applications submitted in response to 
the calls for proposals made in 1985, 262 2-4 year shared-cost 
research contracts, falling in 93 transnational joint 
projects, were negotiated by the Commission services. The 
participating laboratories were selected on the basis of the 
interest and relevance of their proposals to the objectives of 
the programme, their scientific competence, the extent of 
industrial interest and involvement, and the provisions made 
for transnational cooperation. In fact all the 93 joint 
projects are transnational, involving from 2 to 7 partners 
from different Member States. Sixteen industrial firms are 
present in these associations, while 169 other firms expressed 
specific interest in one or more projects, and are now taking 
part in the industrial contact-groups with direct access to 
all scientific events taking place during the programme. 
The sector on "toxicology testing iri vitro" received a 
different treatment. A special call for proposals was 
launched in 1986, resulting in 158 applications out of which 
16 were selected. In contrast to all other parts of BAP, this 
sector had a delayed start and is given here the first 
occasion to report on preliminary achievements. 
The participating laboratories have been sorted out into 9 
sectors of priority research, which correspond to a functional 
rearrangement of the 20 specific research lines initially 
composing the scope of the programme (Table 1). 
One of the main tasks of the Commission services, after 
conclusion of the contracts, was to organize the participating 
laboratories into networks of small nuclei of Community 
expertise. These transnational groupings provide for rapid 
circulation and exchange of information, data and materials, 
and encourage mobility amongst research staff. Ideally, once 
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the competitive advantage resulting from the division of tasks 
and the gradual integration of work becomes established, these 
new transnational entities, composed of one or more research 
associations, evolve into real "European Laboratories Without 
Walls" (ELWWs), each entrusted with a specific research 
objective of the BAP programme. These ELWWs can undergo a 
very active transitory life, as demonstrated by increased 
scientific productivity (see below), and express a remarkable 
capacity to attract industrial interest. 
Strikingly enough, ELWWs have no legal existence. They are 
entities larger than cooperation contracts, but smaller than 
entire Community research programmes. Their existence is the 
direct consequence of the programme and their vitality 
steadily increases during its implementation. By themselves 
they constitute a significant achievement of BAP. 
The number of ELWWs, or of transnational groupings which tend 
to organise work on the same principle, approximates thirty, 
and increases in all sectors of the programme. The pace at 
which wide-ranging cooperations are established varies from 
case to case, and is logically higher when • contractual 
partners have known each other through their participation in 
the former Community programme (BEP : 1982-1986), or when the 
scientific topics considered happen to be of a more basic 
nature. Such differences explain why some ELWWs reached 
their steady state at an early stage, while others still 
undertake gradual integration process. 
The ELWWs listed below may be considered as particularly well 
established : 
genetic engineering of lactic acid bacteria, 
- cellular neuroimmunology, 
mammalian minichromosomes and linear vectors, 
- molecular biology of phytopathogenic Erwiniae, 
- crop improvement through cell biotechnology, 
- extremophile microorganisms, 
automation of DNA sequencing, 
computer-aided peptide and protein engineering software 
development, 
folding, assembly, stability and genetic modification of 
Penicillin acylase and its precursor, 
protein engineering of the Elongation factor Tu, 
biocatalysis by novel metal clusters, 
pollen biotechnology, 
molecular biology of cereal.seed protein genes, 
plant hormone receptors, 
late symbiotic genes : improvement of Rhizobium strains. 
etc, 
In some cases the progress in research and the economic 
relevance of the results obtained point towards . competitive 
developments. When this occurs, industrial pressure removes 
the laboratories out of the ELWW structure and inserts them, 
as a direct follow up of the Community programme, into an 
independent, often confidential, relationship of industrial 
cooperation. 
This multiform transnational cooperation constitutes the basic 
justification for the programme. It would not have been 
possible without the sustained willingness to cooperate and 
the mutual esteem for the scientific competence of the 
laboratories involved. The role of Commission services there 
is modest, but essential. They provide a structure comparable 
to a marriage bureau which operates through three major 
mecanisms: meetings, visits to laboratories and publications. 
From July 87 to June 19 88, four sectoral meetings of 
contracting laboratories were organized, as well as forty 
smaller working seminars of ELWWs. 
Seven scientific officers from the Biotechnology Division made 
98 visits to contracting laboratories, to discuss progress, 
problems or opportunities with project leaders. 
Detailed information on the activities and the results 
obtained by BAP contractors has been assembled and made 
available through a series of reports and review articles in 
scientific journals (cf. lists in the next section of this 
volume). 
PRELIMINARY ACHIEVEMENTS 
The programme has now reached its half-way mark. 
A panel of independent experts was invited by the Commission, 
at the beginning of 19 88 to carry out an evaluation of its 
implementation mechanisms and of its early achievements. The 
conclusions of their analysis, both- critical and encouraging, 
have appeared as report no. EUR 11 833 by the Office of 
Official Publications of the European Communities 
(Luxembourg). Commenting on both BEP and BAP, the evaluation 
panel • stated that "a major achievement of the research 
programmes, and one that is important for the future, has 
been to break down national frontiers between laboratories. 
We commend the Commission's initiative in linking groups into 
European Laboratories Without Walls, a useful concept that 
could be applied in other domains". It also noted that 
programmes objectives had been sometimes over-ambitious for 
the resources available; and thé lack of a critical mass of 
researchers in certain sectors was mentioned. Ambitious is 
the correct term, indeed, to charaterize the whole range of 
activities supported by the programme and reported in the 
following volumes. And scientific contractors themselves are 
not less ambitious when they embark on these many 
transnational ventures which are described below. 
Fortunately; this Community endeavour is credited with an 
abundance of scientific achievements, many of them appearing 
already in a preliminary form at this intermediate stage of 
programme advancement. 
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As examples of some of the results, among many others, which 
the reader will find across the three volumes of reports, the 
following recent achievements can be quickly mentioned : 
- Development of a kit to distinguish between vaccinated 
and infected pigs (pseudo rabies). The kit is now in 
exploitation phase. 
- Isolation, for the first time, of thermotolerant 
methylotrophic Bacillus species with promising 
biotechnological potential. 
- The finding that glycolysis in yeast is unregulated and 
that some of the enzymes are rate-limiting. 
Cloning for the very first time of a regulatory gene 
from cultivated higher plants by research of 2 groups 
supported continuously through BEP and BAP : the gene is 
"opaque-2" which controls zein synthesis in maize. 
In the framework of a collaboration between 7 BAP 
Contracts, cloning (expected to be completed by the end 
of 1988) of the first receptor protein gene controlling 
auxin perception. 
- Preliminary encouraging results on the ability of 
engineered red blood cells to produce and release 
antineoplastic drugs from encapsulated pro-drugs. 
- for the first time at pilot plant phase, successful 
achievement of co-factor regeneration. 
Through a more comprehensive and statistical approach, the 
usual indicators of transnational activity have been studied 
during the reporting period, resulting in a graphical 
assessment of programme output which is presented in a 
condensed form below. 
Credit must be given to several contractors for having so 
rapidly integrated their work that 47 joint publications have 
already appeared. Table 4 lists the joint publications for 
all sectors of the programme. 
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The exploitation of research results for the benefit of 
European agriculture and industry is one of the essential 
objectives of the BAP programme which can be achieved by 
giving all interested firms in the Community access to these 
results as they arise ; such access was systematically 
provided by the Commission services at all the sectoral 
contractors* meetings (see next section). In parallel to this 
effort, contractors were encouraged to protect, particularly 
through patenting, research results likely to lead to 
exploitation. A list of patents deposited to date in 
connection with the research under contract is provided in 
table 5. A review of development prospects will however not 
be possible before the end of the programme. 
An obvious criterion of the success of the programme, however 
difficult to monitor, is the intensity of transational 
activities. Based on motivated statements requested from the 
contractors in their individual reports, an attempt has been 
made at quantifying the various types of cooperation 
agreements and exchanges taking place within the programme. 
Their frequency is reported in Figure 2. 
Joint meetings rank very high, as a direct result of the 
coordinating activity of Commission services through sectoral 
meetings or working seminars of ELWWs. The exchange of 
materials is highly rated by the scientists as one of the 
easiest ways to initiate cooperation. 
Joint experiments and staff exchange appeared to be more 
difficult to organize; nevertheless about 50 % of the 
participating laboratories were able to implement such 
activities which represent the ultimate phase .of coordination. 
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MANAGING PRINCIPLES AND FUTURE TRENDS 
Since February 19 85, on the eve of the adoption of BAP, the 
Commission services have been helped in managing the programme 
by the advice of the CGC-Biotechnology. This was in 
consequence of the decision by Council of 29 June 1984 to 
establish CGCs (management and coordination advisory 
committees) providing guidance to the Commission services on 
all tasks related to the preparation, implementation and 
evaluation of Community R & D programmes. 
The services of the Commission wish to acknowledge with 
gratitude the help and advice v/hich they have received from 
the CGC "Biotechnology" at the time of the launching phase of 
the programme and during its early implementation. 
The CGC-Biotechnology, the composition of which is presented 
in table 6, has a large field of responsibility since it also 
covers the whole range of training activities in the field of 
biotechnology, COST actions related to primary aquatic biomass 
and to plant in_ vitro culture, concertation activities for the 
harmonization of biotechnology-related policies, and new 
initiatives under the Biotechnology sub-line of the Second 
Framework Programme. 
The committee now provides the Commission with advice in 
connection with the preparation of the BRIDGE programme 
proposal. BRIDGE, which stands for Biotechnology Research for 
Innovation, Development and Growth in Europe, will replace BAP 
after 1989. 
Considering the evolution of biotechnology R & D over the last 
ten years, and the increasing possibility of scientific 
breakthroughs reaching the market place, it is now essential 
to extend industrial participation beyond the implementation 
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phase and to associate European industry at all stages of the 
conception phases. An industrial advice, required throughout 
the entire preparatory phase of any new action, is being 
essentially provided through the expert assessments of IRDAC, 
the Industrial Research and Development Advisory Committee. 
This committee was created by a decision of the Commission of 
29 February 1984. Having acknowledged the pervasiveness of 
biotechnology across many industrial sectors, and the 
specificity of products and production methods based on the 
exploitation of living matter, IRDAC has generated a working 
party on biotechnology, the composition of which is given is 
table 7. Members of the working party were selected on the 
basis of their industrial experince, but represent neither 
their employer nor their country of origin. They are 
consulted, as has been the CGC-Biotechnology, on the needs and 
opportunities for industrial R & D in this particular field. 
They issued in December 19 87 a report on future R & D 
programmes in the field of biotechnology. 
F. van Hoeck, D. de Nettancourt, 
Director Head of Division 
Biology Biotechnology 
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T A B L E S 
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F I G U R E S 
Table 1 : Organization of the programme into research sectors 
SCOPE OF THE PROGRAMME MAJOR RESEARCH SECTORS 
I. CONTEXTUAL MEASURES 
1. Bio-informatics 
1.1. Data capture technologies 
1.2. Updating and design of data banks 
related to biotic materials 
1.3. Modelling techniques & algorithms 
1.4. Advanced computer software, 
including expert systems 
2. Collections of biotic materials 
2.1. Upgrading of existing collections 
of importance as supporting 
resources for biotechnology R&D, 
and creation of new collections, 
required and made possible by the 
advances of science. 
2.2. Development and improvement of 
technical methods of storage and 
resuscitation as well as improved 
methods of identification, 
description and classification. 
1. BIO-INFORMATICS 
2. CULTURE COLLECTIONS 
II. BASIC BIOTECHNOLOGY 
1. Enzyme engineering 
1.1. Development of bioreactors (multi-
enzymatic, multiphasic, co-factor 
requiring or utilizing viscous 
media) 
1.2. Stability of enzymes during 
industrial exploitation 
1.3 Protein design including new 
concepts in enzyme catalysis, 
structural and functional pre-
dictions, chemical and genetic 
modifications, construction of 
artificial enzymes. 
3. BIOREACTORS 
4. PROTEIN DESIGN/ 
MACROMOLECULAR 
MODELLING 
2. Genetic engineering 
2.1 Microorganisms : gene charac-
terization and gene transfer 
for potential applications by 
industries. 
2.2. Plants : Analyses of the structure 
and regulation of plant genomes. 
2.3. Plants : transfer and cloning of 
genetic material in plant cells. 
2.4. Microorganisms and plants : asso-
ciations (in particular symbiotic 
relations) between crop plants and 
microorganisms. 
5. BIOTECHNOLOGY OF 
INDUSTRIAL 
MICROORGANISMS 
6. BIOTECHNOLOGY OF 
PLANTS AND 
ASSOCIATED 
MICROORGANISMS 
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Table 1 
(ctd) Organization of the programme into research sectors 
SCOPE OF TflE PROGRAMME MAJOR RESEARCH SECTORS 
II. BASIC BIOTECHNOLOGY (ctd) 
2. Genetic engineering (ctd) 
2.5. Plants : early detection of genetic 
- or pathological modifications in .-
cultivated plants. 
2.6. Animals (livestock, including 
fish) : cloning of substances 
important for animal husbandry, 
cloning vectors for animal cells, 
cloning of genetic material in 
animal cells. 
6. BIOTECHNOLOGY OF 
. PLANTS & ASSOC.. 
MICROORGANISMS (ctd) 
7. BIOTECHNOLOGY OF 
ANIMALS 
3. Technology of cells and tissues 
cultured in vitro 
3.1. Physiological and genetic factors 
governing yield and stability 
during continuous cultivation of 
microbial species important to 
industry. 
3.2. Control of the differentiation of 
plant cells and of their regene-
ration in entire plants. 
3.3. Novel methodologies of animal 
cells cultures. 
4. Assessment of risks 
Development of new methods for 
detecting contamination and for 
the assessment of possible risks 
associated with applications in 
industry and agriculture of bio-
molecular engineering. In parti-
cular, development of methods for 
the assessment of risks resulting 
from the release of genetically 
engineered organisms. 
5. Testing methods 
The development of in vitro 
screening methods for the 
evaluation of the toxicological 
effects and the biological acti-
vity of molecules. 
5. BIOTECHNOLOGY OF 
INDUSTRIAL 
MICROORGANISMS 
(ctd) 
6. BIOTECHNOLOGY OF 
PLANTS & ASSOC. 
MICROORGANISMS (ctd) 
7. BIOTECHNOLOGY OF 
ANIMALS (ctd) 
8. RISK ASSESSMENT 
9. IN VITRO 
TESTING METHODS 
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Table 2 : Feature articles issued during the reporting period 
in each research sector of the BAP programme. 
Research sector 
Bio-informatics 
Culture 
collections 
Bioreactors 
Protein 
engineering 
Biotechn. of 
iudust. microbes 
Biotechn. of 
plants & assoc. 
microorganisms 
Biotechn. of 
animals 
Risks assessment 
In vitro tests 
Number of 
labs 
(1) 
42 
13 
19 
26 
35 
64 
43 
7 
16 
Number of 
articles 
(2) 
ul 
3 
44 
76 
77 
171 
85 
9 
23 
Number of 
articles 
witb trans-
national 
authorship(*) 
3 
2 
2 
7 
8 
19 
6 
0 
0 
(2)/(l) 
in 1988 
1.12 
0.23 
2.32 
2.92 
2.20 
2.67 
1.98 
1.29 
1.44 
(2)/(l) 
in 1987 
0.61 
0.15 
1.27 
1.08 
1.00 
1.27 
0.69 
0.00 
— 
(*) only those impljing the participation of other BAP contractors. 
Table 3 : Feature articles from BAP contractors tabulated 
against project sizes (situation applying to the 
reporting period) 
Project cize 
(Number of 
participating 
laboratories) 
1 
2 
3 
4 
5 
6 
7 
Number of 
labs in the 
category 
(1) 
3 
98 
66 
36 
50 
6 
7 
Nurrber of 
articles 
(2) 
5 
216 
125 
59 
103 
23 
L 
(2)/(l) 
in 1988 
1.67 
2.20 
1.89 
1.64 
2.06 
3.83 
0.57 
(2)/(l) 
in 1987 
0 
0.85 
Ö.90 
0.74 
1.14 
1.83 
Table 4 : List of feature articles in scientific journals to 
which BAP contractors from different countries 
jointly contributed, partly or entirely as a result 
of their cooperation under the Community programme 
(as per 1.7.1988) 
BIO-INFORMATICS 
BAP - 0293 (with sub-Contracts ) : 
Superresolution in Confocal Scanning Microscopy. 
M. Bertero, P. Brianzi, E.R. Pike, Inverse Problems, 3, 195-212, 
1987 
BAP-0293 (with sub-Contractors) : 
An Analytic Inversion Formula for Confocal Scanning Microscopy. 
M. Bertero, C. De Mol, E.R. Pike. JOSA A-4, 1748-1750, 1987 
BAP-0293 (with sub-Contractors) : 
Inverse Problems in Confocal Scanning Microscopy. 
M. Bertero, P. Boccacci, P. Brianzi, E.R. Pike, in Inverse 
Problems : An Interdisciplinary Study (Ed. P.C. Sabatier), 
Advances in Electronics and Electron Physics, Supplement 19^ , 225-
239, (Academic Press, 1987) 
CULTURE COLLECTIONS 
BAP-0002 & BAP-0007 : 
European Resource Centres for Plasmid Bearing Bacterial Strains. 
C. Rohde and V.M. Hugues. REGEM I. (Release of Genetically 
Engineered Microorganisms Conference), 1988 
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BAP-0004, BAP-00Ö5 & BAP-0134 : 
Structuring strain data for storage and retrieval of information 
on fungi and yeasts in MINEr the Microbial Information Network Europe. 
W. Gams, G.L. Hennebert, J.A. Stalkers, D. Janssens, Ti.A.A. 
Schipper, J. Smith, D. Yarrow and D.L. Hawksworth. J. Gen. 
Microbiol.. 1988 
BIO-REACTORS 
BAP-0060 & BAP-0065 : 
Synthesis and application of water-soluble macromolecular redox 
coenzyme derivatives. 
A.F. Buckman and G. Carrea. Adv. Biochem. Eng. Biotechnol., in 
press, 1988 
BAP-0056 & BAP-0055 : 
Improved metabolic properties of hexokinase overloaded human 
erythrocytes. 
M. Magnani, L. Rossi, M. Bianchi, G.' Fornaini, V. Benatti, L. 
Guida, E. Zocchi and A. De Flora. Biochim. Biophys. Acta, in 
press, 1988 
PROTEIN ENGINEERING . "' ' 
BAP-0 52 & BAP-02 4 6 : 
Mechanism of ferritin iron uptake : activity of the H chain and 
deletion mapping of the ferro-oxidase.site. 
S. Levi, A. Luzzago, G. Cesareni, A. Cozzi, F. Franceschinelli, 
A. Albertini and P. Arosio. J. Biol. Chem., in press, 1988 
BAP-0066 & BAP-0058 : 
Properties of a Genetically Engineered G-Domain of Elongation 
Factor Tu. 
A. Parmeggiani, G.W.M. Swart, K.K. Mortensen, M. Jensen, B.F.C. 
Clark, L. Dente and R. Cortese. Proc. Natl. Acad. Sci. USA 84, 
3141-3145, 1988 
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BAP-0066 & BAP-0058 : 
Site-Directed Mutagenesis of Elongation Factor Tu. 
A. Panneggiarli, E; Jacquet, M. Jensen, P.H. Anborgh, R.H. Cool, 
J. Jonak and G.W.M. Swart. In : Metabolism and Enzymology of 
Nucleic Acids Including Gene Manipulations (J. Zelinka & J. 
Balan, eds) p. 175-187, Vol. 6, Slovak Academy of Sciences, 
Bratislava, 1987 
BAP-0066 & BAP-0058 : 
The Polypeptide Chain Elongation Factor Tu i Charaterization of 
Mutants and Protein Engineering. 
A. Parmeggiani, P.H. Anborgh, R.H. Cool, E. Jacquet, M. Jensen, 
F. Gümüsel, G. Parlato and G.W.M. Swart. In : Genetics of 
Translation : New Approaches (M. Bolotin-Fukuhara, & M. Picard, 
eds) p. 259-269, NATO ASI series, 1988 
BAP-0062 & BAP-0071 : 
Phospholipase A2 inhibithors : acylamino-glycero-phosphocholines 
derivatives. 
G.H. de Haas, M.G. van Hoort, R. Dijkman and R. Verger. Biochem. 
J. , in press, 1988 
BAP-0148 & BAP-0149 : 
Secondary structure prediction : combination of three different 
methods. 
V. Biou, J.F. Gibrat, J.M. Levin, B. Robson and J. Gamier. 
Protein Engineering, 2_ (3), in press, 1988 
BAP-0259 & BAP-0269 : 
Hydrogen production and deuteriuitf-proton exchange reactions 
catalyzed by Desulfovibrio Ni(II) substituted rubredoxins. 
P. Saint-Martin, P.A. Lespinat, G. Fauque, Y. Berlier, J. LeGall, 
J.J.F. Moura, M. Teixeira, A.V. Xavier and I. Moura. Proc. Natl. 
Acad. Sci., in press 1988 
BIOTECHNOLOGY OF INDUSTRIAL MICROORGANISMS 
BAP-0061 & BAP-0026 : 
Transformation of the yeast Kluyveromyces lactis by new vectors 
derived from the 1.6 um circular plasmid pKDl. 
M. Bianchi, C. Falcone, X.J. Chen, M. Wesolowski-Louvel, L. 
Frontali and H. Fukuhara. Cur. Gent.. 1987 
19 
BAP-0061 & BAP-0026 : 
A gene cloning system for Kluyveromyces lactis and isolation of a 
chromosomal gene required for killer toxin production. 
X.J. Chen, M. Wesolowski-Louvel, C. Tanguy-Rougeau, H. Fukuhara, 
M.M. Bianchi, L. Fabiani, M. Saliona, C. Falcone and L. Frontali. 
J. Basic. Microbiol., in press, 1988 
BAP-0061 & BAP-0026 : 
New vectors for yeast transformation : replication in different 
yeast genera and stability in non selective media. 
M.M. Bianchi, X.J. Chen, M. Wesolowski-Louvel, H. Fukuhara, C. 
Falcone, L. Fabiani, M. Salióla and L. Frontali. In : 
Physiological and Genetic Modulation of Product Formation. 
Dechema Monographs. Vol. 105-VCH. Verlag Gesellshaft, 1987 
BAP-0 04 4 & BAP-0 04 6 : 
Conjugal gene transfer in Clostridium acetobutylicum. 
A. Davies, J.D. Pennock, D.R. Williams, D.F. Richars, N.P. Minton 
and M. Young. In : Genetics and Biotechnology of Bacilli. 
Academic Press. Orlando, USA, in press, 1988 
BAP-0044 & BAP-0046 : 
Contruction of plasmid vector systems from Clostridium 
acetobutylicum. 
J.K. Brehm, J.D. Oultral, D.E. Thompson, T.J. Swinfield, H. Peck, 
M. Young and N.P. Minton. In : Genetics and Biotechnology of 
Bacilli. Academic Press. Orlando, USA, in press, 1988 
BAP-0008 & BAP-0012 : 
Cloning and characterization of the tetracycline resistance 
determinant of and several promoters from within the conjugative 
transposon Tn919. 
C.J. Hill, G. Venerna, C. Daly and G.F. Fitzgerard. Appi. 
Environ. Microbiol., 1988 
BAP-0152 & BAP-0153 : 
Ethanol production by Zymomonas mobilis entrapped in alumina 
pellets. 
A.A. Koutinas, M. Kanellaki, A. Lykourghiotis, M.A. Typas and C. 
Drainas. Appi. Microbiol. Biotechnol., 19 88 
BAP-0039, BAP-0064 & BAP-0248 : 
Transformation of Aspergillus oryzae using A. niger pyrG gene. 
I.E. Mattern, S.E. Unkles, J.R. Kinghorn, P. Pouwels and 
C.A.M.J.J. van den Hondel. Mol. Gen. Genet., 1988 
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BIOTECHNOLOGY OF PLANTS AND ASSOCIATED MICROORGANISMS 
Recent advances in plant electroporation. 
II. Jones, M.J. Tenpelaar and M.G.K. Jones, Oxford Surveys of 
Molecular and Cell Biology (Ed. B.J. Miflin), OUP, 4, 347-357, 
1987 
BAP-0082 & BAP-0101 : 
Modulation and direction of the electrofusion response in plant 
protoplasts. 
M.J. Tempelaar, A. Duyst, S.J. de Vlas, G. Krol, C. Symmonds, 
M.G.K. Jones, Plant Science, 48, 99-105, 1987 
BAP-0082 & BAP-0101 : 
Electrofusion of nitrate reductase deficient Nicotiana 
plumbaginifolia mutants : studies on optimization and 
complementation. 
S.C. de Vries, E. Jacobsen, M.G.K. Jones, A.E.H.M. Loonen, M.J. 
Tempelaar, J. Wybrandi and W.J. Feenstra, Plant Science, 51, 105-
112, 1987 
BAP-0082 & BAP-0101 : 
Somatic hybridization of amino-acid analogue resistant cell lines 
of potato (Solanum tuberosum L.) by electrofusion. 
S.C. de Vries, E. Jacobsen, M.G.K. Jones, A.E.H.M. Loonen,- M.J. 
Tempelaar, J. Wybrandi and W.J. Feenstra, Theor. Appi. Genet., 
73, 451-458, 1987 
BAP-0084 & BAP-0111 : 
Direct gene transfer in protoplasts of Nicotiana plumbaginifolia. 
F. Sala, M.L. Marchesi, S. Castiglione, J. Paszkowsky, M. Saul, 
I. Potrykus and I. Negrutiu, in : Biotechnology in Agriculture 
and Forestry (Ed. Y.P.S. Bajaj), Springer-Verlag, New York (in 
press) 
BAP-0092 & BAP-0093 : 
Carrot somatic embryogenesis depends on the phytohormone— 
controlled expression of correctly glycosylated extracellular 
proteins. 
S.C. de Vries, H. Booj, R. Janssens, R. Vogels, L. Saris, F. 
LoSchiavo, M. Terzi and A. van Kammen, Genes and Development, 2, 
462-476, 1988 
BAP-0213- & BAP-0214 : 
Molecular cloning of the o2-m5 allele of Zea mays using 
transposon marking. 
M. Motto, M. Maddaloni, G. Ponziani, M. Brembilla, R. Marotta, N. 
Di Fonzo, C. Soave, R. Thompson and F. Salamini, Mol. Gen. Gent., 
212, 488-494, 1988 
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BAP-0213 & BAP-0214 : . • ' . ' 
The b-32 protein from maize endosperm, an albumin regulated by 
the 02 locus : nucleic acid (cDNA) and amino acid sequences. 
N. Di Fonzo, H. Hartings, M. Brembilla, M. Motto, C. Soave, E. 
Navarro, J. Palau, W. Rohde, F. Salamini, Mol. Gen. Genet., 212, 
481-487, 1988 
BAP-0213 & BAP-0214 : 
Maize seed storage proteins : genetic structure and regulation. 
N. Di Fonzo, H. Hartings, M. Maddaloni, L. Manzocchi, 'G. 
Ponziani, J. Palau, F. Salamini, C. Soave, A. Spada, R. Thompson 
and M. Motto, Genet. Agr. (in press). 
BAP-0213 & BAP-0214 : 
Molecular studies of the high-lysine genes Opaque-2 and Opaque-6 
in maize. 
N. Di Fonzo, H. Hartings, M. Maddaloni, L. Manzocchi, G. 
Ponziani, J. Palau, F. Salamini, C. Soave, R. Thompson and M. 
Motto, UCLA Symposium : The molecular basis of plant development. 
Steamboat Springs, Co., 1988 
BAP-0190 & BAP-0212 : 
Characterization'and virulance properties of Erwinia chrysanthemi 
lipopolysaccharide-defective, phiEC2-resistant mutants. 
E. Schoonejans,- D. Expert and A. Toussaint, J. Bacteriol. 169, 
4011-4017, 1987 
BAP-0190 & BAP-0212 : 
Chromosonal mapping of ,' the pel andi cel genes in Erwinia 
chrysanthemi strain B 374.' 
M. Piecq, F. van Gijsegem, E. Schoonjans and A. Toussaint, Molec. 
Microbiol. 2, 297-302, 1988 
BAP-0190 & BAP-0212 : 
Molecular cloning and mutagenesis in Escherichia coli of 
pectinase genes from Erwinia chrysanthemi '. 
A.■• Kotoujansky, A. Diolez,' M. Rouve, F. Van Gijsegem, S. 
Reverchon et al., Proc. 6th Int. Conf. Plant Pathogen. Bact., 
College Park, Maryland, pp. 139-151, Nijhoff/Junk, Dordrecht, 
1987 
BAP-0080 & BAP-0081 : 
Organization and partial sequence of a DNA region of the 
Rhizobium leguminosarum symbiotic plasmid pRL6JI containing the 
genes fix ABC, nifA, nifB and a novel open reading frame. 
P. Grönger, S.S. Massian, H. Reiländer, M. O'Connell, U.B. 
Priefer and A. PÜhler, Nucleic Acids Research, 15, 31-49, 1987 
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BAP-0096 & BAP-0173 : 
Regulation of nodule-specific plant genes. 
E.O. Jensen, J. Stougaard, J.E. Jorgensen, N. Sandal, F.J. de 
Bruijn, J. Schell and K.A. Marcker, Proc. 7th Int. Cong. Nitrogen 
Fixation Cologne, Gustav Fisher, Stuttgart, 605-609, 1988 
BAP-0096 & BAP-0173 : 
Interaction of a nodule-specific trans-acting factor with 
distinct DNA elements in the soybeam leghaemoglobin lbc _ 5*-
upstream region. 
E. 0. Jensen, K.A. Marcker, J. Schell and F.J. de Bruijn, The 
EMBO Journal 7/5, 1265-1271, 1988 
BAP-0095 & BAP-0096 : 
Plastid transformation : a progress report. 
M.J. Cornelissen, M. De Block, M. van Montagu, J. Leemans, P.H. 
Schreier and J. Schell, In : Gene Research-Plant DNA Infections 
Agents (Ed. T. Hohn and J. Schell), pp. 311-320, 1987 
BAP-0202 & BAP-0204 : 
Three-dimensional image and mitochondrial distribution in sperm 
cells of Euphorbia dulcis. 
M. Murgia and H.J. Wilms, In : Plant sperm cells as tools for 
biotechnology (Ed. H.J. Wilms and C.J. Keijzer) Pudoc, 
Wageningen, pp. 75-79, 1988 
BAP-0202 & BAP-0204 : 
Confocal scanning laser microscopy of Galanthus generative cells. 
H.J. Wilms, M. Murgia and E.A. van Spronsen, In : Plant sperm 
cells tools for biotechnology (Ed. H.J. Wilms and C.J. Keijzer) 
Pudoc, Wageningen, pp. 35-39, 1988 
BIOTECHNOLOGY OF ANIMALS 
BAP-0156 & BAP-0114 : 
Analysis of the Structural Polypeptides of a Porcine Group C 
Rotavirus. 
M. Bremont, J. Cohen and M.A. McCrae. Journal of Virology 62, 
21183-2185, 1988 
BAP-0115 & BAP-0116 : 
Cis - and Trans-acting elements responsible for the cell specific 
expression of the human al-antitrypsin gene. 
V. De Simone, G. Ciliberto, E. Hardon, G. Palla, L. Lundberg and 
R. Cortese. EMBO J. 6, 2759-2766, 1987 
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BAP-0115 & BAP-0116 : 
Recombinant Interleukin 6 Regulates the Transcriptional 
Activation of a Set of Human Acute Phase Genes. 
G. Morrone, G. Ciliberto, S. Oliviero, R. Arcone, L. Dente, J. 
Content and R. Cortese. J. Biol. Chem, in press 
BAP-0115 & BAP-0116 : 
The human al-antitrypsin gene is transcribed from two different 
promoters in macrophages and hepatocytes. 
E. Perlino, R. Cortese and G. Ciliberto. EMBO J. 6, 2767-2771, 
1987 
BAP-0123 & BAP-0157 : 
Immunity conferred to mice by anti-LPS monoclonal antibodies in 
murine Brucellosis. 
J.N. Limet, A.M. Plommet, G. Dubray and M. Plommet. Ann. 
Immunol. Inst. Pasteur, 138, 417-424, 1987 
BAP-0131 & BAP-0146 : 
Genetic analysis of the role of toxins and protein A in the 
pathogenosis of Staphylococcus aureus infections. Properties of 
an unexpressed alpha-toxin locus from a clinical isolate. T.J. 
Foster, M. O'Reilly, A.H. Patel, P. Nowlan, J. Bramley, in 
Bacterial Protein Toxins (Ed. F. Fehrenbach), Gustav Fischer, 
Stuttgart, New York, 1988 
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T a b l e 5 : L i s t o f p a t e n t s d e p o s i t e d i n c o n n e c t i o n w i t h t h e BAP 
programme b e f o r e t h e 1 s t J u l y 1 9 8 8 ( w i t h i n b r a c k e t s 
i s t h e name o f t h e p r o j e c t l e a d e r i n v o l v e d , who i s 
n o t n e c e s s a r i l y t h e f i r s t a u t h o r o f t h e p a t e n t ) . 
Sampling of material (M.S. Beck) 
Monofilament sampling (M.S. Beck) 
Res i l i ent s t r i p (M.S. Beck) 
Editeur de séquences biologiques (the ID e d i t o r ) ( J . F . S a l l a n t i n ) 
PDOS:the emulation of DOS for the communication board ( J . F . S a l l a n t i n ) 
PC DRA : the 3D editor (J .F . S a l l a t i n ) 
Tool Box Crim (graphic too l box) (J .F. S a l l a n t i n ) 
GOR I I I , Homologue, Bit pattern, Combine : Programmes ( J . Garn ie r ) 
Process for the production of N subst i tuted NAD, NADP or FAD 
(A.F. Bückmann) 
Procédé de dosage des l i p a s e s (R. Verger) 
Lipases e t e x t r a i t s l i p a s i q u e s , l e u r procédé de p r é p a r a t i o n e t l eu r 
appl icat ion , notamment en thérapeutique (R. Verger) 
Vita l gene and enzyme - two patents (M. Gasson) 
Vecteurs de clonage e t d'expression comportant l e génome du v i r u s de 
l ' érythroblastose av ia ire ou l e génome du v i r u s he lpe r RAV-1 
(V.M. Nigon) 
Inhibiteur de la synthèse protéique, procédé d ' i s o l e m e n t , u t i l i s a t i o n 
e t composition pharmaceutique en contenant (F. St irpe) 
Inmunotoxines, procédé de p r épa ra t i on e t composit ions pharmaceutiques 
en contenant (F. Stirpe) 
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Table 6 : Members of the Advisory Committee for the 
Management and Coordination of the Biotechnology 
Action Programme. 
BELGIQUE - BELGIE 
M. Bienfet 
J. de Brabandère (**) 
A.M. Prieels (+) 
(G. Thiers) 
BUNDESREPUBLIK DEUTSCHLAND 
N. Binder (+) 
H. Klein (*) 
R. Wandel 
(E. Warmuth) 
DANMARK 
P.O. Larsen (+) 
K.A. Marcker (****) 
I. Petersen 
ELLINIKI DIMOKRATIA 
C.E. Sekeris 
A.L. Stavropoulos (+) 
A.S. Tsaftaris (**) 
ESPANA 
A. Albert (**) 
R. Revilla Pedreira (**) 
FRANCE 
P. Douzou (+) 
M. Lelong 
P. Printz (*) 
(G. Pelsy) (+) 
COMMISSION : 
IRELAND 
E.P. Cunningham (+) 
B. Finucane (**)(+) 
B. McSweeney (+) 
J. O'Grady (****) 
J. Ryan (****) 
ITALIA 
A. Albertini 
M. Moretti 
(M. Lener) 
(G. Magni) 
LUXEMBOURG 
F. Arendt 
A. Betz 
NEDERLAND 
H.J. Grande (+) 
B.A. Heide (***) 
. M.C.F, van den Bosch 
R.R. van der Meer (<) 
(E. Veitkamp) 
PORTUGAL 
F..J.A, Carvalho Guerra 
A. Xavier (**) 
UNITED KINGDOM 
R.H. Aram (+) 
D.A. Jonas (+) 
D.G. Lindsay (***) 
A.F. Lott (*) 
(F.P. Woodford) (+) 
(H. Pickles) (****) 
F. Van Hoeck 
D. de Nettancourt 
(**) 
(*) from 1985 
(**) from 1986 
(***) from 1987 
(****) from 1988 
(<) Chairman 
( ) Substitutes 
(+) resigned 
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Table 7 : Members in 1988 of the Biotechnology Working 
Party of IRDAC. 
K. 
R. 
Dr 
G. 
Dr 
D. 
A. 
M. 
Dr 
B. 
R. 
N. 
B. 
M. 
W. 
Baker 
Brown 
. Castell 
Delheye 
. Dornauer 
Gunary 
Herrero 
(* ) 
Hilmer Nielsen 
. Hirsinger 
Jarry 
Jeambourquin 
Kossen 
Le Buanec 
Le Hodey 
Leuchtenberger 
P. 
B. 
G. 
M. 
M. 
K. 
J. 
V. 
E. 
A. 
M. 
R. 
J. 
D. 
Mangold 
McSweeney 
Mignoni 
Miller 
Nomine 
Powell 
P. Raynaud 
Rubio 
Shejbal 
Stavropoulos 
A. van Damme 
R. van der Meer 
E. Veldhuijzen van Zanten 
von Wettstein 
(*) Chairman of the working party 
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Table 8 Commission staff for the implementation of BAP 
DIRECTORATE-GENERAL XII 
SCIENCE, RESEARCH AND DEVELOPMENT 
Director-General : P. Fasella 
COST-SHARED ACTIONS 
(Directorates C, E, F and FUSION) 
Deputy-Director-General : H. Tent 
DIRECTORATE F 
BIOLOGY 
Director : F. van Hoeck 
DIVISION F-2 
BIOTECHNOLOGY 
Head : P. de Nettancourt 
B A P research actions : 1985 - 1989 
Bio-informatics 
Culture 
collections 
Bioreactors 
Protein 
engineering 
Industrial 
microorganisms 
Plants & assoc. 
microorganisms 
Animals 
In vitro testing 
methods 
Risk assessment 
-
P. 
B. 
P. 
A. 
A. 
B. 
I. 
B. 
A. 
A. 
A. 
E. 
P. 
H. 
A. 
P. 
A. 
U. 
I. 
BAP training actions 
All sectors A 
D 
Reiniger 
Nieuwenhuis 
Reiniger 
Aguilar 
Goffeau 
Nieuwenhuis 
Economidis 
Nieuwenhuis 
Goffeau 
Aguilar, 
Goffeau 
Magnien 
Larvor 
Bazin 
Klepsch 
Larvor 
Klepsch 
Bertazzoni, 
Economidis 
(D, (2) 
(1), 
(2) 
(3), 
(4). 
(5) 
f (3) 
(3) 
(6) 
(7) 
(6), 
(7) 
(5) 
: 1985 - 1989 
. Goffeau (3). 
. de Nettancourt(8) 
Future actions 
B R I D G E : 
1990 - 1994 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
until 
from 
until 
until 
from 
until 
from 
from 
31 
01 
31 
15 
16 
31 
01 
01 
.03 
.04 
.12 
.09 
.09 
.07 
.08 
.01 
.87 
.87 
.86 
.87 
.87 
.87 
.87 
.87 
- 28 
ro 
IO 
-Nuci.Acids Res. (24 art.) 
-EMBO Journal (IB art.) 
-Molec.Gen.Genet. (16 art.) 
-Eur.J.Biochem. (14 art.) 
-Plant Sciences (13 art.) 
-J.Bacteriol. (12 art.) 
-Plant Mol.Biol. (11 art.) 
-Appi.Environ.Microbiol. (10 art.) 
-Gene (9 art.) 
-Thear ..Appi .Genet. (8 art.) 
-Current Genet. (8 art.) 
-FEMS Microbiol.Lett. (8 art.) 
-An.N.Y.Acad.Sc. (8 art.) 
-Planta'(6 art.) 
-Proc.Natl.Acad.Sci.USA (6 art.) 
-J.Mol.Biol. (5 art.) 
-359 other articles in 
many different journals 
Fig.l; Frequency distribution of feature articles in major 
scientific „journals during the reporting period 
R i g . 2: F r e q u e n c y d i s t n i o u t i o n . p e n n e s e a n c h s e c t o n . o f l a b o r a t o r i i 
c o m m i t t e d t o o n e o n a n o t h e n -fonm o-f c o o p e n a t i o i 
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(?6 o-f t o t a l n u m b e n ) " 
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J o i n t 
i x p e n i m e n t : 
9 S e c t o n n u m o e n 
1 — B l o — i n - f o n m a t i c s 
2 — C u l t u n e c o l l e c t i o n s 
3 — B i o n e a c t o n s 
-4 — P n o t e i n e n g i n e e n i n g 
5 — B i o t e c h . o f i n d <_i s t . m i c n o o n g . 
6 — B i o t e c h , o-f p l a n t s 
a n d a s s o c i a t e d m i c n o o n g 
"7 — B i o t e c h n o 1 o g y oT a n i m a l : 
B — R i s R a s s e s s m e n t 
9 — I n v i t n o t e s t i n g m e t h o d : 
F"ig.3: S c i e n t i f i c p r o d u c t i v i t y a n d c o o p e r a t i o i 
p r o -f i 1 e s w i t h i n g r o u p s o r c o n t r a c t o n s 
o-f 3 s u c c e s s i v e g e n e n a t i o n s 
1 s t g e n e r a t i o n c o n t r a c t o n s j o i n e d t h e C o m m u n i t y 
p r o g r a m m e s w i t h B E R ( 1 9 B 2 - 1 9 B 6 ) . T h e y l o g i c a l l y 
y i e l d m o r e o u t p u t p r e s e n t l y in B A P a n d D a s e 
c o o p e r a t i o n m o r e o n p r a c t i c a l e x c h a n g e s . 
2 n d / 3 
s u c c e 
p r e f e 
r e s 
r d g e n e r a t i o n c o n t r a c t o r s a r r i v e d w i t h t w o 
s s l v e r o u n d s o f B A P p r o p o s a l s a n d t e n d t o 
r m e e t i n g s d e r o r e i n t e g r a t i n g - f u r t h e r 
» e a r c h w o r k . 
F R E Q U E N C Y (»O P E R 
A V E R A G E C O N T R A C T O R OF: 
P u b i i c a t l o n s [ 
«Joint p u b l i c a t i o n s = □ D 
E x c h a n g e s or s t a r r D D D 
E x c h a n g e s or m a t e r i a l 
.Joint e x p e r i m e n t s D D ü 
« J o i n t m e e t i n g s 
(*e) r o r t h e 
p e r i o d 
r e p o r t i n g 3 2 1 
r d n d s t 
g e n e r a t i o n ¡ 
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C O O R D I N A T I N G A C T I V I T I E S 

Scientific meetings, visits to contracting laboratories, 
publication of reports and surveys have been the three main 
actions on which the coordinating activity by the services of 
the Commission has . been based during the initial implementa-
tion of the Biotechnology Action Programme. 
Meetings were organized on the site of participating 
laboratories on different occasions, to allow the 
constitution or the reinforcement of study groups working on 
a list of priority topics. 
Visits to laboratories were carried, out throughout the 
reporting period, with the aim to facilitate, whenever 
requested, the administrative -. steps of contract 
implementation and to contribute to the establishment of a 
network of individual scientists willing to increase their 
involvement, in cooperative research.. 
Publications in scientific journals constitute the normal and 
most efficient way for the dissemination of results obtained 
in the. 'framework of the programme (see references at the end 
of each individual report presented in Volume 2) ; in 
addition, the services of the Commission initiate, whenever 
useful, surveys of activities and of specific results which 
characterize one' or several research areas in the Community. 
They, also circulate reports or analyses prepared on their 
request by selected contractants to cover activities carried 
out within particular groups. 
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Scientific meetings 
Four sectoral meetings were organized to'bring together all 
contractants, connected with a particular research sector of 
BAP. In addition, 40 meetings were convened upon specific 
requests : in the latter cases, the objectives of the 
meetings were to strengthen transnational cooperation and 
integrate further the work of ELWWs (European Laboratories 
Without Walls), or to provoke cross-fertilization between 
remote contracting groups which considered that the 
confrontation of their scientific ideas and of their 
particular skills would be a mutual benefit. These other 
meetings were convened in smaller configurations, adapted to 
the detailed discussion of very specific needs : they are 
more of the spontaneous type. 
Finally, the Commission services also organized several 
exploratory meetings of experts for the assessment of new 
promising areas of R&D. Sixteen such meetings took placé 
during the reporting period. They included the participation 
of BAP contractors and of scientists outside the programme as 
well as of experts nominated by the CGC Biotechnology and by 
the Commission, and of representatives from industrial 
organizations or learned societies. The. conclusions of these 
brainstorming activities have been reported to the Commission 
and can: be made, available upon' request. . The corresponding 
reports are listed with all publications appearing in the 
last section of this chapter on coordinating activities. 
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SECTORAL MEETINGS 
SALAMANCA, 25-28 October 1987 
55 participants from 10 countries and the Commission. 
Subject : 
Genetic engineering for animal husbandry. 
Local organizer : 
E. Vinuela, Centro de Biologia Molecular (CSIC-UAM), Madrid 
(Spain). 
Dimension and structure : 
34 individual presentations including 3 invited lectures, one 
working group session. 
Objectives : 
First meeting whereby contractants from 34 laboratories working 
under the sector "Genetic engineering for animal husbandry" could 
convene and disseminate their preliminary results. During the 
meeting, there v/as a working session to discuss future programmes 
(BRIDGE). 
BAYREUTH, 26-28 October 1987 
52 participants from 12 countries and the Commission. 
Subject : 
Risk assessment for the release of genetically manipulated 
microorganisms. 
Local organizer : 
Prof. W. Klingmüller, University of Bayreuth (Germany) 
Dimension and structure : 
22 lectures of invited speakers and BAP contractors. 
Objectives : 
First meeting of BAP contractors working in the sector of risk 
assessment. The meeting was open to participants of many other 
European laboratories (including non-EC members) active in the 
same field. Various research approaches were discussed and 
different views were expressed about the important problem of 
safety evaluation in biotechnology. 
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DOURDAN, 25-27 February 1980 
31 participants from 11 countries and the Commission. 
11 industrial representatives from different firms. 
Subject : 
Biotechnology of Gram-positive industrial microorganisms. 
Local organizer : 
S.D. Ehrlich, Institut Jacques Monod, Paris (France). 
Dimension and structure : 
23 oral presentations, one round-table discussion on future 
trends and industrial involvement within the framework of BRIDGE, 
and a presentation by DG XII Commission staff. 
Objectives : 
To encourage groups towards a stronger collaboration in the 
framework of ELWW (European Laboratories Without Walls) and to 
allow opinions and suggestions to be exchanged with industrial 
partners. 
A report' on the round-table is inserted with reports by 
organizers of meetings in the following section. 
BAD IRSEE, 30 March - 1 April 1988 
68 participants from 13 countries, including 3 industrial firms, 
and the Commission. 
Subject : 
In vitro evaluation of the toxicity and pharmacological activity 
of molecules. 
Local organizer : 
T. Krieg, Ludwig-Haximillians-Universität München (Germany) 
Dimension and structure : 
3 invited lectures, 16 oral communications, 17 posters on 
display, one round-table and a working group session. 
Objectives : 
First occasion for 16 contracting laboratories in the sector "In 
vitro evaluation of the toxicity and pharmacological activity of 
molecules" to meet and to discuss research strategies and 
collaboration at the beginning of their contract period. At the 
round-table presentation, the state of the art on reconstruction 
of skin was reviewed. The working group session gave the 
opportunity to discuss future programmes (BRIDGE). 
2. SPONTANEOUS MEETINGS 
Due to the usually informal approach to the organization 
of spontaneous meetings, some have also taken place with 
little information passed to the Commission. The 
description below does not therefore include all events 
having occurred in the framwork of BAP, but only a list of 
well documented examples. 
Many of the well documented spontaneous meetings took place 
in European Laboratories Without Walls (ELWWs). The 
participants in ELWWs usually convened in turn at the site 
of each associated laboratory to review the progress of 
research and to plan future experiments jointly. Depending 
on the number of partners and the type of cooperation 
established between them, spontaneous meetings of ELWWs 
were trimestrial, semestrial or annual. 
In contrast with other spontaneous meetings organized upon 
specific requests justified by their conveners, the 
periodic seminars of ELWWs led, in particular, to written 
up-to-date conclusions on on-going activities. Summaries 
of these conclusions appear in the next section of the 
volume with reports by organizers of meetings. 
Spontaneous meetings are normally supported with travel 
funds raised from the BAP budget. But in the case of 
ELWWs, an extra-support is only provided once for the 
initial integration of work to be promoted. On other 
occasions, meetings of ELWWs are financed from the contract 
money perceived by each participating laboratory. 
39 
BRUSSELS, 14-15 January 1987 
7 participants from 2 countries. 
Subject : 
Spontaneous discussion on cloning in Pseudomonas. 
Local organizer : 
J. Davison, ICP, Brussels (Belgium) 
Dimension and structure : 
Discussion of mutual results and of the work of a visiting 
scientist from Groningen. Institute seminar by M. Kok. 
Objectives : 
Development of mutual interests and ideas. Exchange of materials 
and techniques. 
PARIS, 7-9 February 1987 
14 participants from 3 countries. 
Subject : 
Analysis of replication and stability functions of plasmids in B. 
subtilis. 
Local organizer : 
S.D. Ehrlich, Université Paris-VII (France) 
Dimension and structure : 
Presentations by the two collaborating groups and common 
discussions including the invited speakers. 
Objectives : 
Discussing the joint research programme. 
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BAARN, 19 May 1987 
BRÜSSELS, 11 June 1987 
KEW, 21 September 1987 
BRAUNSCHWEIG, 25 January 1988 
KEW, 30 April 1988 
Common subject : 
Implementation of MINE. 
Local organizers : 
The meetings were locally organised respectively by M.A.A. 
Schipper ; J. de Brabandere ; D.L. Hawksworth ; D. Claus and D.L. 
Hawksworth. 
Dimension and structure : 
All the MINE general meetings, except the one on 30 April 1988, 
were attended by 3-5 scientists from each node of MINE. 
Representatives from the Working Party on Culture Collections 
attended the meetings in Brussels, Kew (September) and 
Braunschweig. Representatives from culture collections from 
Canada, Sweden and Israel participated in some of the meetings. 
Objectives : 
Development and implementation of the MINE project. In addition 
to the general MINE meetings, a number of specialised meetings 
took place : 
Computer expert meetings 
BAARN, 21 May 1987 (NL) 
KEW, 3 August 19 87 (UK) 
Format meetings : 
5 (2 for bacteria and 3 for fungi/yeast). 
MINE-MiCIS-CEC meeting : 22 September 1987, London. 
Computer expert meeting : (MINE, MiCIS, MSDN, CEC) December 10, 
1987, Brussels (Belgium). 
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ORSAY, 7 - 1 2 July 1987 
17 participants from 4 countries. 
Subject : 
EC-CECAM Workshop on Force-fields for computer simulations on 
macromolecules. 
Local organizer : 
S. Wodak, ULB, Brussels (Belgium) 
Dimension and structure : 
Oral presentations, round-table discussions, benchmark 
calculations. 
Objectives : 
A collaborative effort between European and US scientists for 
improving force-fields, to standardise simulation procedures and 
to discuss recent developments. 
VAALS, 15 - 17 July 1987 
10 participants from 4 countries. 
Subject : 
Computer modelling and control of bioreactors and fermentors. 
Local organizer : 
Dr. J. Thio, DSM/Stamicarbon (The Netherlands) 
Dimension and structure : 
Opening lecture on the activities of DSM in biotechnology. 
Presentations by the four project leaders and discussions. 
Demonstration of GIDS (Graphic Interactive Dynamic Simulation) a 
computer based simulation system. 
Objectives : 
Review of the progress made by each group, discussion on the 
necessary relationships with industry, establishment of future 
plans. 
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TUTZING, 22 July 1987 
18 participants from 2 countries. 
Subject : 
Folding, assembly, stability and genetic modification of 
penicillin acylase and its precursors. 
Local organizer : 
G. Schumacher, Boehringer Mannheim, Tutzing (D) 
Dimension and structure : 
Working group session.' 
Objectives : 
Discussion on research progress, organization of the 
collaborative programme of the four laboratories, planning of 
future research. 
GHENT, 24 August 1987 
4 participants from 2 countries. 
Subject : 
Transformation of fungi. 
Local organizer : 
W. Fiers, L.M.B. Ghent (Belgium) 
Dimension and structure : 
Presentation of results obtained so far by each laboratory and a 
general discussion. 
Objectives : 
Coordination of the research efforts, and development of 
protocols for efficient transformation in A_^  niger and A. 
oryzae. Delineation of priorities in both laboratories. 
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ROMA, 15-16 September 1987 
15 participants from 4 countries. 
Subject : 
Hairy root and plant cell differentiation. 
Local organizer : 
P. Costantino, University of Roma "La Sapienza" (Italy) 
Dimension and structure : 
First day : presentations by each participating group of the 
latest achievements in the field ; 
Second day : discussions on the prospects of hairy root research 
and definition of collaborations. 
Objectives : 
Setting up of a new ELWW, partly anchored in the BAP programme 
and including contributors from other non-contracting 
institutions. 
NORWICH, 18 September 1987 
15 participants from 5 countries. 
Subject : 
Mitochondrial molecular genetics in relation to crop improvement. 
Local organizer : 
D.R. Davies, John Innes Institute, Norwich (united Kingdom) 
Dimension and structure : 
Three sessions of oral presentations by the participating groups 
on structure/function of the mitochondrial genome, mitochondrial 
transformation and organelle transfer. 
Objectives : 
Enlargement of the ELWW, initially with 5 partners, to 2 new 
laboratories with expertise in the development of transformation 
vectors. Activation of transnational exchanges. 
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GHENT, 25-29 September 1987 
4 participants from 2 countries. 
Subject : 
Regulatory elements for heterologous gene expression. 
Local organizer : 
W. Fiers, L.M.B. Ghent (Belgium) 
Dimension and structure : 
Round-table discussions. 
Objectives : 
Coordination of research in both laboratories. Discuss the 
participation of Dr. Unkles and Dr. Campbell in Ghent to sequence 
the Nia-regulatory (promoter) region. 
DUBLIN. 15-16 October 1987 
11 participants from 4 countries. 
Subject : 
Symbiotic genes in Rhizobium : construction of improved strains. 
Local organizer : 
M. O'Connell, NIHE, Dublin (Ireland) 
Dimension and structure : 
Small-scale working seminar of those scientists working on the 
project. Presentations from the 4 participating groups followed 
by an extensive round-table discussion. 
Objectives : 
Second periodic meeting of the ELWW. New cooperation agreements 
established, and industrial contacts explored. 
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ORSAY, 19-23 October 1987 
2 5 participants from 6 countries. 
Subject : 
EC-CECAM Workshop on Electrostatics in recognition processes 
between biological macromolecules. 
Local organizer : 
E. Westhof, IMBC-CNRS, Strasbourg (France). 
Dimension and structure : 
Oral presentations, round-table discussions, informal exchange. 
Objectives : 
A collaborative effort of European and US scientists to describe 
new methods for the calculation of the electrostatic field around 
proteins and to discuss new approaches in this area. 
SALAMANCA, 1-5 November 1987 
104 participants from 13 countries and the services of the 
Commission. 
Subject : 
African Swine Fever and pig immunology. 
Local organizer : 
E. Vinuela, Centro de Biologia Molecular (CSIC-UAM), Madrid 
(Spain) 
Dimension and structure : 
8 sessions with 38 communications, 70 posters and 1 panel 
discussion. 
Objectives : 
Meeting on pig immunology with emphasis on African Swine Fever 
reviewing the current research efforts and discussing future 
research activities. 
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COPENHAGEN, 5 November 1987 
7 participants from 3 countries. 
Subject : 
Embryogenesis in plant tissue culture. 
Local organizer : 
P. Olesen, De Danske Sukkerfabrikker, Copenhagen (Denmark) 
Dimension and structure : 
5 oral presentations and discussion. 
Objectives : 
Bringing together 4 research contracts that were initially 
negotiated in isolation and could be cross-fertilizing. 
HAREN, 6-7 November 1987 
19 scientists from 6 countries. 
Subject : 
Crop improvement through cell biotechnology. 
Local organizer : 
M.J. Tempelaar, University of Groningen (The Netherlands) 
Dimension and structure : 
11 oral presentations, with repeated discussion times. 
Objectives : 
Enlargement of the ELWW (originally with 6 participating 
laboratories) to 2 new groups contributing work on cereals more 
particularly. 
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VILLEURBANNE. 12-13 November 1987 
2 participants from the Belgian laboratory and all French 
research staff. 
Subject : 
Molecular biology of plant pathogenic and plant beneficial 
bacteria. 
Local organizer : 
J.M. Robert-Baudouy, INSA, Villeurbanne (France). 
Dimension and structure : 
Working group sessions, plus Institute seminars by F. Brunei and 
J. Davison. Development of mutual interests and ideas of possible 
future collaboration. Exchanges of materials and techniques, 
discussions. 
Objectives : 
Discussion on the molecular mechanisms of plant pathogenesis and 
on the antagonism between phytopathogens and plant beneficial 
bacteria. 
DUBLIN, 14-17 November 1987 
10 participants from 2 countries. 
Subject : 
Replication functions of B^ subtilis plasmids. 
Local organizer : 
K. Devine and D. McConnell, Trinity College, Dublin (Ireland) 
Dimension and structure : 
Presentations by the two collaborating groups and common 
discussions. 
Objectives : 
Discussion on research progress, planning of future research. 
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MANCHESTER, 28 November - 2 December 1987 
12 participants from 2 countries. 
Subject : 
Automation in DNA sequencing. 
Local organizer : 
J.W Martin, UMIST, Manchester (United Kingdom) 
Dimension and structure : 
Working group session. 
Objectives : 
Discussions on research progress, coordination of activities of 
the four centres involved. 
LONDON, 13 December 1987 
2 participants from 2 countries. 
Subject : 
Genetic regulation of yeast glycolysis 
Local organizer : 
B.S. Hartley, Imperial College, London (United Kingdom) 
Dimension and structure : 
Working sessions. 
Objectives : 
Review of progress and strategy for joint project. 
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MONTPELLIER, 28-29 January 1988 
14 participants from 7 countries. 
Subject : 
Expression of cereal seed protein genes. 
Local organizer : 
P. Joudrier, INRA, Montpellier (France) 
Dimension and structure : 
12 oral presentations to cover planned activities of contributing 
laboratories, 10 reports on achievements in 4 major cereals, 
followed by a general discussion to assess needs and 
opportunities for closer work integration in Europe. 
Objectives : 
The launching of a ELWW on the molecular biology of seed 
proteins. 
LYON, 1-2 February 1988 
17 participants from 3 countries. 
Subject : 
Pollen biotechnology. 
Local organizer : 
C. Dumas, CNRS/University of Lyon (France) 
Dimension and structure : 
Review of data produced in 1987 (10 presentations), planning of 
scientific exchanges six months ahead. 
Objectives : 
To activate further the life of this ELWW, newly established in 
BAP. 
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RHENEN, 28 February - 1 March 1988 
16 participants from 4 countries and the services of the 
Commission. 
Subject : 
Genetic engineering of foot-and-mouth disease virus antigen. 
Dimension and structure : 
21 short communications with discussion. 
Objectives : 
Discussion of different research strategies and organisation of 
collaboration between the different groups. 
COPENHAGEN, 24-25 March 1988 
22 participants from 8 countries, including 2 industrial firms. 
Subject : 
Fundamental aspects of plant cell regeneration. 
Local organizers : 
S. de Vries, The Agricultural University, Wageningen (The 
Netherlands) 
P. Olesen, De Danske Sukkerfabrikker, Copenhagen (Denmark) 
Dimension and structure : 
8 scientific reports, a round-table discussion, a concluding 
session with the view of industry and future-oriented talks. 
Objectives : 
To set up a new ELWW on plant cell regeneration, where industry 
expects more coordinated work. To identify gaps in basic 
knowledge which should be addressed in priority. 
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LONDON, 24-25 March 1988 
8 participants from 2 countries. 
Subject : 
Electrophoresis of proteins : data capture, analysis and 
construction of databanks. 
Local organizer : 
L.R. Hill, NCTC, London (United Kingdom) 
Dimension and structure : 
Working group session. 
Objectives : 
Discussion on research progress, organization of the 
collaborative programme of the four laboratories, planning of 
future research. 
ATHENS, 25-26 March 1988 
9 participants from 3 countries. 
Subject : 
Bioconversion of hydrophilic and hydrophobic compounds by enzyme 
systems. 
Local organizer : 
Dr. F. Kolisis, The National Hellenic Research Foundation, Athens 
(Greece) 
Dimension and structure : 
Progress reports and discussions by the three collaborating 
groups. 
Objectives : 
Organization of collaborative work and common assessments on 
opportunities for an enlargement of this area of activity. 
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BAD HONNEF, 11-14 April 1988 
33 participants from 4 countries, including 2 industrial firms. 
Subject : 
Plant hormone receptors. 
Local organizer : 
D. Klämbt, University of Bonn (D) 
Dimension and structure : 
Oral presentations from all 5 groups in the same ELWW and from a 
guest scientist. Discussion with all contributors and the 
industrial representatives. 
Objectives : 
To review progress at cloning genes for plant hormone receptors. 
To rationalize cooperation during the coming year. This was the 
first meeting of a newly created ELWW. 
COVENTRY, 14-16 April 1988 
27 participants from 3 countries, including 2 industrial 
representatives. 
Subject : 
Molecular biology of phytopathogenic Erwiniae. 
Local organizer : 
G.P.C Salmond, University of Warwick (United Kingdom). 
Dimension and structure : 
Nineteen oral presentations falling under the areas of plant 
pathogenesis, protein targetting and industrial production. 
Detailed discussions on further collaborations. 
Objectives : 
Semestrial meeting for the 5 participating groups in this ELWW. 
Exchange of materials, joint assessment of data. Definition of a 
common strategy to organize the involvement of interested 
companies. 
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BRUSSELS, 19 - 20 May 1988 
18 participants from 6 countries and the services of the 
Commission. 
Subject : 
Mammalian minichromosomes and linear vectors. 
Local organizer : 
J. Rommelaere, Université? Libre de Bruxelles (Belgium) 
Dimension and structure : 
1 invited lecture, oral presentations by all participating 
groups, workshop and a site visit at Solvay. 
Objectives : 
To share expertise and material from different model systems and 
to discuss future cooperation. 
SIENA, 27 - 28 May 1988 
2 2 participants from 6 countries, including 4 industrial firms. 
Subject : 
Pollen biotechnology. 
Local organizer : 
M. Cresti, University of Siena (I) 
Dimension and structure : 
6 oral presentations to cover the work of 3 laboratories in the 
same ELWW and of 2 guest scientists. A poster session and a final 
discussion have been foreseen as well. 
Objectives : 
Planning of future work, with the possible participation of 
Spanish and Portuguese laboratories and in the light of 
industrial needs. This was the fourth meeting of the ELWW. 
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ERICE, 29 May - 7 June 1988 
3 Greek, 2 Portuguese and 1 Spanish scientists sponsored by BAP. 
Subject : 
Crystallography of molecular biology. 
Local organizer : 
W. Hoi, University of Groningen (The Netherlands). 
Dimension and structure : 
Lectures, poster sessions, round-table discussions. 
Objectives : 
A course for young scientists from all over the world (total 
number of participants being 210 from 36 countries) to acquire 
knowledge in this area. Financial contribution from the 
Commission was furthermore for travel expenses of some of the 
speakers. 
HEIDELBERG, 30 May 1988 
4 participants from 2 countries. 
Subject : 
G-binding proteins in neuro-endocriñe cells 
Local organizer : 
P. Gierschik, University of Heidelberg (D) 
Dimension and structure : 
Working group session. 
Objective : 
G-binding proteins recently became of interest in processing 
neurotransmitter signals. The antibodies available in Heidelberg 
are of great interest for studies carried out in Paris. Exchange 
of material and collaboration between the groups were discussed. 
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NANCY, 30-31 May 1988 
2 4 participants from 2 countries. 
Subject : 
Biochemical-physical, knowledge, control, optimization of animal 
cell cultures in bioreactors. 
Local organizer : 
J.M. Engasser, Institut National Polytechnique de Lorraine 
(France). 
Dimension and structure : 
10 scientific presentations with discussions. 
Objectives : 
To review and discuss recent results of the different groups and 
to coordinate future activities. 
CAMOGLI, 2 - 4 June 1988 
2 8 participants from 7 countries. 
Subject : 
Crop improvement through cell biotechnology. 
Local organizer : 
F. Sala, University of Pavia (Italy) 
Dimension and structure : 
17 oral presentations to review the contributions of all eight 
associated laboratories, including one presentation from a 
Spanish guest. General discussion on the present state of 
cooperation, and on prospects created by the future BRIDGE 
programme proposal. 
Objectives : 
Periodic (semestrial) assessment of progress within this ELWW, 
which held here its 4th meeting from the time BAP started. 
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GRENOBLE, 6 - 7 June 1988 
10 participants from 3 countries. 
Subject : 
Advanced monitoring and computer control of biotechnological 
processes. 
Local organizer : 
Prof. A. Cheruy, Ecole Nationale Supérieure d'Ingénieurs 
Electriciens de Grenoble (France). 
Dimension and structure : 
Progress reports and discussions by the four collaborating 
groups. 
Objectives : 
Organization of collaborative work and coordinative planning for 
the Bioreactors-Biotransformations meeting in Athens on 18-21 
October 1988. 
PARIS, 17-18 June 1988 
22 participants from 7 countries, including representatives from 
3 industrial firms, and the services of the Commission. 
Subject : 
Cellular neuro-immunology. 
Local organizer : 
C. Kordon, INSERM, Paris (France) 
Dimension and structure : 
5 workshop sessions. 
Objectives : 
Information about material and know-how that can be exchanged and 
used by laboratories following different research strategies. 
Discussions on future collaborations between research groups, and 
relations with industry. 
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GRONINGEN, 30 June 1988 
4 participants from 2 countries. 
Subject : 
Progress on gene cloning in Pseudomonas. 
Local Organizer : 
B. Witholt, Groningen Biotechnology Centre (The Netherlands). 
Dimension and structure : 
Working discussions. 
Objectives : 
Discussions on past progress, future ventures, joint 
publications, possible future ELWW meeting. Views on homologies 
and computer modelling of ferredoxins. 
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Visits to contracting laboratories and affiliated firms 
Personal contacts of CEC staff with project leaders and their co-
workers can favour the construction of a European scientific 
network based primarily on the quality of human relationships. 
The direct connections established in this way also prove 
beneficial to the management planning of the entire programme. 
The visits facilitate monitoring of the administrative steps 
necessary for the correct implementation of the contracts, as 
well as discussions of the latest results of the research 
activities. They also provide a unique opportunity for 
contractants to influence later developments of Community R&D 
programmes by their personal feelings and suggestions. They 
constitute a major information feedback for the overall 
coordination activity. 
By June 1988, 98 contracting laboratories had been visited by CEC 
staff. Each of these visits gave rise to the preparation of a 
standard itemized report, used by Commission services for their 
evaluations. These reports were not circulated outside the 
Commission ; they contain confidential information which can only 
be exploited in the framework of the Division of Biotechnology. 
Indeed, the visits are exclusively meant to serve two specific 
purposes : 
to facilitate the participation of contractants in the on-
going programme, 
to sustain new developments in biotechnology R&D which serve 
the interest of the Community. 
The list of items covered by each report from a site-visit is 
detailed below : 
Personal contacts, expertise covered ; 
Insertion of the laboratory in the local academic environment; 
Facilities and special equipment available in the laboratory ; 
Precise stage of the research programme reached at the time of 
the visit ; 
Existence of an important obstacle to research progress (if 
applicable) ; 
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Important and recent breakthroughs claimed by the laboratory 
(if applicable) ; 
List of publications issued during the preceding year ; 
Pending questions related to the administrative and financial 
management of the contract ; 
Tendency to diverge from the conditions foreseen by the 
contract (if applicable) ; 
Suggestions by the contractant (prospective studies, possible 
meetings, evolution of the content and the implementation 
methods of the Community programme) ; 
Industrial interest and type of relationships established with 
industrial firms. 
An essential outcome of the programme of visits has been an 
increase in mutual knowledge throughout the Community : 
contractants become more closely acquainted with activities and 
operational mechanisms at Community level ; Commission staff has 
more direct insight into European science and cooperation 
prospects ; contractants may be invited to explore other contacts 
in Europe for any reason that would emerge from the detailed 
discussions between scientists and the programme manager. 
More recently, Commission services strongly responded to their 
commitment to sustain a proper information flow from and to 
industrial firms with an interest in the programme. Apart from 
regular invitations to affiliated firms to attend contractors 
meetings, Commission staff made themselves as much as possible 
available to informal meetings between industrial representatives 
and the services of the Commission. On these occasions, 
discussions are held on factors which determine the support of 
the firms to the Community projects, the prospects for 
exploitation of the results of the programme are envisaged, and 
more prospective thinking is developed with regard to the future 
trends of European cooperation in biotechnology R&D. Meetings of 
this kind have already taken place with 30 different companies 
and more will be planned. 
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Publications and reports 
Next to 535 scientific articles and 16 patents published by 
contractants themselves (see volumes 2-3-4 of this progress 
report), the services of the Commission produced informative 
materials describing BAP structure and activities, initiated 
reviews covering entire sectors of the Biotechnology Action 
Programme, entrusted experts with the task of reporting on 
specific scientific events. 
The list of these reports and publications issued before July 
1988 is provided below. 
MOLECULAR BIOLOGY AND CROP IMPROVEMENT : A CASE STUDY OF 
WHEAT, OILSEED RAPE AND FABA BEANS. R.B. Austin. 
With R.B. Flavell, I.E. Henson, H.J.B. Lowe, Cambridge 
University Press for the CEC, 114 p., 1986 
BIOMOLECULAR ENGINEERING IN THE EUROPEAN COMMUNITY. 
Achievements of the Research Programme (1982-1986). 
Final Report. Ed. E. Magnien. 
Martinus Nijhoff published for the Commission of the European 
Communities. 1172 p., 1986 
ALTERNATIVE USES FOR AGRICULTURAL SURPLUSES. Eds. W.F. Ragman 
and P. Larvor. 
Elsevier Applied Science. CEC, 134 p., 1986 
BIOTECHNOLOGIES COMMUNAUTAIRES. Un programme chasse l'autre. 
D. de Nettancourt. 
Biofutur, 45: 3-4, 1986 
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SECTORAL CONTRACTANT MEETING. 
Risks assessment in biotechnology. U. Bertazzoni, Brussels, 
IS March 1986. 
DG XII. CEC, 19 86 
TRAINING ACTIVITIES IMPLEMENTED IN THE FRAMEWORK OF THE 
BIOMOLECULAR ENGINEERING PROGRAMME. FACTS AND STATISTICS. 
DG XII/F/2, CEC, 1986 
EC-BIOTECHNOLOGY : A EUROPEAN CHALLENGE. 
R. van der Meer. 
Trends in Biotechnology. 4 : 277-279, 1986 
DOSSIER 1986. 
Biotechnologie: la carta europea. L'apporto della CEE. 
Direzione Generale Informazione, Communicazione, Cultura, CEC, 
15 p., 1986 
THE EUROPEAN COMMUNITY OF RESEARCH AND TECHNOLOGY. BEP-BAP. 
BIOTECHNOLOGY. 
DG XII. CEC, 16 p., 1986 
IMPULSE TO EUROPEAN COOPERATIVE RESEARCH IN THE FIELD OF 
AGRICULTURAL MICROORGANISMS : INTERACTIVE PROGRAMME FOR 
INTERACTIVE MICROBES. 
E. Magnien. 
Symbiosis, 2 : 265-274, 1986 
Idem : Chimica oggi, Gennaio-Febbraio 1987, 69-72 
LIST OF RESEARCH CONTRACTS IN THE BIOTECHNOLOGY ACTION 
PROGRAMME (1985-1989). 
DG XII/F/2. XII/62/87-EN, 89 p., 1987 
BOOK OF ABSTRACTS. 
Culture collections and genetic engineering of microorganisms. 
Sectoral meeting of contractors. Ioannina, 23-25 April 1987. 
DG XII. CEC, 133 p., 1987 
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BOOK OF ABSTRACTS. 
Genetic and cellular engineering of plants and microorganisms 
important for agriculture. 
Sectoral meeting of contractors. Louvain-la-Neuve, 23-26 March 
1987. 
DG XII. CEC, 228 p., 1987 
BOOK OF ABSTRACTS. 
Enzyme engineering : protein design and applications in 
biocatalysis. Sectoral meeting of contractors. Capri, 
2-6 May 1987 
DG XII. CEC, 135 p., 1987 
BOOK OF ABSTRACTS. 
Novel methodology for animal cell cultures. 
Sectoral meeting of contractors. Seillac, 25-27 May 1987. 
DG XII. CEC, 8 6 p., 19 87 
BOOK OF ABSTRACTS. 
Genetic engineering for animal husbandry. 
Sectoral meeting of contractors. Salamanca, 
26-27 October 1987. 
DG XII, CEC, 1987 (in preparation) 
PLANT BIOTECHNOLOGY AND COMMUNITY DEVELOPMENT. 
E. Magnien 
Proceedings of the NATO A.S.I, on Plant Cell Biotechnology 
M.S. Pais Ed., Albufeira 30 March - 10 April 1987 (in press) 
L'EUROPE DES BIOTECHNOLOGüES EXISTE : JE L'AI RENCONTREE. 
E. Magnien. 
Biofutur 59, p. 24-26, juillet 1987 
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IN VITRO CULTURE OF STRAWBERRY PLANTS. 
Proceedings of a workshop organized in the framework of action 
COST 87 in Brussels, 18-19 December 1984. 
EUR 10871, 100 p., 1987 
COMMUNITY RESEARCH IN BIOTECHNOLOGY : TOWARDS A STRONGER 
INVOLVEMENT OF INDUSTRIES. 
D. de Nettancourt. 
DG XII, CEC, 4 p., 1986 
RESEARCH AND TRAINING ACTIVITIES OF THE EUROPEAN COMMUNITIES 
IN BIOTECHNOLOGY. 
D. de Nettancourt. 
Proceedings of the meeting of the Belgian Chemical Society : 
"Genetic engineering in Belgium, research and perspective of 
industrial applications", Brussels, 20 February 1987 (in 
press) 
THE EUROPEANIZATION OF BIOTECHNOLOGY R & D AND THE 
MEDITERRANEAN DIMENSION : COMMON INTERESTS, COMMON DESTINY. 
E. Magnien 
Proceedings of the International Conference on Biotechnology 
and Agriculture in the Mediterrean basin. 
G. Tzotzos and A. Saint-Remy Eds. 
Athens 26-28 June 1986 (in press, 1987) 
ELWWs : 'LABORATORI APERTI' PER L'AGRICOLTURA E L'INDUSTRIA 
NEL CAMPO DELLE BIOTECNICHE. 
E. Magnien e D. de Nettancourt 
Biotec 4/87, p. 50-53, 1987 
ACTIVITIES OF THE EUROPEAN COMMUNITIES IN THE AREA OF BIO-
INFORMACTICS. 
B. Nieuwenhuis, Proceedings of the Royal Irish Academy 
(section B), in press 
REPORT ON BAP SECTORAL MEETING IN CAPRI. 
A.R. Rees, Protein engineering 1 (4), 271-274, 1987 
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BOOK OF ABSTRACTS. 
Extrcmophiles. 
Horizontal meeting of BAP contractors. London, 2 December 
1987. 
DG XII. CEC, 18 p., 1987 
A BRIDGE PROJECT IN STREPTOMYCES MOLECULAR BIOLOGY ? 
Report of an expert meeting to the Commission. 
DG XII, CEC, 4 p., 1987 
THE USE OF RFLPs FOR BASIC RESEARCH AND PLANT BREEDING. 
Report of an expert meeting to the Commission. 
DG XII, CEC, 7 p., 1987 
MANIPULATION OF CORE PROCESSES IN PLANT BREEDING. 
Report of an expert meeting to the Commission. 
DG XII, CEC, 11 p., 19 87 
EUROPEAN LABORATORIES WITHOUT WALLS : FOCUSED PRECOMPETITIVE 
RESEARCH. 
R. van der Meer, E. Magnien and D. de Nettancourt. 
Trends in Biotechnology, 5 : 318-321, 1987 
EUROPEAN LABORATORY WITHOUT WALLS IN THE FIELD OF CROP 
IMPROVEMENT THROUGH CELL BIOTECHNOLOGY. 
E. Magnien 
DG XII. CEC, 8 p., 1987 
IRDAC OPINION ON FUTURE RfiD PROGRAMMES IN THE FIELD OF 
BIOTECHNOLOGY. 
DG XII. CEC, 16 p., 19 87 
THE APPROACH OF THE BIOTECHNOLOGY INDUSTRY TO BRIDGE. 
European Biotechnology Co-ordination Group, 
c/o CEFIC, Brussels, 5 p., 1987 
BIO-INFORMATICS IN EUROPE. 
CEFIC position paper, Brussels, 14 p., 1987 
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SAFETY EVALUATION THROUGH RISK ASSESSMENT IN BIOTECHNOLOGY. 
European Biotechnology Co-ordination Group, 
c/o CEFIC, Brussels, 9 p., 1987 
RISK ASSESSMENT. 
Brainstorming group report to the CGC Biotechnology. 
DG XII. CEC, 6 p., 1988 
BIOREACTORS AND BIOTRANSFORMATION. 
Brainstorming group report to the CGC Biotechnology. 
DG XII. CEC, 9 p., 1988 
PROTEIN ENGINEERING. 
Brainstorming group report to the CGC Biotechnology. 
DG XII. CEC, 4 p., 1988 
CULTURE COLLECTIONS, DATABANKS, MEGASEQUENCING AND 
BIOINFORMATICS. 
Brainstorming group report to the CGC Biotechnology. 
DG XII. CEC, 4 p., 1988 
PHYSIOLOGY AND MOLECULAR GENETICS OF INDUSTRIAL 
MICROORGANISMS. 
Brainstorming group report to the CGC Biotechnology. 
DG XII. CEC, 6 p., 1988 
BIOTECHNOLOGY OF CROP SPECIES AND ASSOCIATED ORGANISMS. 
Brainstorming group report to the CGC Biotechnology. 
DG XII. CEC, 5 p., 1988. 
BIOPROCESSING OF AGRICULTURAL PRODUCTS FOR INDUSTRIAL 
EXPLOITATION/DOWNSTREAM PROCESSING. 
Brainstorming group report to the CGC Biotechnology. 
DG XII, CEC, 3 p., 1988 
IN VITRO TESTING METHODS. 
Brainstorming group report to the CGC Biotechnology. 
DG XII. CEC, 5 p., 1988 
G6 
ANIMAL PRODUCTION AND HEALTH CARE. 
Brainstorming group report to the CGC Biotechnology. 
DG XII. CEC, 4 p., 1988 
RESEARCH AVENUES FOR BRIDGE. 
Brainstorming group report to the CGC Biotechnology. 
DG XII. CEC, 3 p., 1988 
BOOK OF ABSTRACTS. 
Biotechnology of Gram-positive industrial microorganisms. 
Sectoral meeting of contractors. Dourdan, 26-27 February 1988. 
DG XII, CEC, 43 p., 1988 
BOOK OF ABSTRACTS. 
Microbiology of traditionally fermented foods in the 
Mediterranean countries. 
ELWW meeting. 
DG XII. .CEC, 28 p., 1988 
BOOK OF ABSTRACTS. 
Plant molecular pathology. 
ELWW meeting. 
DG XII. CEC, 45p., 1988 
CONTROL OF DIFFERENTIATION AND MORPHOGENESIS IN PLANTS. 
Report of an expert meeting to the Commission. 
DG XII. CEC, 16 p., 1988 
LA STRADA DELLA RICERCA PER UNA VALUTAZIONE RAZIONALE DEL 
RISCHIO. 
U. Bertazzoni. 
Biotec, 1/88, 18-19, 1988 
LE PROTEINE DEL SEME DEI CEREALI; 
M. Motto 
Biotec, 2/88, 25-27, 1988 
LA RESISTENZA AI PATOGENI. 
M. Buiatti. 
Biotec, 4/88, 36-38, 1988 
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IL MIGLIORAMENTO DEI RACCOLTI. 
M. Racchi. 
Biotec, 4/88, 39-40, 1988 
LABORATOIRES EUROPEENS SANS MURS : UNE RECHERCHE 
PRECOMPETITIVE CIBLEE. 
R. van der Meer, E. Magnien and D. de Nettancourt. 
Biofutur, 70, 53-56, 1988 
EUROPESE LABORATORIA ZONDER MUREN. 
B. Nieuwenhuis. 
Biotechnologie in Nederland, 1988/1, 13-16, 1988 
PLANT BIOTECHNOLOGY RHYMES WITH EUROPE. 
E. Magnien. 
Plants Today, 1988 (in press) 
VERS DES PROTEINES SUR MESURE. 
A. Sari. 
Science & Technologie, NO 4 - avril 1988, 40-50, 1988 
OPINION AND RECOMMENDATIONS OF GIBiP ON THE PRIORITIES, 
GENERAL LINES AND TRENDS IN THE BRIDGE-PROGRAMME OF THE 
COMMISSION OF THE EC. 
Green Industry Biotechnology Platform. 
c/o HOM business & venture development, Den Haag, 3 p., 1988 
THE FUTURE FOR ANIMAL CELL BIOTECHNOLOGY. 
R. Spier. 
Report of the Symposium at the opening of the Wolfson 
Cytotechnology Laboratory, 19-20 May 1988. 
DG XII. CEC, 5 p., 1988 
BIOTECHNOLOGY ACTION PROGRAMME : AUTOPSY OF A CALL FOR 
PROPOSALS. 
D. de Nettancourt and M. Mongini. 
DG XII. CEC, 23 p.. 1988 
EVALUATION OF THE BIOMOLECULAR ENGINEERING PROGRAMME, BEP 
(1981-85), AND OF THE BIOTECHNOLOGY ACTION PROGRAMME, BAP 
(1985-89). 
DG XII. CEC, 15 p. and annexes, 1988 
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FORCE-FIELDS FOR COMPUTER SIMULATIONS ON MACROMOLECULES 
Short report on the CECAM-EC workshop held in July 1987 
and 
proposal for a follow-up workshop in 1988 
April 14, 1988 
Shoshana Wodak 
With the increasing use of molecular modelling in the fields 
of drug design and protein engineering, the issue of developing 
reliable models for simulating properties of biological molecules 
and, in particular macromolecules, becomes a crucial one. 
The basic methodologies for these simulations - computation 
of the conformational energy, energy minimization, Molecular 
Dynamics, Monte-Carlo sampling - are essentially well established 
and more or less standard. But the particular energy functions 
used, the parameters and simulation conditions may vary widely 
from one laboratory to the next. 
An earlier CECAM meeting (October, 1986) discussed the urgent 
need for a systematic effort aimed at setting standards for 
simulation conditions and for deriving improved force-fields, and 
recommended to hold a workshop on this subject that would set the 
pace for a coordinated effort among European and American 
laboratories active in the field. 
This workshop was sponsored jointly by CECAM and the EC and 
held on July 7-12 1987. 17 scientists (see enclosed list) from the 
major laboratories engaged in computer simulations of biological 
molecules attended. Discussions were focused on force fields and 
computer simulations of protein-solvent systems. 
Ongoing efforts to improve and test force fields in different 
laboratories (Harvard-Karplus; Univ. of Pitsburg-Brooks; 
NIH-Brooks; Biosym-Dinur; UCSF-Kollman; Groningen-Van Gunsteren; 
Cornell-Brady; Univ. of Lille-Vergoten; Univ. of Michigan-Krimm) 
were presented and discussed. Noteworthy were the detailed 
presentations on the collaborative efforts already well underway 
on optimizing force fields with respect to vibrational spectra of 
N-methylacetamide, alanine dipeptide, sugars, simple alkanes and 
aromatic molecules, in the gas phase as well as crystalline state. 
Progress and remaining bottlenecks in simulations of liquid 
water and protein-water systems were also extensively discussed. 
The problem of handling long-range forces electrostatic 
interactions in these systems received particular attention, the 
use of flexible versus rigid water models was debated, and the 
question of how to adjust force fields and simulation conditions 
so as to fit satisfactorily not only equilibrium properties, but 
also dynamic parameters was examined. 
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Recent methods for computing differences in solvation free 
energies and free energies changes in closely related 
conformational states by Molecular Dynamics simulations were 
analyzed. Free energy values computed by these procedures can be 
readily compared to experimental quantities and possibly used to 
calibrate force fields and energy parameters down stream of other 
well established calibration procedures. 
The use of experimental data from inelastic neutron 
scattering of proteins and peptides in solutions to test 
force-fields and parameters was also brought up, as indeed, 
theoretical calculations of the picosecond dynamic behaviour of 
BPTI were not able to reproduce measured neutron spectra without 
fine adjustments of the force-fields : use of explicite positions 
for non polar hydrogens and better truncation methods for 
electrostatic interactions. 
The use of ab-initio quantum mechanical calculations in 
deriving better force-fields has also been discussed, albeit less 
extensively. They were retained as very useful for computing and 
calibrating rotational barriers and electronic partial charges, 
with a note of caution for the latter of fitting potentials rather 
than charge distributions. Simulations in which a combined quantum 
mechanical (semi-empirical) and molecular mechanical potential is 
used to describe chemical reactions in condensed phase were 
described, and it has been suggested that the method, which 
stipulates a quantum mechanical treatment for special portions of 
the system (atoms involved in a chemical reaction), may remove 
some of the needs to derive classical force-fields and energy 
parameters that mimiek the special behaviour of these portions. 
Last but not least, benchmark calculations - Molecular 
Dynamics and energy minimization - were performed on the alanine 
crystal (zwitter ion form) using five parameter sets : "old 
CHARMM" (1984- 1985), "new CHARMM" (1987-1988), OPLS/AMBER 
(1986-1987); "old AMBER" (1983-1984) and GROMOS (1987). Simulation 
results were distributed among all workshop participants and are 
being presently analyzed by the different groups. 
In conclusion, consensus has been reached among workshop 
participants to consider this event as a starting point for a 
larger collaborative effort for improving force-fields, 
standardizing simulation procedures and critically overviewing 
recent developments. 
Standard formats for energy parameter library and, in 
general, the constitution of a data base of parameters were 
discussed. More important still, an overall strategy for improving 
force-fields and energy parameters was proposed: 
1) Perform ab-initio quantum mechanical calculations on small 
molecules in the gaz phase to fit rotational barrier, partial 
electronic charges and bond distance and angles 
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2) Fit potential energy function (most certainly include Urey 
Bradly cross terms) and force constants to gaz phase 
experimental vibrational spectra for a sufficiently large 
spectrum of small molecules so that the different functional 
groups in proteins are well represented 
3) With the intra-molecular force-field obtained from 1-2, 
non-bonded force-field should be adjusted by fitting parameters 
in the condensed ordered phase (structural parameters and 
vibrational spectra of crystals) 
4) Compare the results of steps 1-3, iterate if necessary, to 
obtain the best compromise between intra molecular and 
non-bonded parameters 
5) Test the performance of the obtained parameters in simulations 
of solvated systems for which experimental data are available 
6) Emphasis should be given to testing transferability of derived 
force fields, and to devising standard protocol for achieving 
transferability for cases in which it does not apply directly. 
The fact that points 1-3 are already an active area of 
endeavour in a number of laboratories and that improved force 
fields which fit well spectral data start to be available was 
considered a very positive point from which further efforts should 
benefit. 
In line with these efforts, a proposal by the Harvard group 
(J. Smith and M. Fields) to estabilish a data bank of model 
systems well suited for calibrating computational procedures 
against experimental data was retained as particularly valuable. 
These model systems should be composed of small molecules, with 
functional groups relevant to proteins on which experimental data, 
ranging all the way from crystal structure, to solvation energies, 
to vibrational spectra, etc., are available. 
In view of these conclusions, of the impact they may have on 
future activities in the field, and in view of the enthusiasm and 
interest expressed by all participants to pursue activities in 
this area, we propose to hold a follow-up workshop on force-fields 
in the summer of 1988, immediately after the planned workshop on 
Free Energy Calculations by Perturbation Methods, as a number of 
participants in the latter event are also implicated in the 
force-field effort. 
We hope very much that the EC will recognize the importance 
of keeping up the momentum of this very important area of interest 
by subsidizing the travel expenses of scientists participating in 
the follow-up workshop. 
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CECAM Workshop 
en 
ELECTROSTATICS IN RECOGNITION PROCESSES 
BETWEEN 
BIOLOGICAL MACRCM3LECÜLES 
ORSAY, October 19-23, 1987 
With the support of the 
Centre National de la Recherche Scientifique 
and the 
Biotechnology Action Programm of the European Communities 
Organized by-
Eric WESTHOF 
IBMC-CNRS 
15, rue R. Descartes 
F - 67084 Strasbourg 
This workshop follows a preceding CECAM workshop held in Orsay in June 
1986 on "Nucleic acids and Solvent Structure". That workshop was itself a 
follow-up of a workshop held during July 1983 and organized by Wilma 
OLSON and Herman BERENDSEN. The organizers of 1983 workshop brought 
together scientists with expertise either in experimental and theoretical 
work on nucleic acid conformations and dynamics. During the 1983 
workshop, the electrostatic problem related to the polyelectrolyte nature 
of nucleic acids was much discussed. During the 1986 workshop , the 
emphasis was more on the analysis of the solvation of nucleic acids both 
from an experimental and a theoretical point of view. The appropriate way 
to compare results from simulation studies and from experimental work, 
especially crystallography was a main point of discussion. 
Due to the advances made in the developments of method and software for 
the calculation of the electrostatic field around proteins, the 1987 
workshop was devoted to the description of the new methods, their 
advantages, and drawbacks as well as their applictions mainly to 
proteins. Two methods appeared strongly similar, those of Malcolm 
DRUMMOND and of Randy ZAUHAR where the interaction between the solute and 
the polarizable dipoles of the solvent are calculated through the induced 
surface charge distribution on surface elements of the protein. The 
differences in applicability with the finite difference method of Jim 
WARWICKER and Barry HONIG were made clear.. Several other approaches to 
the elctrostatic problem were also addressed and discussed. 
As in the previous workshops, the set-up of the workshop and its 
organization left time for informal discussions and exchanges between 
participants. 
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WORKING SEMINARS 
O F 
EUROPEAN LABORATORIES WITHOUT WALLS 
(E.L.W.W.) 

BIO-INFORMATICS 

EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-0138-B 
BAP-0133-UK 
BAP-0142-UK 
BAP-0145-F 
Queen Mary College, 
London 
In the field of 
ELECTROPHORESIS OF PROTEINS 
- 01 
BAP Contractors Meeting 
24-25 March, 1988, at NCTC Colindale, London NW9 5HT. 
Electrophoresis of proteins: data capture, analysis and construction of 
databanks 
Day 1 Attendence; 
K. Kersters, B. Pot, (LMG, Gent) BAP 0138-B 
L.R. Hill, M. Costas, L. Sloss, S. On (NCTC, London) BAP 0133-UK 
M.J. Dunn (RPMS, London) BAP 0142-UK 
K. Smith (QMC, London), participant 
(R.G. Whalen, Paris, BAP 0145-F unable to attend due to prior commitments) 
Progress in the participating laboratories was reviewed. At NCTC, a 2-D 
LKB laser scanner interfaced with a COMPAQ micro-computer, programmes 
translated to TURBO-PASCAL. Standard protocol for protein extraction and 
electrophoresis applied to strains of: Campylobacter laridis/UPTC, Campylobacter 
jejuni subsp. doylei, Campylobacter pylori, Listeria denitrifleans,Mycoplasma 
mycoides. 
L. Sloss has evaluated a radio-labelling system AMBIS, with, however, poor 
results. Strategy of databanks was discussed: pro tern advisable to store 
both actual patterns of centrotypes of EP-types, as well as hypothetical or 
average patterns of EP types. At NCTC, Bio Image's VISAGE 110 image analyser 
system was recently installed and, especially for 2-D work, will greatly enhance 
data capture and analysis. 
At LMG, an interpolation program up-and-running, differing in detail from 
NCTC software but achieving the same end. Interpolation involves 400 data 
points and positions of selected reference peaks are statistical averages 
of 100 + runs of LMG 1125 reference strain. Database software developed on 
mainframe. Groups studied include further Xanthomonas spp., Bacillus spp., 
lactic acid bacteria, pseudomonads and rhizobia. 
At RPMS, PD Quest installed, software locally operational at database level; 
data acquisition being done in USA and returned to RPMS. Databases being 
constructed of composite 2-D gels, and system has capacity to compare up to 
to 30 2-D gels. The subjectivity of choosing reference spots was discussed, 
and will arise also in the NCTC VISAGE system and agreed direct comparison 
of the two systems should be made. 
At QMC (unit renamed Centre for Parallel Computing), a holistic approach is 
being developed, a statistical classification pattern recognition system. 
Attention was drawn to the Advanced Informatics in Medicine (AIM) document 
of the CEC. (Meeting adjourned for a demonstration of VISAGE.) 
Day 2: LMG and NCTC Groups only 
LMG and NCTC actual gels were exchanged to separately analyse on respective 
systems. Detailed comparison made of how the NCTC and LMG software packages 
operate, and further discussion took place of the shared standard protocol 
for preparation of gels. Prospected joint work: to explore in more detail 
differences noted in 1-D separations between pigmented and non-pigmented 
variants of Serratia rubidea, to extend to 2-D work and, if practicable, 
to restriction endonuclease digests of DNA. 
- 82 -
EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-0029-UK 
BAP-0035-UK 
BAP-0036-D 
BAP-0135-D 
In the field of 
AUTOMATION OF DNA SEQUENCING 
03 
BIOTECHNOLOGY 
ACTION PROGRAMME 
Automation of DNA Sequencing 
UK 
ATCCATCTGGA 
AAT TTGGCA 
i i i i i i i i i i i r-v 
FRG 
UMIST 
RAL 
University of Constance 
TCCIDP 
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^AUTOMATION OF ENA SEQUENCING" PROJECT 
COORDINATION MEETING NO 3 
The third meeting of the contraertors from the four centres engaged in the 
"Automation of DNA Sequencing" project took place in Manchester 
Biotechnology Centre from 28 November to 2 December 1987. There were 12 
participants, ten from the centres involved and two guests (one, Dr. M. 
Browne from DIAS, UMIST and the other Dr. S. Beck from MRC, Cambridge who 
previously worked with Prof. Pohl at Konstanz). 
The current status of the Automatic Plaque Selection and Culture 
Inoculation Robot (APSCIR) was demonstrated by Mr. P. Courtney. The 
TCCIDP (Konstanz) designed and built VME based imaging computer, which 
runs under an OS/9 operating system, had arrived some time previously in 
MBC. The imaging software, originally formulated by Mr. P. Courtney in 
Pascal on a Magiscan II image processor, had been transposed to "C", and 
loaded in the TCCIDP computer. Aspects of the XYZ robot plaque selection 
device were also operational. The Automatic Reagent Manipulating System 
(ARMS) which instruments primer/template annealing and the Sanger 
Sequencing reactions was demonstrated by Dr. P. Jasiobedzki, who also 
presented a report on commercially available vision systems for colony 
selection. 
Dr. J.E. Bateman read a paper describing progress to date at Rutherford 
Appleton Laboratory on the design and constructuion of the EEC funded 
multi-wire proportional counter for imaging radiolabelled sequencing 
gels. Mr; C. Heller presented an account of work in progress on the 
Direct Blotting Electrophoresis device currently under development in 
Prof. Pohl's laboratory at the University of Konstanz. Prof. Massen's 
group discussed current activity in the TCCIDP on real-time symbol 
extraction with fast greylevel vision preprocessors. An imaging system 
developed by Dr. M. Browne was demonstrated and Dr. S. Beck read a paper 
on his work in Cambridge on Direct Blotting Electrophoresis. 
Discussions were held to coordinate activity between the four centres and 
a June 1988 date for the next meeting (at Konstanz) was agreed. 
Dr. W.J. Martin 
Manager, 
Manchester Biotechnology Centre 
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CULTURE COLLECTIONS 

EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-0143-GR 
BAP-0144-F 
In the field of 
LACTIC ACID CULTURES 
COLLECTION 
89 
CREATION D'UNE COLLECTION DE SOUCHES DE BACTERIES LACTIQUES 
MODELISATION ET CONTROLE AUTOMATIQUE 
DE CULTURES MIXTES THERMOPIIILES 
Compte rendu de la réunion de coordination scientifique 
La réunion s'est tenue à Grignon le 3 septembre 1987. 
Participants : C. BEAL, M. DESMAZEAUD, A. ZOURARI 
G. KALATZOPOUL05, E. SPINNLER 
Suite à un problème de conservation de souches, l'équipe du Professeur 
KALATZOPOULOS n'a pu poursuivre les essais de mesure d'acidification des 
souches de sa collection. Néanmoins, ce t te équipe a travaillé à la mise en place 
des protocoles d'estimation des qualités technologiques de ces souches : 
- mesure de vitesse d'acidification 
- mesure d'activité peptidasique 
- mesure d'activité estérasique 
- Les profils électrophorétiques des différentes souches seront comparés. 
- Un travail sur l'influence sur trai tement thermique des laits sur la croissance 
et une étude des plasmides de ces souches complétera le travail. 
L'équipe de G.CORRIEU, a pour sa part, travaillé à l'amélioration des 
techniques de mesure d'activité acidifiante afin de pouvoir comparer entre eux 
des ferments de diverses origines. 
Ce travail a consisté à effectuer des cinétiques d'acidification avec des 
concentrations variables d'un même ferment. Toutes les 1/2 heures et tous les 
1/4 d'heure pendant la phase exponentielle, un tube est utilisé pour faire les 
mesures suivantes : 
- nombre de germes vivants / ml 
- ATP intracellulaire 
- pH 
Parmi ces mesures, seules les deux dernières ont une reproductibilité stisfaisante. 
De plus le pH peut être facilement mesuré en ligne. Cet te mesure sera donc 
priviligiée par la suite. 
Le travail concernant le suivi en ligne des populations de streptocoques s'est 
aussi poursuivi en travaillant non plus sur les concentrations en C02 dissous, 
mais sur les volumes de C02 libérés à partir d'urée. Ces mesures impliquent 
l'ajout de 15 g d'urée par li tre de lait et permettent de faire une estimation des 
populations de streptocoques au delà de 5-10^ bact/ml en cultures pures et en 
cultures mixtes. 
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Le travail se poursuit aussi sur la quantification des effets coopératifs entre 
Streptococccus thermophiles et Lactobacillus bulgaricus sur un milieu à base 
de lactosérum. 
L'équipe de Monsieur DESMAZEAUD (avec A. ZOURARI) a terminé lft 
travail commencé sur les souches isolées de yagourts grecs. Parmi les 360 souches 
étudiées (180 Streptococcus thermophilus et 180 Lactobacillus bulgaricus) dans 
une même espèce, on n'observe aucune variablité en ce qui concerne la 
consommation au moins une dizaine de sucres différents. Par contre, d'autres 
critères plus technologiques semblent différencier certaines d'entre elles (variants 
à vitesse de croissance lente par exemple : 
Un travail va être entrepris sur ces souches concernant : 
- leurs courbes d'acidification 
- les électrophorégrammes de leurs protéines 
- la viscosité engendrée 
- la postacidification 
Un séjour de Madame Ellena KAMBARAKI (équipe de G. KALATZOPOULOS) 
est prévu du 4 au 17/10/87 au Laboratoire de Microbiologie Laitière (Jouy-en 
Josas) pour mettre en place les conditions d'isolement et de conservation des 
bactéries lactiques thermophiles isolées de produits traditionnels grecs. 
Un voyage d'Eric SPINNLER à Athènes est prévu début décembre pour mettre 
en place le bioréacteur acheté par l'ESAA. Des lyophilisats de cultures pures 
et mixtes produits à Grignon seront testés en fabricatioon de yagourt à Athènes. 
Eric SPINNLER 
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EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-0143-GR 
BAP-0144-F 
In the field of 
MICROBIOLOGY OF TRADITIONALLY FERMENTED 
FOODS IN THE MEDITERRANEAN COUNTRIES 
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MINUTES OF THE MEETING ON MICROBIOLOGY OF TRADITIONALLY 
FERMENTED FOODS IN THE MEDITERRANEAN COUNTRIES. 
The days 28th and 29th of April,1.988, the E.L.W.W. moo-
ting on Microbiology of traditionally fermentad food3 in the 
Mediterranean countries was held in Madrid at the Instituto 
del Frío (Spanish Council for Scientific Research). 
Financial support for the meeting was provided by the Co-
mmission of the European Communities, Directorate General for 
Science,Research and Development, and in part by the Spanish 
Council for Scientific Research. 
The-list of participants was as follows: 
Dr.Alfredo Aguilar(Belgium), in the Chairj M.Barbasa(Por-
tugal),« V.Bottazzi(Italy) | M,Desmazeaud(France)} G.Ka-
latzopoulos(Greece)} J.C.Le Jaouen(France); B.Moreno 
(Spain)} M.Núñez(Spain); C.Peláez(Spain) ; H.E.Spinnler 
(France) 
Also attended as invited researchers: 
Dr.M.Ramos(Spain); M.Juárez(Spain); M.Medina(Spain). 
Welcome and Introduction 
Dr. Aguilar welcomed the participants and began the mee-
ting describing the present and future Biotechnology Program-
mes of the European Communities. He explained the basic orien-
tation of the BAP Programme which started in 1,986 and has be-
en recently revised for an enlargement in 1.988^90 with the 
attachment of Spain and Portugal. 
The joint Spanish and Portuguese proposals to the diffe-
rent subjects hsve been 82 and 22 respectively, including 2 
Spanish proposals to the subject "culture collection", high-
ly related to the topic of this meeting. Some other subjects 
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to Which proposals have been presented too, are: Bio-Informa-
tics» including Information Technology and Protein Engineering 
Risk Evaluation? Plants}Microorganisms ; Animal Cells;Pharmacology 
and Biorreactors.Moreover,Dr.Aguilar reported valuable data 
referring to the financial support for the BAP revision,stan-
ding out the budget assigned to Spain and Portugal, as well 
as the Training Contracts. 
Finally^ Dr. Aguilar referred to the actions, conditions, 
budget and topics, in relation to the BRIDGE Programme fore-
seen for 1.990-94 
Short Oral Contributions 
D r a. Barbosa presented a report about- the research carried 
out in Portugal on sheep's and goat's milk cheeses standing 
out the work on physicochemical and microbiological composi-
tion, technological procedure and ripening conditions of the 
cheeses. 
Or, Bottazzi deacribed the objectives and the different 
steps which might be pointed out in a common project within 
the EEC, dealing with the traditional fermented producta from 
the Mediterranean countries. Me referred aa well to the inade-
quacy of the available data on this subject and the necessity 
of studies describing the products, chemical composition, cha-
racterization of the lactic microflora and the creation of a 
culture collection. Furthermore, the different tasks of the 
different research teams working together in a possible trans-
national cooperation were also described. 
Dr.Desmazeaud summarized the work carried out in hia Ins-
titute as an actual BAP contractor, in relation to the charac-
terization of thermophilic streptococci and lactobacilli iso-
lated from yoghourt produced in Greece. He pointed out the po-
ssibility of a future BAP Programme in cooperation with the 
other Mediterranean countries, explaining to what extent he 
could contribute to the creation of a microorganisms collection 
through a biochemical and genetic characterization of the iso-
lated strains. 
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In the same way, Dr.Kalatzopaulos presented the proposal 
of a potential future common Programme on the subject already 
mentioned, suggesting the possibility of making it extensive 
tö other fermented producta, auch as wine, bread, fermented 
sausages etc. In these products do exist a specific microflora 
which might be known in order to improve the quality and at 
the same time, extent the storage life of the products. 
Dr. Le Jaouen referred to a better standardization of the 
traditional sheep's and goat's producte from France, achieved 
by an improvement of the technological parameters of produc-
tion, either in the farm or in the small industries. At the 
same time, a better characterization of their mioroflora and 
understanding of legislative aspects would be necessary. 
Dr* Moreno reported the research carried out in the Food 
Hygiene and Food TechnoLogy Department of the Veterinarian 
School in Lødn(Spain). Concerning the dairy products, he men-
tioned the work on the microbiological quality of Spanish --
sheep's and goat's milk cheeses, aswell as the effect of growth 
of lactic acid bacteria on the development of Staphylococcus 
aureua and its enterotoxin production. 
Dr. Nunez.considered that lot of work has still to be done 
in order to improve-the bacteriological quality of the raw milk 
cheese varieties by means of inoculation of selected lactic -
acid bacteria (Str. lactis and Lb. plantarum) aa biological in-
hibitors of undesirable microorganisms. 
Dra. Peláez described the situation of the Spanish cheese-
making production made from sheep's and goat's milk; the main 
current problems involved in it and tho multiple aspects which 
should be approached. She pointed out the validity of the cha-
racterization of the products, selection of microorganisms, an-
tagonistic properties of lactic acid bacteria against pathogens 
and freezing of curda as a technology used to standardize the 
products troughout the year. 
Finally, Dr. Spinnler reported the results obtained on the 
development of a method to measure the kinetics of acidifica-
tion by thermophilic lactic acid bacteria (Str* thermophilus 
CNRZ 404 and Lb. bulgacicus CNRZ 398, using different inoculum 
levels. 
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Besides the oral contributions, all the participants took 
part in n round table and it was agreed that the main objective 
of a possible future common project within the"European Labo-
ratory Without Walla" Programme, would be to preserve our tra-
ditional Mediterranean products with"appellations d'origines 
contrôleés". The participants focused the attention especially 
in thoae products which presented a potential economical into-
rest in the Mediterranean aroa and susceptible to be improved 
by means of the Biotechnology. 
Once the meeting was over, a visit to the Instituto del Frio 
and the Instituto de Fermentaciones Industriales ( both from the 
Spanish Council for Scientific Research) took place. 
The day after the meeting, all the participants visited n 
Manchego cheese-making factory, nearby Madrid (Toledo). 
Dra.Carmen Peláez 1 P r o f . | G . K a l a t z o p o u l o s 
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EUROPEAN PLASMID DATABASE - Expert meeting 
Braunschweig, 19/20 May 1988 
Participants: A. Aguilar (CEC, Brussels), V. Hughes (NCTC, 
London), C. Jones (NCTC, London), E. Kampert 
(Phabagen, Utrecht), C. Leslie (NCIMB, Aberdeen), 
D. Osborne (NCTC, London), K. Painting (NCYC, 
Norwich), F. Pfeiffer (MIPS at MPI, 
Martinsried/Munich), 
A. Pindar (MiCIS, London), M. Vicente (CIB, 
Madrid). 
D. Claus, E. Breyel, M. Kracht, 
A. Regensburger, C. Rohde, E. Senghas (members of 
DSM, Braunschweig) 
Opening: 
C. Rohde, the chairperson of the meeting, welcomes the 
participants and thanks the Services of the Commission of the 
European Communities for financial assistance. This first meeting 
to discuss questions on the establishment and organization of a 
European plasmid database takes place with the aim to discuss 
general and detailed technical aspects and has the definite aim 
to create a standardized common database format. 
Introduction by A. Aguilar: 
A. Aguilar presents "biotechnological projects supported by the 
CEC (BEP and BAP as the pioneer and the current programme) and 
the BRIDGE project which is planned for the near future and which 
could support the establishment of the European plasmid database. 
The preconditions for participating in the BRIDGE project are 
well defined, very important aspects for the European plasmid 
database are transnationality, precompetitiveness, and the 
database has to be user-orientated and beneficial for all 
scientists. A possible culture collections' use by itself would 
not be supported, but of course the data information would have 
to come from the participating collections. 
Brief presentations, given by the participants: 
DSM: 
C. Rohde gives a short overview on the tasks and projects of the 
DSM's plasmid group, which was extended at the beginning of 1988. 
So far a plasmid database at DSM does not exist, but it is just 
in the process to be established, together with the preparation 
of the new DSM catalogue edition (being published probably by 
autumn 1988). A format for the European plasmid database was 
worked out at DSM. This format was created to be a basis for the 
discussions during the meeting. 
D. Claus describes the new aspects of DSM's service and research 
activities in connection with the DSM expansion. 
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NCTC: 
V. Hughes presents the organization of NCTC's plasmici database 
established 2 years ago. 2 major files are the heart of the 
system: a plasmid file and an accession file. The necessity of 
having a house-keeping file for a culture collection is pointed 
out, but similar aspects have to be taken into consideration for 
the European database. V. Hughes lays stress on the importance of 
literature data and on the aspect of flexibility of the European 
database. 
MiCIS: 
A. Pindar describes the history of MiCIS, the UK national system 
for microbial strain data, designed 3 years ago. A. Pindar 
mentions that MiCIS is not necessarily an initiative for the 
participants from the UK exclusively, but it will be open for 
European projects like the plasmid database, sharing costs and 
enhancing collaboration. 
MIPS: 
F. Pfeiffer gives a short report on the MIPS activities. At the 
Martinsried Institute for Protein Sequence Data the protein data 
bank was established 2 years ago, financed by the BMFT (the 
German Ministry for Research and Technology) and by the CEC, as a 
5 years project, being part of the PIR-International 
(International Association of protein sequence data banks). 
F. Pfeiffer describes the collaboration of MIPS (Europe) with 
JIPID (Asia) and NBRF-PIR (America), having one common protein 
sequence data set and using one standardized format. F. Pfeiffer 
also describes VecBase, a cloning vector sequence data base 
containing only vectors which are sequenced completely. 
NCYC : 
K. Painting briefly presents the relational database system at 
NCYC, being connected to a VAX system. The necessity of a special 
order of the fields for the European plasmid database is pointed 
out. 
NCIMB: 
C. Leslie describes the plasmid database situation at NCIMB and 
its integration into the MiCIS system. For the future NCIMB would 
like to increase the capacity of the database system in respect 
to genetical data. 
CIB: 
M. Vicente demonstrates the capacity of the user-orientated 
database at CEDIG, the Spanish database on genetic engineering. 
An updated catalogue was elaborated. The database files include 
fields for plasmids and cosmids, phages, recombinant vectors, 
genotheques, bacteria for genetics, cells and laboratory data. So 
far CEDIG is a system open for recherches by Spanish scientists. 
The CEDIG database includes the indexes of the Elsevier 
catalogue. 
PHABAGEN: 
E. Kampert describes the situation at the Phabagen collection 
with respect to a plasmid database, which is not yet established, 
though a detailled proposal for its format does exist. 
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Minutes of the general discussions about the establishment of a 
European Plasmid and phage database 
C. Rohde mentions questions, which may be difficult to be 
answered at this early stage but which should be discussed: 
- DSM proposes a centralized database, situated at any location 
where experts are working. Are there arguments for a node 
structure instead? 
- Should the database offer its service to anybody? 
- Who enters the data? Who updates the data and how often 
should they be updated? 
- Should plasmids and phages be integrated into one single 
database? 
During the presentations given by the participants it became 
obvious that successfully running databases do exist at the 
different institutions. In some way they have to be "combined", 
and, in order to have a single plasmid database in Europe, 
certainly a collaboration between MINE (Microbial Information 
Network Europe), MiCIS (Microbial Culture Information Service) 
and MSDN (Microbial Strain Data Network) will be necessary. This 
is agreed by all participants. 
M. Kracht mentions that for interconnecting the databases a 
special field for linkages might be created and - at a later 
stage - a database host has to be discussed. The advantages of a 
centralized database are mentioned: it would be faster, cheaper 
and less complicated. 
A. Pindar stresses the importance of an identical format and 
suggests a centralized structure, because a network would be too 
complicated. 
F. Pfeiffer describes how recherches at VecBase can be done: on-
line recherches are not possible, recherches are sent to PIR, 
Washington, by electronic mail. Depending on the inquiries copies 
of the database are distributed. 
A. Aguilar proposes that the databases of bacteria and of 
plasmids have to be harmonized. Data should be entered by culture 
collections. The importance of the establishment of the proposed 
European information centre - besides the "node" system for the 
MINE bacteria/fungi database - at one of the culture collections 
is mentioned. 
It is generally agreed that the question of charges (for database 
users) is not relevant at this stage. 
C. Jones outlines the necessity of updating the database 
regularly and as often as possible. It is of course a question of 
money. Each collection should send updates regularly. 
It is agreed that plasmids and phages should be integrated into . 
one database, as most of the fields representing genetic data 
refer to plasmids and phages. 
A. Aguilar mentions that the CEC has great interest in having 
this European database, and financial support will be possible, 
although in what form is open at the moment. 
F. Pfeiffer points out that database updates should be done 
regularly, having a "combined movement", e.g. a 3 months cycle. 
He proposes - for reasons of flexibility and data exchange - to 
have an identifier or subidentifier for combining different 
systems. 
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V. Hughes offers the NCTC's plasmid database for "export" to the 
European database, to make the first steps of the establishment 
easier, or to function as a pilot format. 
General discussion about the format 
It is generally agreed that the database should be organized as a 
menu file structure, being the easiest possibility for the user. 
All the fields referring to collection data should be one block 
of fields. A splitting point within the format is the field 
"element type", giving the user the possibility to enter either 
the database for plasmids or phages or transposons. 
E. Kampert mentions the importance of the transposons, which make 
some specific fields necessary. 
M. Vicente, E. Kampert and A. Regensburger outline the different 
vector types to be mentioned, a well-devised structure of fields 
for this kind of application is necessary. 
V. Hughes mentions the absolute need to have a common and a 
correct nomenclature for phenotypic characteristics etc. at a 
very early stage, otherwise problems cannot be avoided. 
V. Hughes mentions the publications of Novick et al. (1976), 
Bacterid. Reviews 4_0, 168-189 and Demerec et al. (1966), 
Genetics 54, 61-76. 
M. Vicente proposes to ask a phage expert for advice, as there 
exist aspects specific for phage genetics. 
E. Senghas proposes to create a specific field for the transposon 
type, referring to the classification of transposons. Other Tn 
specific data are integrated in the other fields. 
The format structure proposed by DSM is discussed in detail. The 
revised format (enclosed) contains all the ideas which originated 
during the expert meeting. It was decided that a minimal data set 
should not be created for the European plasmid database. 
The participants of the meeting recommend 
- to continue as fast as possible with the establishment of the 
European plasmid database 
- to contact scientists being experts on plasmids/phages and to 
invite their critical comments on the format proposal before 
the database is going to be established 
- DSM and NCTC will start to combine their databases (a possible 
pilot format) 
- a publication of the format in its final structure is planned, 
a genetic journal should be chosen (GENETICS or NUCLEIC ACIDS 
RESEARCH or a similar one) 
- a small article should then be published in a European journal, 
describing this database project 
Braunschweig, June 14, 1988 
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EUROPEAN DATABASE : PROPOSAL FOR THE PLASMID/PHAGE/TRANSPOSON -
FORMAT (worked out during the database congress at DSM, May 1988) 
New modifications (proposed by DSM): 
- organization of fields under special headings (A - F), 
- abbreviated names for each field (in relation to the MINE 
format) 
In DSM's opinion there is probably no need at this early stage to 
define the detailed organization of each field, e.g. its 
different possibilities for answering with yes/no or with +/-. 
But this has to be done as soon as the general structure of the 
database has been agreed. It should be presumed that a common 
standardized format has to be used by the individual collections 
to establish their plasmid database, and thereafter, based on 
these standardized individual databases, the European integrated 
database can be established. Some problems have to be discussed 
then: who will write an integration program; which fields have to 
be integrated and checked for redundant information, which fields 
can simply be added, etc. 
Numbers : field numbers, 
i: field should be indexed 
ph: field for phages only 
pi: field for plasmids only 
tn: field for transposons only 
A. Database administration 
B. Name 
C. Element administration 
D. Host and history 
E. Biological properties 
F. Applications 
A. Database administration 
1 ACCN (i) : code number (accession number, record 
number) 
: date of input into database 
: date of update 
: responsible scientist 
(i) : element type (Ph = phage, Pi = plasmid, 
Tn = transposon) 
2 
3 
4 
5 
B. 
6 
7 
EDI 
E DU 
ID 
ET 
Name 
NAME 
PLREF 
(i) : element name 
(pi): plasmid reference center 
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8 OTHNAM (i) 
(+ registered, - not registered) 
other names (synonyms) 
C. Element administration 
9 NUM 
10 OCC 
11 EDA 
12 CHK 
13 PRE 
14 SUPPLY 
15 ISOM 
16 PREC 
17 REG 
18 LIT 
19 REM 
(i) 
(i) 
(Ph) 
element number in collection(s) 
subfield: distributed in 
other culture collection numbers 
date of accession 
collection check 
subfield: last update 
preservation method 
form of supply 
isolation method (propagation method) 
subfield: recommended host 
precautions (hazard group) 
restrictions (regulations concerning supply) 
literature (first publication and a new one) 
remarks and comments 
D. Host and history 
20 CLASS (i) : 
21 ORIHST (i) : 
22 RNGHST : 
23 CONSTR : 
24 CONSTRFR : 
25 DEP : 
26 HIS : 
element classification 
(natural or constructed element) 
original host 
host range 
subfield: host specificity 
constructed by 
constructed from (sources) 
depositor 
history 
E. Biological properties 
27 PHAMORPH(i)(ph) 
28 LYSO (i)(ph) 
29 PLAFO (i)(ph) 
3 0 PLAMORPH(i)(ph) 
31 SOLVSEN (i)(ph) 
32 IMM (i)(ph) 
33 NT (i) (ph) 
3 4 INSERT 
35 MWT 
36 
37 
38 
39 
INC 
REPL 
COPYNR 
AMPL 
(i)(pl) 
(i)(pl) 
(i) (PD 
(i)(Pi) 
phage morphology 
subfield: particle size 
lysogenic (+/-) 
plaque forming phage 
plaque morphology 
solvent sensitivity 
immunity 
nucleic acid type (dsDNA, ssDNA, RNA, 
unknown) 
insert (cloned fragment) 
molecular weight (in kb and Mdal) 
subfield: method of determination 
(EM contourlength, agarose gel 
electrophoresis, sequence analysis, 
restriction fragment lengths) 
incompatibility group 
replicón 
copy number (high, low) 
amplifiable 
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40 RESTR (i) 
41 MAP 
42 SEQU 
43 ILLUSTR 
44 TRANS (i)(pi) 
45 PATH 
subfield: method 
unique restriction sites 
either: 
subfield: for cloning 
or: 
mark restriction enzyme(s) with a sign. 
In brackets: enzyme(s) for inactivated 
resistance gene 
restriction map (reference) 
sequence (reference number, code link for 
entering sequence database) 
illustration (graphical) 
linear, not circular form!? 
transfer 
subfields: conjugative (+/~) 
mobilizable/non-mobilizable 
unknown 
pathogenicity (like toxin production, 
Ti plasmid) 
F. Applications 
46 PHATYPE (i)(ph): phage type 
subfields: transducing phage 
(generalized/specialized) 
pilus specific 
47 TNTYPE (i)(tn): transposon type 
subfields: IS element 
48 VECTYPE (i) 
49 MARKER (i) 
vector type 
subfields: 
composite Tn 
other Tn 
cloning vector 
shuttle vector 
expression vector 
promotor probe vector 
suicide vector 
replacement vector 
cosmid 
phasmid 
Charon vector 
other vector 
markers 
subfields: 
50 PATENT 
phenotype 
production of (pathway) 
degradation of (pathway) 
resistance to (mechanism) 
genetic markers 
F primes 
: patent (free patent, patent number) 
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Report to Biotechnology Action Program section 
2.1: Culture Collections. 
Subject: meeting on 24.02.87 in Genova (Italy) at 
National Institute for Cancer Research (Prof. 
Ferrara). 
Participants: Prof.G.B. Ferrara and coworkers; 
Prof. Dr.H. Grosse-Wilde (Essen, GFR); 
Dr.A.Doyle (Salisbury, G.B.); 
Prof.dr.M.F.Niermeijer (Rotterdam, The Netherlands) 
Greneral Aim of the meeting 
This meeting was organised at the request of Dr. H.Reiniger to 
discuss various points in the coordination of the culture 
collection program of the EEC, including diagnostic strategies 
for AIDS in samples submitted to and distributed by culture 
collections, and on the organisation of a data network. 
1. Format and organisation of participating cell culture 
collections 
a. The institute for Immunogenetics, university Hospital, 
Essen (Prof. Dr.H.Grosse-Wilde) has a collection of: 
. HLA-homozygous lymphoblastoid lines, for reference, 
typing, biochemical and genetic research on the HLA-
locus; these cells are also present in the institute in 
Genova. 
. lymphoblastoid cell lines of patients with HLA-associated 
diseases, concentrating on families with at least two-
affected patients with diabetes mellitus, coeliac 
disease, congenital adrenal hyperplasia and its variant 
forms, multiple sclerosis, ankylosing spondylitis, 
Alzheimer disease, SLE, haemochromatosis, etc. 
b. The Laboratory of Immunogenetics, Natl. Institute for Cancer 
Research, Genova (Italy) (Prof. G.B.Ferrara): 
. HLA homozygous typing lymphoblastoid lines (see above); 
for protection against loss these strains are preserved 
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in two independent facilities. 
. Lymphoblastoid cell lines from families with HLA-related 
diseases (see earlier). 
. Lymphoblastoid cell lines from various genetic cancer 
syndromes (including familial breast , lung and colonic 
carcinoma, a.o. polyposis coli). 
c. European Collection of Animal Cell cultures 
(at the Public Health Laboratory Services establishment, 
Salisbury, Great Britain) (Dr.A.Doyle). 
. animal cells from a large number of spiecies and tissues; 
. human tumour fibroblasts and cells from a large variety 
of tumours. 
. HLA-typing lymphoblastoid lines, in cooperation with the 
UK transplantation program. 
. lymphoblastoid cell lines from various human genetic 
diseases, in cooperation with the European Human Genetic 
Mutant Cell Bank (Rotterdam and Salisbury). 
d. Dept. Clinical Genetics, Erasmus University, Rotterdam 
(the Netherlands) (prof.Dr.H.Galjaard, Prof.Dr.M.F. 
Niermeijer). 
. Fibroblasts of patients, carriers and other informative 
relatives of genetic Mendelian and chromosomal disorders. 
The EEC biotechnology programs support would allow 
establishing both fibroblast-cultures (in Rotterdam) and 
long-term lymphocyte cultures (at Salisbury) simulta-
neously, from the same individuals. The availability of 
such well defind cell strains is of paramount importance 
with the introduction of DNA-markers identifying disease-
genes (either directly or through linkage) and will 
enable future generations of relatives of studied persons 
to use these new predictive methodologies in genetic 
counseling and family planning. 
The joint efforts of the Salisbury and Rotterdam group 
would be directed towards the storage of: 
. rare diseases and their variants 
. index cases of recessive, X-linked and dominant diseases, 
for reference to future studies using DNA-marker studies 
(by linkage) in the future; 
. well studied families, wherein certain genetic diseases 
with severe health implications and of an important 
frequency are segregating: 
f.i.: X-linked diseases: fragile X-syndrome (a few well 
studied families only); 
Duchenne muscular dystrophy, haemofilia, etc. 
Autosomal dominant diseases (some larger and well 
.analysed families): 
Huntington's disease, Alzheimer's disease, 
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neurofibromatosis, tuberous sc le ros i s , familial 
cancer syndromes (polyposis c o l i , von Hippel 
Lindau's d i sease , e t c . ) ; 
cases of new mutations of some of the previous d iseases ; 
chromosomal t rans loca t ions of selected chromosomes 
( re la ted to d isorders mentioned above); 
p a t i e n t s with two "rare" diseases (by allowing gene 
l o c a l i s a t i o n or detect ion of de le t ions ) . 
Coordination of a c t i v i t i e s as European Collection for 
Biomedical Research 
The p a r t i c i p a n t s a t the meeting concluded that their 
co l labora t ion could r e s u l t in the in s t i t u t ion of an European 
Col lect ion for Biomedical Research. This would be a f a c i l i t y 
offering exchange of biomedical materials and information in 
the areas of research on gene t ics , cancer and ageing. 
Exchange and a v a i l a b i l i t y of the various c e l l s t ra ins would be 
the f i r s t goal , f a c i l i t a t e d by easy excess to catalogues of 
severa l cen ters by computer. At the next meeting of the 
Biomedical Action Program, i t would be decided if i t i s 
des i r ab le to extend the ECBR to include : 
. co l l ec t i on of gene probes; 
. co l l ec t i on of tumor t i s s u e s ; 
. co l l ec t i on of monoclonal ant ibodies and hybridomas 
(possibly to be coordinated with the f ac i l i t y in Nice 
(France). 
This approach, of course, wi l l need the approval and f inancial 
support fom the EEC Biotechnology program, or other action 
program within the EEC (as on cancer) . 
Overlap in the present a c t i v i t i e s 
There i s no s ign i f i can t overlap between the par t ic ipa t ing 
c e n t e r s . In contac ts with the UK transplantat ion program i t 
w i l l be decided if supplementary a c t i v i t i e s for storage of 
HLA homozygous c e l l s i s needed in the UK, in the presence 
of s torage elsewhere. 
In the co l l ec t ion of c e l l s t r a i n s the centres wi l l c r i t i c a l l y 
review cases /d i seases submitted for banking,- as to relevance 
to future family s tud ies , level of data andstudies already 
done in the respect ive famil ies , a v a i l a b i l i t y of c e l l s fro* 
r e l a t i v e s , frequency of d isease , developments in research, 
e t c . 
:om 
Diagnostic tests for AIDS in samples submitted to and 
distributed by the cell banks 
With an incidence of 0,1 to 0,01 AIDS-positive blood donors in 
CCC AC various Western countries, it is of paramount importan-
ce to : 
a. protect workers in laboratories against unexpected 
exposure; 
b. to be able to guarantee that no AIDS-infected materials may 
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be distributed through cell banks. 
Since B-lymphocytes (in longterm lymphoblastoid lines) may 
harbour the AIDS virus, those centers handling blood (for 
establishing cultures) or handling lymphoblastoid cultures 
must have facilities available for testing at various stages. 
i. Testing for AIDS in blood samples, submitted for culturing. 
Laboratories (Essen, Salisbury, Genova) plan to introduce 
AIDS antibody screening in serum by indirect immunofluores-
cence staining. This is a convenient and sensitive test and 
is more practical for small numbers of samples as the ELISA 
test. 
Positive cases will have to be confirmed by the Western 
blotting technique. 
Incoming samples will be handled under PII conditions, 
which are thought to be satisfactory, if laboratory routine 
is strictly applied. The low expected incidence of AIDS in 
the incoming samples would make the routine use of PHI 
facilities prohibitively laborious and expensive (even if 
available in some places). 
The donors of the blood samples will be informed, either 
directly or through the physicians referring the samples, 
that tests for infectious substances will be done, for the 
protection of workers working the donor's cells. If a positive 
test is found and confirmed, information of the donor will 
be by his general practitioner or by the referring physi-
cian. 
An information leaflet for donors will be prepared on this 
subject by the various centers. 
Financing of diagnosis in incoming samples has not been 
provided for in the EEC Biotechnology program. The cost-
estimate is about 10.000 DM for each of the three centres. 
The EEC Biotechnology program is requested to provide this 
supplementary funding. 
The situation may change when techniques will become avai-
lable in the future for direct identification of the virus 
in blood specimens. 
ii.Testing for AIDS in lymphoblastoid cultures handled, stored 
and distributed by the cell banks. 
Since this is a very specific area, still in the research 
phase, it was decided that the centre at Salisbury will 
perform AIDS testing in lymphoblastoid cultures. There is, 
at Salisbury, availability of high level containment faci-
lities (PHI) when required, and collaboration is possible 
with local expertise from the PHLS. 
Testing techniques will involve (on + 1000 cultures/year): 
reverse transcriptase; various techniques for direct detec-
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tion of the virus, by immunological and other techniques. 
The EEC Biotechnology program is asked to give additional 
funding for one molecular biologist/virologist and two 
technicians and laboratory expenses during the next four 
years. 
During this phase the most efficient and reliable technolo-
gy may become established. 
When other techniques allowing easier identification of 
HIV-virus (f.i. by the DNA-probing) become available, the 
necessity for continuing this additional funding may be 
reconsidered, provided the techniques become sufficiently 
specific and easy to be conducted by all local cell banks. 
5. Communication between and with cell banks 
Various needs and utilisations of electronic data handling and 
communication were reviewed at the meeting. 
The Essen centre is already connected to the MINE data net, the 
Genova centre will be in short. The Essen centre sees utilisation 
of such a net for rapid communication. 
For general cell banking purposes, a computerized catalogue is 
essential. This is available in Essen and Salisbury, and in 
preparation in Genova and Rotterdam. 
Access to the catalogue may be through periodical distribution of 
a printed catalogue (like from Salisbury), or through acces by a 
data network. Especially in the latter situation, strict rules for 
privacy protection are needed, since a registry containing for 
example diagnosis and date of birth may easily lead to patient 
identification. 
The acceptance by the general public of any form of genetic 
registry will be dependent upon guarantees for maintaining 
privacy and confidentiality. 
Even if a catalogue will not be immediately perceived as a 
registry by most scientists, it is prudent to develop regulations 
for electronic registries of genetic data on individuals. 
It was proposed to discuss this point at the coming Biotechnology 
meeting in Tours and to see if institution of privacy protection 
rules and a steering committee might be desireable. 
It was agreed, that depending upon the main focus of each 
collaborating service, the need for direct electronic 
communication differs. It is more important in a HLA-typing 
laboratory (also involved in transplantation) than in a pure cell 
banking facility. 
Financing; additional staff for data introduction- and management 
will be outside the EEC Biotechnology program's support for most 
centres and additional funding would become needed for staff, 
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equipment, maintenance and subscription/user fees for data 
distribution networks. 
Coordination in cataloguing will be discussed at the meeting in 
Tours: 
- the format of already existing computer cataloguing 
systems: Salisbury, Rotterdam, Essen. 
- utilisation of identical codes for genetic disease (like: 
the Mc Kusick numbers for Mendelian disorders). 
- coordination with other networks, like the Italian 
Interlab system. 
6. Conclusion, continuation of the program 
The participants agreed that this program is an important 
step towards guaranteing an increasing number of the European 
population to profit of the new advances in genetics, and to 
use these findings in their personal life (by informed genetic 
counseling) and reproductive decisions. For continuous support 
to such international research activities, facilities for storage 
of cells, tissues, biomedical reagents (like gene probes and 
monoclonal antibodies) will be essential for future genera-
tions. Only through continuing international support, the 
European population may benefit in the next decades. 
Prof.Dr.M.F.Niermeijer. 
cc. Prof.Dr.G.B.Ferrara 
Istituto Nazionale per la Recerca sul Cancro 
Viale Benedetto XV no. 10 
16132 GENOVA (Italia) 
ce. Prof.Dr.H.Grosse-Wilde 
Institut Immunogenetik 
üniversitats Klinikum Essen 
Virchowsstrasse 171 
D-4300 ESSEN 1 
Federal Republic Germany 
cc. Dr.A.Doyle, curator ECACC 
Public Health Laboratory Service 
PHLs Centre for Applied Microbiology & Research 
Porton Down 
SALISBURY WILTSHIRE SP4 OJG 
Great Britain 
ce. Prof.Dr.H.Galjaard 
Dept.Cellbiology-Genetics 
Erasmus University 
Rotterdam 
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Group Meeting of the European Communities 
Biotechnology Action Programme 
"Folding, assembly, stability and genetic modification 
of penicillin acylase and its precursor" 
Tutzing, 22nd of July, 1987 
Participants : 
1. University of Newcastle upon Tyne 
Dr. C. Lindsay 
Prof. R. H. Pain 
Dr. A. Slade 
Dr. R. Virden 
2. University of York -
Dr. C. Hill 
Mr. S. Smerden 
3. University of Munich 
Prof. Bock 
Fr. D. Sizmann 
4. Boehringer Mannheim GmbH 
Dr. K. Beaucamp 
Dr. P. Buckel 
Dr. Dvorak 
Dr. S. Fischer 
Dr. M. Jarsch 
Dr. Prinz 
Dr. G. Schumacher 
Dr. Tischer 
Dr. Popp 
Dr. H. Lenz 
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Report 
of the Group Meeting of the European Communities Biotechnology 
Action Programme on 
"Folding, Assembly, Stability and Genetic Modification 
of Penicillin Acylase and its Precursor" 
The group meeting was attended by the three EC contrators and by 
two guest groups from Newcastle upon Tyne (biochemical 
characterization of the enzyme reaction) and from York 
(crystallography and X ray analysis of penicillin acylase). 
Summary of the presented talks: 
1. Dr. Schumacher, Boehringer, Tutzing: 
The DNA sequence of the penicillin acylase structural gene 
reveals that the two dissimilar subunits of the mature enzyme, 
a and ß, are derived from a common precursor polypeptide. 
Plasmids wee constructed coding for a , for ß, for both sub-
units in an operon, for an N-terminally extended a subunit and 
for a precursor protein lacking the signal peptide. Problems 
of penicillin acylase overproduction were discussed. 
2. D. Sizmann, Munich: 
a and ß subunit as well as a stabilized form of the precursor 
without signal peptide were purified as inclusion bodies. A 
model for the processing pathway of the penicillin acylase 
precursor was presented derived from in vitro processing 
experiments. Three mutant precursor polypeptides showing 
impaired processing behaviour have been obtained and in-
vestigated. Constructions of further mutant precursor proteins 
were discussed. 
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3- Dr. Virden, Newcastle upon Tyne: 
Approaches for the chemical and kinetic characterization of 
the active site of penicillin acylase were presented. 
Different inhibitors were investigated for their inhibition 
potential. Inhibition of enzyme activity by PMSF and re-
activation of activity by 6-APA were studied and the reaction 
constants were determined. The catalytic pathway proceeds via 
an acyl-intermediate . Enzyme-substrate interactions were dis-
cussed. 
4. Dr. Slade, Newcastle upon Tyne: 
Chemical studies of the active site using the irreversible 
inhibitor PDCP and the reversible inhibitor PMSF were re-
ported. Identification of the active site with the help of 
S-radi olabe led PMSF proved to be difficult due to loss of 
the label. A method for thiol modification of the active site 
was presented; the data allocate the catalytic center to the 
ß-subuni t. 
5. Dr. Hill, York: 
A method for purification of penicillin acylase by hydrophobic 
interaction chromatography was discussed. Crystallization of 
the pure penicillin acylase has been achieved and studies of 
o o 
these crystals at 7 A and 2.8 A resolution were reported. 
Approaches to obtain heavy metal derivatives of the crystals 
were explained. 
6. Prof. Pain, Newcastle upon Tyne: 
A model for folding of proteins from a fully denatured form to 
the native state was presented. The implications in protein 
synthesis and in protein export as well as factors affecting 
the refolding were discussed. 
7. Dr. Linsey, Newcastle upon Tyne: 
The characteristic solution conformation of penicillin acylase 
and the process of unfolding was investigated by circular 
dichroism and fluorescence spectrometry studies. Intermediate 
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concentrations of the denaturing agent resulted in p r e c i p i t a -
tion of penicillin acylase whereas the fully denatured form of 
the protein stays s o l u b l e . 
In order to coordinate the scientific activities of the p a r t i -
cipating groups a rough time schedule for future experiments was 
set up for the period of a year. 
It was the general feeling of all participants that the meeting 
was extremely useful for the exchange of ideas and for the co-
ordination of e f f o r t s . There is hope that penicillin acylase will 
be one of the best studied models on protein design since 
excellent expertises from many directions flow together in this 
joint p r o j e c t . It was felt that the group should meet immediately 
again when the 3D structure of the enzyme is a v a i l a b l e , at least, 
h o w e v e r , after one year. 
The organizers and all p a r t i c i p a n t s thank the EC BAP programme 
for the financial support of this w o r k s h o p . 
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P R O G R A M M E 
Workshop/Meeting of contractants of the EC Biotechnology Action 
Programme 
■GENETIC MANIPULATION OF LACTIC ACID BACTERIA 
FOR IMPROVED DAIRY FERMENTATION' 
a t 
I n s t i t u t e of M i c r o b i o l o g y , F e d e r a l D a i r y R e s e a r c h C e n t r e , 
K i e l , F e d e r a l R e p u b l i c of Germany 
S e p t e m b e r 17 t o 1 9 , 1987 
T h u r s d a y , S e p t e m b e r 17 
18:00 (6 p.m. ) - 19 :30 
Opening: 1. Representation of activities of the Federal Dairy 
Research Centre at Kiel (Teuber) 
2. Presentation of Kiel-group 
a) Phage systematics (Teuber) 
b) Phages of thermophilic lactic streptococci 
(Krusch/Neve) 
c) Phage resistance of mesophilic streptococci 
(Ge is/Neve) 
d) Specificity of protease (Bockelmann) 
20:00 (8 p.m.) 
Dinner at local pub 'Forstbaumschule1(very informal and relaxing) 
Friday, September 18 
9 :00 to 10 :30 
Presentation of Cork-group 
1. Phage resistance 
2. Transposons 
3. Proteinase 
4. Lactobacillus 
(Daly, Vaughan, Hill, Coffey) 
10:30 to 11:00 Coffee break 
11 :00 - 12 :30 
Presentation of Groningen-group 
1. The proteinases of lactic streptococci: 
a genetical approach (Kok) 
2. Characterization and use of Streptococcus cremoris 
promoter sequences (van der Vos sen ) 
3. Deletion formation of pAMß in Bacillus subtilis 
(van dër Lelie) 
4. Campbel1-type integration of plasmid DNA in 
Streptococcus lactis (Leenhouts) 
12 :30 to 13 :30 
Lunch at cafeteria of the Federal Dairy Research Centre 
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13 :30 to 15 :00 
Presentation of Ede-group 
Genetic Characterization of Leuconostoc spp. from 
Dutch Starter Cultures (David) 
Expression Vectors for Lactic Streptococci (Simons) 
Organization of the S. crémor is SKll proteinase gene 
(Vos, P.) 
Replication of the S.lactis plasmid pSH71 (de Vos) 
Characterization of related S.crémor is SKll phages 
(de Vos) 
1. 
2 
3 
4 
5 
15:00 to 15:30 coffee break 
15 :30 to 17 :00 
Presentation of Reading/Norwich-group (Gasson) 
Programme to be anounced 
17 :00 to 18 :30 
General discussion 
20:00 Buffet-dinner at Flintbek (Invitation to the home of M. 
Teuber ) 
Saturday, September 19 
10:00 to 15:00 (open end) 
Workshop at the Institute: 
Electronmicroscopy of phage and plasmids 
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L I S T OF PARTICIPANTS 
( a s o f A u g u s t 2 8 , 1 9 8 7 ) 
1. University college Cork 
Charly Daly 
Elene Vaughan 
Colin Hill 
Eden Coffey 
2. NIZO, Ede 
Willem M. de Vos 
Silke David 
Pieter Vos 
Guus Simons 
3. University Groningen 
Gerard Venerna 
Jan Kok 
Jos van der Vossen 
Niels van der Lelie 
Kees Leenhouts 
Maarten van de Guchte 
Marco van Belkum 
Alfred Haandrikman 
4. National Food Research Institute Reading/Norwich 
Michael Gasson 
further participants to be anounced 
5. Bundesanstalt für Milchforschung Kiel 
Michael Teuber 
Arnold Gels 
Horst Neve 
Uli Krusch 
Sylvia Sellmer 
Rolf Braun 
Wilhelm Bockelmann 
Barbara Kiefer 
Sven Paul 
Stefan Hertwig 
Kwang-hee Lee 
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BAP-0199-D 
In the field of 
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PROGRAMME 
May 27 Friday 
Aims of the meeting; Proposition of the schedule; 
Introducing each other. (H.Fukuhara) 30' 
9:30-12:00 . What is Kluyveromyces ? (Chair Whittaker) 
M.Smith : Classification of the genus Kluyveromyces v.d.Walt 30' 
Steensma : Electrophoretic karyotype of K.marxianus and 
K.lactis strains. 30' 
F.Sor : Chromosomes of Kluyveromyces 30' 
P.Whittaker: Protoplast fusion 30' 
-Lunch- * 
14:00-16:00 Transformation and cloning systems (Chair Frontali) 
M.Bianchi : 2u-like plasmmid pKDl and chromosomal ARS 30' 
L.Frontali: ARS elements of K.lactis 15' 
X.J.Chen : pKDl-derived vectors 30' 
M.Wésolowski-Louvel/C.Tangy-Rougeau: KEX1 protease of K.lactis 30' 
-Pause-
16:30-18:30 Regulation related topics (Chair Breunig) 
K.Breunig : Regulation of the yeast LAC genes 30' 
A.Reynal/C.Gerbaud/F.Iborra: Promoter of the B-glucosidase gene 
from K.fragilis 30' 
C.Falcone : Alcohol dehydrogenase genes of K.lactis 30' 
A.Domínguez : Acide phophatase of yeast 30' 
-Dinner- *• 
May 28 Saturday 
9:00-11:00 Mitochondria related topics (Chair Ferrerò) 
A.Ragnini : Mitochondrial DNA of K.lactis 30' 
P.Whittaker: Problems with mitochondrial antibiotics/ 
Pathways of alternative respiration. 30' 
I.Ferrero/P.Goffrini: RAG genes 30' 
11:00-12:00 Coffee and general discussion 
K.lactis as a genetic system, origin of our strains, 
known genes and mutations, nomenclature, genetic 
techniques, prospects for K.lactis and related species, 
making a list of concerned labs, future meetings, etc. 
-End-
The detailed content of the seminar will not be published. A short 
report will be sent to the CEC. 
* The lunch will be taken at the university cantine (36.50 F); the 
dinner will be served at the "Restaurant des Pins" in the campus near 
the building 400 ( 110 F). 
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REPORT OF THE ELWW SEMINAR "BIOLOGY OF THE YEAST KLUYVEROMYCES" 
ORSAY, 27-28 May 1988 
23 participants (10 laboratories including 3 contractants) from 6 
countries. 
Subject ; 
Biology of the yeast Kluyveromyces. 
Local organizer ; 
H.Fukuhara, Institut Curie, Orsay. 
Dimension and structure : 
One invited lecture, 14 oral presentations, a general discussion. 
Objectives; 
This is the first attempt to make a working network specialized for 
this area of research, although several important groups could not be 
included this time. The general objectives are (i) to put into contact 
the laboratories to allow direct exchange of information on their 
activities, and (ii) to prepare future gatherings of greater dimension. 
Specific objectives are (i) to construct a coherent genetic system for 
Kluyveromyces lactis, (ii) to evaluate the possibilities of cooperation 
between laboratories, and (iii) to have an overview of the current 
research in this field and, identify, if any, difficulties and 
deficiencies. 
Conclusions 
Among the species of Kluyveromyces, K.lactis is the only species 
for which a workable genetic system has been known. However, the other 
species are taxonomically well studied, and molecular approaches allow 
us to exploit their physiological particularities. Molecular analysis of 
chromosomes and mitochondrial DNA confirmed earlier taxonomic studies 
and added new insights into the relatedness between these species. 
Vector systems have become available for several of them, and .being used 
for cloning of genes. A few studies on gene regulation are quite 
advanced, especially for the lactose metabilism which is one of the 
major interests of this group of yeast. Concerning the mitochondria and 
their role in the general biology of K.lactis, new aspects seem to 
emerge with respect to what has been known in Saccharomyces. Active 
participation of researchers from the applied field was most 
appreciated. 
We were aware of other progresses in the field such as killer 
system, secretion and their applications, which are the leading topics 
in Kluyveromyces research. They should be discussed in next meetings 
with participation of representative laboratories. In order to set up a 
formal genetic system of K.lactis, it was proposed to standardize the 
nomenclature of mutations isolated in different laboratories. A list of 
available K.lactis gene clones will be prepared. It was a generally 
expressed wish of the participants that another European meeting of 
this type be organized within a year. 
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ELWW SEMINAR: Biology of the yeast Kluyveromyces 
May 27-28 1988, Institut Curie, Section de Biologie, Building 111, 
University of Paris, Orsay Campus, France. 
Names 
PARTICIPANTS 
Laboratory and address 
Breunig, Karin Institut of Microbiology, University of 
Dusseldorf, Uiversitatstrasse 1-GEB.2612, D-
4000 Dusseldorf, RFG 
Bianchi, Michele Maria Department of Cellular and Developmental 
Falcone, Claudio 
Frontali, Laura 
Smith, Maude 
Steensma, Yde 
Gerbaud, Claude 
Iborra, François 
Reynal, Alain 
Ferrerò, Iliana 
Goffrini, Paola 
Whittaker, Peter 
Domínguez, Angel 
Fleer, Reinhard 
Yeh, Patrice 
Ratomahenina 
Biology, University of Rome, Piazza A.Moro, 
Rome 00185, Italy 
Centraalbureau voor Schimmelcultures. Yeast 
Division. Julianalaan 67a 2628 BC Delft, The 
Netherlands 
Delft University of Technology, Department of 
Microbiology & Enzymology, Julianalaan 67, 2628 
BC Delft, The Netherlands 
Laboratoire de Génétique Moléculaire, 
Université de Paris-Sud. Bâtiment 400, Orsay 
91405 France 
Institute of Genetics, University of Parma, 
Corgo Carissimi 10, 43100 Parma, Italy 
Department of Biology, St.Patrick's College, 
Maynooth, Co. Kildare, Ireland 
Department of Microbiology, University of 
Salamanca, 37008 Salamanca, Spain 
Genetic/Rhone-Poulenc-Santé, 160 Qauai de 
Polangis, 94340 Joinville-le-Pont, France 
Chaire de Microbiologie, ENSA-INRA, Place 
Viala, 34060 Montpellier, France 
Chen, Xin-Jie 
Tanguy-Rougeau, Christine 
Sor, Frederic 
Ragnini, Antonella 
Wésolowski-Louvel, Micheline 
Wilson, Cathal 
Suda, Kohta 
Institut Curie, Section de Biologie, 
Centre universitaire, Orsay, 91405, France 
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EUROPEAN LABORATORY 
WITHOUT WALLS 
ßAP-0153-GR 
BAP-0152-GR 
BAP-0200-D 
In the field of 
BIOTECHNOLOGICAL 
OF Zymomonas 
APPLICATIONS 
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WORKING SEMINAR OF THE ELWW 
in the field of : BIOTECHNOLOGICAL APPLICATIONS OF ZYMOMONAS 
* * 
1. Local organizer : Dr. Milton A. Typas 
2. Proposed dates for the seminar : 19-20th December , 1987 
3. Proposed site for the seminar : Department of Biochemistry, Cell & Molecular 
Biology and Genetics , Athens University 
4. Designation of laboratories whose par t ic ipa t ion would be requested : 
4 . 1 . From the BAP programme: Athens Universi ty , Dept.Biochemistry, Cell & Molecular 
Biology and Genetics 
Ioannina University , Dept of Chemistry , Div.of 
Biochemistry and Organic Chemistry 
Jülich , Kernforschungsanalage , Biotechnologie 
4.2. From outside the BAP_£rogramme : 
Invited speaker 
4.3. From interested firms : "BIOHELLAS" , Biotechnology Company in Greece 
- 134 
The Athens meeting on "Biotechnological applications of 
Zymomonas" under the scheme of E.L.W.W. seminars, was organized 
in order to bring the collaborating groups together and enable 
them to exchange recent results, discuss in detail experimental 
difficulties, new ideas and approaches towards the common final 
goal. The overall progress was discussed and the groups came up 
with the following conclusions : 
a) techniques for helped conjugation are of common use now by 
all researchers involved in the common project, with 
satisfactory rates and they are the best tool for genetic 
recombination in the bacterium for the moment. 
b) the structural analysis of Z.mobilis natural Plasmids is now 
nearly finished and physical maps of all Plasmids are available 
c) the promoter of the pyruvate decarboxylase gene from 
Zymomonas has been isolated and various recombinant vectors 
have been constructed 
d) similarly, expression vectors have been constructed and the 
transfer of foreign genes (e.g.alanine dehydrogenase) show some 
promissing results 
e) auxotrophic markers of all different strains have been 
produced, by various ways, and these mutants show a greater 
stability than antibiotic resistance markers. However, stable 
glutamine non-utilizing mutants have not been isolated yet 
f) transposons have been succesful ly transferred in Zymomonas 
but they show great instability. Similarly, several indications 
for genetic instability and rearrangements in Zymomonas have 
been presented 
g) gene banks have been established for the study of the 
recombination system in the bacterium 
h) although an operational transformation system has not been 
established, results show that radioactively labeled DNA is 
uptaken by the bacterium, but it is rapidly degraded in the 
host cells 
i) optimum protoplast formation and fusion conditions have been 
established in the organism 
j) immobilization of Zymomonas on y a lumina pellets shows that 
this system has several advantages.over the traditional yeasts 
for continuous ethanol production. 
It was generally agreed that the organism still presents 
several difficulties, which should be looked into, more 
carefully. The transformation system of the organism will be a 
valuable tool and research into this field should be carried 
on, bearing in mind that the sofar published systems do not 
work with Zymomonas. The failure to isolate any strain specific 
phages or to succeed in infecting the organism with a wide 
variety of phages tested shows that more work on this field 
should be done. Gene stability and genetic rearrangements 
present great difficulties for all genetic studies and thus, 
apart from further research to find the possible reasons for 
'these phenomena, only genetically stable markers and auxotrophs 
should be used. The succesful transfer of transposons in the 
organism and their subsequent instability gives more ground for 
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transposon mutagenesis experiments which should be also 
expanded to strain construction. Curing of Plasmid species in 
the various strains of Z.mobilis proved to be a very difficult 
task and this is approached now with hybridisation experiments 
using probes from some of these natural Plasmids. In view of 
all these, the collaborating groups have decided to join their 
efforts in a study of the recombination system of the organism-
Gene banks of the genome of Z.mobi1 is have been made and 
several U.V.-sensitive mutants have been isolated. For a more 
efficient and effective approach in this study, a visit of the 
two leaders of the Breek research groups to Jülich, in late 
June, has been organized. It was also decided that along with 
the above study the same gene banks should be used for 
complementation experiments with a large selection of 
autotrophs in order to isolate the genes responsible for 
various types of auxotrophy. 
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N A H E S L A B O R A T O R Y CITY a n d COUNTRY 
M.A.Typa s 
E.Alexandri 
I.Galani 
B.J.Mouzak 
S.Kolyva 
C.Drainas 
A. Af en d ra 
G.Barthol ornatos 
G.Koll ios 
A.Perisynakis 
A.Skordaki 
J.Roussis 
A.A.Koutinas 
M.Kanellaki 
A.Lykouriotis 
H.Sahm 
G.Sprenger 
M.Reynen 
l.Uchlenbusdi 
Athens Universi ty , Dept.of Biochemistry, Cell 
& Molecular Biology , and Genetics : Athens , Greece 
Ioannina Univers i ty , Dept. of Chemistry 
Div. of Biochemistry and Organic Chemistry 
Patras Universi ty , Chemistry Department 
Div. Analytical,Environmental and Applied 
Chemistry 
|Jul ich , Kernforschungsan lage , Biotechno-
l o g i e 
Ioannina , Greece 
Patras , Greece 
Jü l ich , FRG 
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BAP-0141-F BAP-0271-E 
BAP-0012-NL 
BAP-0262-IRL 
BAP-0045-D 
BAP-0263-IRL 
BAP-0046-UK 
BAP-00¿4¿4-UK 
In the field of 
BIOTECHNOLOGY OF GRAM-POSITIVE 
INDUSTRIAL MICROORGANISMS 
- 139 
Thursday, February 25th, 1988 
15:00 Registration 
20:00 Dinner 
Friday, February 26th 
9:00 - 9:05 
9:05 - 9:25 
S.D. EHRLICH - Opening remarks 
A. AGUILAR - General introduction 
CHAIRMAN : J.P. AUBERT 
9:25 - 9:50 
9:50 - 10:15 
10:15 - 10:40 
D. McCONNELL :. Solutions to the problem of 
genetic instability in engineered 
strains of Bacillus 
G. VENEMA : Use of genetically engineered 
Bacillus for fermentation purposes 
S.D. EHRLICH : Structurally stable plasmid 
vectors for DNA cloning in Bacillus 
subtilis 
BREAK 10:40 - 11:00 
CHAIRMAN : D. McCONNELL 
11:00 - 11:25 
11:25 - 11:50 
11:50 - 12:15 . 
12:15 - 12:40 
J. ERRINGTON : Bacteriophage vectors for gene 
cloning and genetic analysis in Bacillus 
subtilis 
P. DHAESE : Interaction of the-4)105 repressor 
with operator DNA : a mutational 
analysis and jln vitro binding studies 
S. LE GRICE : Repressible B^ subtilis 
expression systems and their use in 
production of biologically active 
heterologous protein. 
H. de LENCASTRE : The arabinose regulon 
LUNCH 
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Friday, February 26th, 1988 
CHAIRMAN : G. VENEMA 
15:00 - 15:25 
15:25 - 15:50 
15:50 - 16:15 
16:15 - 16:40 
G. RAPOPORT : Use of the sacB system for the 
secretion of proteins from B^ subtilis 
H. HESLOT : Induction of levansucrase by 
sucrose in Bacillus subtilis : 
involvement of an antitermination 
mechanism negatively controlled by the 
PTS 
A. GALIZZI : The Bacillus subtilis outB gene 
is autogenously regulated 
W. SCHUMANN : Isolation of heat-shock genes 
from Bacilli 
BREAK 16:40-17:00 
CHAIRMAN : H. HESLOT 
17:00 - 17:25 
17:25 - 17:50 
17:50 - 13:15 
18:15 - 18:40 
G. GRANDI : The B^ subtilis neutral protease 
precursor is autocatalytically processed 
B. DIDERICHSEN : Construction and analyses of 
amylase hybrids 
A. KLIER : Characterization of the 130 kDa 
protein genes of the Bacillus 
thuringiensis israelensis crystals 
J. MAHILLON : Class II transposon Tn4 4 30: 
involvement of an integrase-like protein 
in the cointegrate-resolution process 
DINNER 
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Saturday, February 27th, 1988 
CHAIRMAN : M- YOUNG 
9:00 - 9:25 
9:25 - 9:50 
9:50 - 10:1! 
10:15 - 10:40 
J.C. PATTE : Genetic transfer and molecular 
biology of corynebacteria 
P. YEH : Isolation and characterization of 
the genes specifically involved in the 
meso-diaminopimelate/lysine biosynthetic 
pathway of Corynebacterium glutamicum 
J.F. MARTIN : Molecular genetics of amine 
acid-producing corynebacteria : 
structural and functional analysis of 
the cloned tryptophan and threonine 
opérons of Brevibacterium lactofermentum 
K. DUNICAN : Genetic studies on 
Corynebacterium glutamicum 
BREAK 10:40 - 11:00 
CHAIRMAN : J.F. MARTIN 
11:00 - 11:25 
11:25 - 11:50 
11:50 - 12:15 
12:15 - 12:40 
M. YOUNG : Efficient transfer of Plasmids and 
transposons into Clostridium 
acetobutylicum 
W.L. STAUDENBAUER : Development of 
thermophilic clostridial vector Plasmids 
N.P. MINTON : Vector development in 
Clostridium acetobutylicum 
J.P. AUBERT : Organization and expression of 
Clostridium thermocellum cellulose 
degradation (eel) genes 
LUNCH 
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Saturday, February 27th, 1988 
15:00 
ROUND TABLE - TRENDS AND PERSPECTIVES 
CHAIRMAN : 
S.D. EHRLICH 
PARTICIPANTS : 
A. AGUILAR, J.P. AUBERT, G.A. van den BERG, B. DIDERICHSEN, 
G. GRANDI, H. HESLOT, B. JARRY, A. KLIER, J.F. MARTIN, 
J.C. PATTE, A. SABATIER, G. VENEMA, M. YOUNG 
143 -
BAP sectorial Meeting 
"Biotechnology of Gram-positive 
industrial microorganisms" 
Dourdan 2 6-27 February 19 8 8 
R O U N D T A B L E 
The final session of the meeting was a round table, centered on 
two main aspects : (1) the quality of research in the field of 
Gram positive organisms in Europe, (2) the involvement of 
induetry in that research, within the frame work of BRIDGE. 
The session was chaired by S.D. Ehrlich (INRA, France), the 
participants were : 
A. AGUILAR (CEE, Bruxelles) 
J.P. AUBERT (Institut Pasteur, France) 
G.A. van den BERG (Gist-Brocades N.V., The Netherlands) 
B. DIDERICHSEN (NOVO Industry, Danemark) 
J. DUARTE (LNETI, Portugal) 
G. GRANDI (ENI Ricerche, Italy) 
H. HESLOT (INA-PG, France) 
B. JARRY (Eurolysine, France) 
J.F. MARTIN (Leon University, Spain) 
D. McCONNELL (Trinity College, Ireland). 
G. RAPOPORT (Institut Pasteur, France) 
A. SABATIER (Rhone Poulenc, France) 
G. VENEMA (Groningen University, The Netherlands) 
M. YOUNG (University College of Wales, United Kingdom) 
(1) The general feeling, expressed explicitely by several of the 
participants (van den Berg, Diderichsen, McConnell, Sabatier), 
was that the research presented at the meeting, which reflects 
the research in Europe, was excellent. Studies on DNA metabolism, 
including stability of genetic information, were given as an 
example where European research has a leading position world-wise 
(Sabatier, Venerna), while in the field of protein secretion the 
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research was perceived to be as good as in the United states 
(McConnell, Venerna). Support for the two domains was called for 
(van den Berg, Martin, Sabatier). Further suggestions included 
support for research in physiology of growth at high temperatures 
(Sabatier), development of genetic methods in less well known 
bacteria (Martin) and studies on sugar transport and Krebs cycle, 
leading towards controlling energy flow in bacteria (Jarry). 
(2) Several of the participants with industrial affiliations 
(Diderichson, Jarry, Sabatier) stressed the importance of good 
basic research for the industry in Europe. The potential for 
involvement of industry appears, however, limited by the fact 
that industry can not invest major amounts of funds in "pre-
competitive" research (van den B e r g ) . Difficulties related to 
confidentiallity are also clearly preceived by both industrial 
and public sectors scientists (Diderichsen, Grandi, Heslot, 
Martin, Venerna), particularly in the context of industrial micro-
organisms, where it is not easy to drow a line between the pre-
competitive and the competitive research (Jarry). Experience 
gained from currently run national programs of cooperation 
between.- 'public and "induetrial. sectors, such as CHVP in France, 
which covers several microorganisms of industrial importance 
(Bacilli, Streptpmuces, yeast), was quoted as potentially useful 
for solving some of the above difficulties (Rapoport). Several 
participants presented their own experience with cooperative 
programs of that kind (Grandi, Helsot, Venerna). Negotiations 
between the industrial and public contractants to define, on a 
case to case basis, the results to be kept confidential and those 
to be published seems to be common to many of these. A question 
which may be raised is whether it would be possible to consider a 
provision of that nature in the BRIDGE contracts involving 
industry. 
Increasing the role of industry in conception of programs and 
choice of projects (Diderichsen) and creating mixed teams, 
composed of university and industry scientists (Sabatier) were 
also seen as potentially furthering cooperation between the 
industrial and the public research. A suggestion, interesting in 
a more global context, to create a European research center in 
microbiology, which would treat problems of industrial importance 
and be capable of providing graduate training, was also made 
(Diderichsen). 
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A b s t r a c t N° 
A. AGUILAR Commission of the European Communities, 
DG XII, F-2, SDME 3/64., 200 rue de la 
Loi, B-1049 Bruxelles, Belgique 
J.P. AUBERT Institut Pasteur, 23 rue du Docteur Roux, 75724 Paris cedex 07, France 
23 
G.A. van den BERG Gist-Brocades N.V., P.O. Box 1, 2600 Ma 
Delft, The Netherland 
R. COCKER BIOCON Ltd, Kilnagleary, Carrigaline, Co 
Cork, Ireland 
T. DAUVRIN Laboratoire d'Enzymologie, UCL, 1 place 
de la Croix du Sud, 1348 Louvin la 
Neuve, Belgique 
P. DHAESS Lab. Genetics, . State University of 
Ghent, B-90Ö0 Ghent, Belgique 
B. DIDERICHSEN NOVO Research Institute, Novo Allé, DK-
2880 Bagsvaerd, Denmark 
J. DUARTE Biotechnology, LNETI, Queluz-de-Baixo, 
P-2745 Queluz, Portugal 
L.K. DUNICAN Department of Microbiology, University 
College, Galway, Ireland 
19 
S.D. EHRLICH Institut Jacques Monod, T43, 2 place 
Jussieu, 75251 Paris cedex 05, France 
J. ERRINGTON Microbiology Unit, Dept. Biochemistry, 
University of Oxford, United Kingdom 
S. GALIZZI Dept Genetica e Microbiologia "A. 
Buzzati-Traverso", Università di Pavia, 
1-27100 Pavia, ITALIE 
10 
G. GRANDI ENI Ricerche, Via San Salvo 1, San 
Donato Milanese, 20097 Milano, ITALIE 
12 
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H. HESLOT Laboratoire de Génétique, I.N.R.A., 
Centre des Biotechnologies Agro-
industrielle, 78850 Thiverval Grignon, 
France 
E. JARRY Laboratoire de Recherche Eurolysine, 
Centre Scientifique d'Orsay, Bâtiment 
403, 91405 Orsay cedex, France 
J. KREFT Institut für Genetik und Mikrobiologie, 
der Universität Würzburg, Lehrstuhl für 
Mikrobiologie, Röntgenring 11, 37 
Würzburh, den, R.F.A. 
S"'. LE GRI CE Central Research uhits, 'F. Hoffmann-La 
Roche'& Co, CH-4002 Basel, Switzerland 
H. de LENCASTRE Laboratorio de Genética Molecular, 
Instituto Gulbenkian de Ciência, Oeiras, 
Portugal 
D. MCCONNELL Dept. Genetics, Trinity College, Lincoln 
Place Gate, Dublin 2, Ireland 
N.P. MINTON Microbial Technology Laboratory, CAMR 
PHLS, Porton Down, Salisburry SP4 OJG 
Wiltshire, United Kingdom 
Abstract N° 
A. KLIER Institut Pasteur, Service de Biochimie 
Microbienne, 28 rue du Docteur Roux, 
75725 Paris cedex 15, France 
14 
J. MAHILLON Plant Genetic Systems N.V., J. 
Plateaustraat 22, B-9000 Ghent, Belgique 
15 
J.F. MARTIN Departamento de Microbiologia, Facultad 
de Biologia, Universidad de Léon, Léon, 
Espagne 
18 
J.C. PATTE Laboratoire de Chimie Bactérienne, 
C.N.R.S., 31 chemin Joseph Aiguier, 
13402 Marseille cedex 9, France 
16 
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RAPOPORT Institut Pasteur, Service de Biochimie Microbienne, 28 rue du Docteur Roux, 
75724 Paris cedex 15, France 
A.M. SABATIER Rhone Poulenc Sante, Centre de Recherche 
de Vitry sur Seine, 94407 Vitry sur 
Seine, France 
VENEMA Dept. Genetics, Center of Biological 
Sciences,. Kerklaan 30, 3751 NN Haren 
(Gn), The Netherlands 
Abstract N° 
V. SCHUMANN Lehrstuhl für Genetik, Universität Bayreuth, D-8580 Bayreuth, R.F.A. 11 
W.L. STAUDENBAUER Technische Universität München, Lehrstuhl für Mikrobiolgie, Arcisstrasse 
21, 8000 München, R.F.A. 
21 
P. YEH Genetica, 160 quai de Polangis, 
Joinville-le-Pont, France 
94340 17 
M. YOUNG The University College of Wales, Dept. 
Botany and Microbiology, School of 
Biological Sciences, Aberystwyth SY23 
3DA, United Kingdom (present adress: 
Institut Jacques Monod T43, 2 place 
Jussieu, 75251 Paris cedex 05, France) 
20 
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Programme for the Working Seminar of ELWWs "Environmental Control of 
Metabolic Fluxes as a Basis for Biotechnological Processes" 
July 6, 7 and 8, 1988; Biological Centre, Haren, The Netherlands 
Wednesday evening, July 6: Arrival at Amsterdam Airport. Departure 
times of direct trains from the Airport to Assen: 16.05 and 17.05 h. 
Arrival of trains at the Railway station Assen: 18.35 and 19.35 h. We 
will meet you at the.station. Accommodation has been arranged at Hotel 
Wapen van Leiden, Oude Rijksweg 1, VRIES (Tel. 05921 - 41316) 
July 7 and 8: Scientific sessions in the Biological Centre Haren 
Thursday, July 7: Chairman Professor W. Harder 
9.30 h: Introduction 
9.45 h: Physiology and biochemistry of methanol utilization by 
thermotolerant methylotrophic Bacillus sp. 
N. Arfman. University of Groningen 
10.30 h: Coffee 
11.00 h: Environmental control of metabolic fluxes in thermotolerant 
methylotrophic Bacillus sp. 
A.G. Brooke, E.M. Watling, M.M. Attwood, University of 
Sheffield 
11.45 h: Physiology of a thermotolerant methylotroph NCIB 12522 in 
chemostat systems 
N. Al-Awadhi. EAWAG 
12.30 h: Lunch 
13.30 h: Further studies on the genetics of thermotolerant 
methylotrophic Bacillus sp. 
G.E. de Vries. University of Groningen 
14.15 h: Possible applications of metabolic control analysis in 
methylotrophic organisms 
J.R. Small. University of Groningen 
15.00 h: Tea 
15.30 h: Effect of heat shock on the growth of cultures of 
Klebsiella pneumoniae and a thermotolerant methylotroph 
NCIB 12522 
A. Heitzer, EAWAG 
16.15 h: General Discussion 
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Friday, July 8: Chairman Professor D.W. Tempest 
9.30 h: Bioenergetic aspects of thermophilic bacteria 
W. de Vrii. University of Groningen 
10.15 h : F u r t h e r s t u d i e s on t h e g r o w t h o f B a c i l l u s 
s tea ro thermophi lus 
R. Burke. Un ive r s i ty of Shef f ie ld 
11.00 h : Coffee 
11.30 h : Is potassium essential for the growth of bacteria under all 
conditions? 
D.W. Tempest*. J. Pennock*, P.M. Neijssel#. M.J. Teixeira 
de Mattos# and E.T. Buurman#, *University of Sheffield; 
#University of Amsterdam 
12.15 h: Lunch 
13.30 h: What does a batch growth curve look like? 
Th. Egli, EAWAG 
14.15 h: General Discussion 
15.00 h: Tea 
15.30 h: Future Research and Funding 
Saturday, July 9: Programme of social activities 
Sunday, July 10: Departure 
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WORKING SEMINAR UNDER THE BAP PROGRAMME 
"ENVIRONMENTAL CONTROL OF METABOLIC FLUXES AS A BASIS FOR 
BIOTECHNOLOGICAL PROCESSES" 
Biological Centre, University of Groningen, Haren, July 6-9 1988. 
Local Organizers: Dr. L. Dijkhuizen/ Prof W. Harder 
A meeting was arranged between the two participating laboratories in 
the BAP programme (Prof. W. Harder, Department of Microbiology, 
University of Groningen, The Netherlands; Prof. D.W. Tempest, 
Department of Microbiology, University of Sheffield, UK). In addition, 
the groups of Prof. O.M. Neijssel (Department of Microbiology, 
University of Amsterdam, The Netherlands) and Prof. G. Hamer (EAWAG, 
ETH Zürich, Switzerland), were invited. Sixteen members of these groups 
participated in the meeting, ten of which presented a research seminar, 
relating to the physiology, biochemistry or genetics of the 
thermotolerant/ thermophilic bacilli under investigation. 
Bacilli are currently used in a variety of industrial processes 
based on carbohydrates as feedstocks. In order to be able to fully 
exploit their biotechnological potential, a detailed knowledge of the 
mechanisms involved in controlling metabolic fluxes in these organisms, 
particularly those leading to useful products, is required. It is our 
intention to examine in a few bacterial species the regulation of 
carbon substrate metabolism, its bioenergetic consequences and the 
carbon flow into metabolites with an industrial potential. The 
organisms selected for these studies are the thermophile Bacillus 
stearothermophilus and recently isolated thermotolerant, methanol-
utilizing, Bacillus species. 
In the first year that the programme has been running, a detailed 
quantitative study of energy transduction and carbon assimilation in 
Bacillus stearothermophilus and methanol-utilizing Bacillus species has 
been undertaken. For this purpose the organisms were grown in 
continuous cultures under a variety of nutrient-limiting conditions. 
This approach also allowed an assessment of the potential of these 
organisms to overproduce compounds of possible industrial importance. 
With cultures of the methylotrophic bacilli grown under, for instance, 
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potassium-limiting and methanol-excess conditions, a substantial part 
of the carbon supplied in the feed was indeed found to accumulate in 
extracellular products. 
Several presentations dealt with an evaluation of the general 
properties of the Bacillus species and the enzymology of growth on 
methanol, glucose or glycerol. In the methylotrophic bacilli an NAD-
dependent alcohol dehydrogenase appears to be involved in the initial 
oxidation of methanol to formaldehyde. In Bacillus stearothermophilus, 
glycerol metabolism was found to proceed via the so-called 
phosphorylative pathway, involving a glycerol kinase. Both these 
enzymes were synthesized upto extremely high levels. The characteristic 
properties of these enzymes, and the possible application of the 
underlying powerful expression systems for heterologous gene 
expression, were discussed. 
During the meeting sufficient time was set aside to discuss future 
joint experiments and publications. In addition, a considerable 
exchange took place of techniques used by the various groups. 
The overall feeling was that the work programme was progressing well 
and that the meeting had been most successful. 
It was agreed to plan the next (biannual) meeting of the participating 
groups in March 1989. 
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List of Participants of the Working Seminar under the BAP Programme 
"Environmental Control of Metabolic Fluxes- as a Basis for 
Biotechnological Processes", Haren July 6-9, 1988. 
Professor W. Harder 
Dr. L. Dijkhuizen 
Dr. G.E. de Vries 
Dr. J.R. Small 
Mr. N. Arfman 
Dr. W. de Vrij 
University of Groningen, The Netherlands 
Professor D.W. Tempest 
Dr. M.M. Attwood 
Dr. A.G. Brooke 
Dr. R. Burke 
Miss L. Watling 
University of Sheffield, United Kingdom 
Professor 0. Neijssel 
Dr. M.J. Teixeira de Mattos 
University of Amsterdam, The Netherlands 
Dr. T. Egli 
Mr. N. Al-Awadhi 
Mr. A. Heitzer 
Mr. R. Schneider 
EAWAG, ETH Zürich, Switzerland 
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HORIZONTAL BAP MEETING ON EXTREMOPHILES 
LONDON, December 2, 1987 
In connection with a symposium entitled "Extremophiles: Exploration 
and Exploitation" organized by the EFB Working Party on Microbial 
Physiology (and sponsored by the Society of Chemical Industry in col-
laboration with the Society for General Microbiology) in London on 
December 3 and 4, 1987, a so-called horizontal meeting of BAP con-
tractors and experts working on extremophiles was held at the premises 
of the Society of Chemical Industry (London) on December 2, 1987. 
Present at the meeting were Prof. M. De Rosa, Napoli, Italy, Dr. J.C. 
Duarte (Lisboa, Portugal), Dr. L. Dijkhuizen (Haren, The Netherlands), 
Prof. C. Grandi (Padova, Italy), Prof. W. Harder (Haren, The Nether-
lands, Chairman), Dr. A. de Leeuw (Delft, The Netherlands), Dr. F. 
Meussdörfer (Düsseldorf, W. Germany), Prof. C. Ratledge (Hull, United 
Kingdom), Prof. M. Rossi (Napoli, Italy), Dr. S. Struwe (Copenhagen, 
Denmark) and Prof. K.O. Stetter (Regensburg, W. Germany). Unfortunately 
Prof. Tempest (Sheffield, United Kingdom) was unable to attend, but a 
short presentation of his project was given by Prof. W. Harder. 
The meeting was .opened at 2.00 p.m. After a word of welcome from the 
chair, each participant introduced himself, stated his particular 
interest in extremophiles and explained how his research projects were 
related and integrated into the BAP programme. Subsequently 10-15 
minutes oral presentations of the various research projects were given 
by Professors Rossi, Grandi and De Rosa on properties of enzymes and 
membranes of thermophiles, by Dr. Dijkhuizen on the physiology of 
methylotrophic thermotolerant bacilli and by Dr. Meussdörfer on fatty 
acid modification by microbial enzymes. Whereas the first three pro-
jects have already been running for 3 years, which was evident from the 
considerable amount of information that was presented, the latter 2 
projects and that of Prof. Tempest had just been started. There was, 
however, no shortage of ideas and it is expected that rapid progress 
will also be made in these programmes. Each of the presentations was 
followed by discussions. See for a summary of the presentations the 
enclosed abstracts. 
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From these discussions it became clear that all participants were 
enthusiastic about the initiative taken by the Commission to bring the 
present group together. Ample scope for future collaboration was ap-
parent in several areas of the existing programme and it was decided to 
submit to the commission a proposal to form a club of scientists work-
ing on extremophiles within the EEC countries. The present BAP con-
tractors could function as a nucleus for setting up this club and are 
prepared to initiate an attempt to organize future collaboration in the 
context of "European Laboratories without Walls" as part of the BAP 
programme. 
It was decided to focus our attention on a limited number of aspects 
of Extremophiles which were considered as being of immediate import-
ance. These are: a) physiology and metabolic regulation, b) membranes 
and proteins c) whole cell biocatalysis and d) genetics. A suggestion 
was made to meet again prior to the forthcoming FEMS symposium on "The 
Microbiology of extreme environments" to be held September 18/23, 1988 
in Lisboa, Portugal. This next meeting should be planned well ahead of 
time and should preferably last one day. 
Towards the end of the meeting Dr. S. Struwe presented various 
research projects on extremophiles that are currently underway in 
Denmark. Interaction of several projects with similar programmes in 
other EEC countries is certainly possible and would be welcomed by the 
participants of this meeting. 
Haren, December 8, 1987 
Prof. W. Harder 
Chairman of the Meeting 
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EEC Meeting Sheffield November 30th - December 1st 1987 
Held at University of Sheffield, Department of Microbiology, Room F35. 
November 30th .1987 
10.00 - 10.15 
10.15 - 10.45 
Programme 
Chairman Professor D.W. Tempest (Sheffield) 
Introduction 
Miss J. Pennock (Sheffield) - The regulation of carbon 
metabolism in thermophilic Bacilli. 
10.45 - 11.15 
11.15 - 11.30 
11.30 - 12.00 
12.00 - 12.30 
12.45 - 14.00 
14.15 - 14.45 
14.45 - 15.15 
15.15 - 15.45 
15.45 - 14.00 
16.00 - 16.30 
16.30 - 17.30 
Dr M.J. Teixeira de Mattos (Amsterdam) - Regulation 
of carbon substrate flux in anaerobic chemostat 
culture. 
Coffee 
Dr A.G. Brooke (Sheffield) - A study of metabolic 
fluxes in thermotolerant methylotrophic Bacilli. 
Miss E.M. Watling (Sheffield) - The physiology of 
thermotolerant methylotrophic Bacilli. 
Lunch 
Dr L. Dijkhuizen (Haren) - Applied aspects of growth 
on methanol. 
Mr N. Arfman (Haren) - The purification and 
characterization of a novel methanol dehydrogenase. 
Dr G. De Vries (Haren) - The genetics of 
thermotolerant methylotrophic Bacilli. 
Tea 
Mr N. Al-Awadhi (Zurich) - Growth of thermotolerant 
and thermophilic solvent utilizing bacteria. 
Overall Discussion 
December 1: 
10 
11 , 
11. 
12, 
14, 
.15 -
.15 -
.30 -
.45 -
.00 -
11 
11 
12 
14 
st 1987 
.15 
.30 
.30 
.00 
Chairman Professor W. Harder (Haren) 
Future Research: further coordination of research 
topics. 
Coffee 
Future funding possibilities 
Lunch 
Free to discuss closer collaboration and writing of a 
joint paper. 
Free afternoon 
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Report of the meeting held in Sheffield University, Department of Microbiology, 
November 30th and December 1st 1987. 
Local organisers: Professor D.W. Tempest/Dr M.M. Attwood, 
EEC contact number BAP-0270-UK (HI). 
A meeting was arranged between the two participating laboratories in the 
above BAP programme; that is, the Department of Microbiology, University of 
Sheffield, U.K. and University of Groningen, The Netherlands. Pertinent work 
groups from ETH-Zurich, Sutherland and The Department of Microbiology, 
University of Amsterdam were invited. The list of participants and the agenda 
for the meeting are enclosed. 
All the lectures were well presented and the discussions were lively and 
well directed. The overall feeling was that the meeting had been most 
successful and the work programme was progressing very satisfactorily. Further 
work schedules were planned and the next research meeting will be on July 
7th-8th 1988 at the University of Groningen, Biological Centre, Haren, The 
Netherlands. 
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List of Participants EEC Meeting Sheffield November 30th - December 1st 1987 
Professor W. Harder 
Dr L. Dijkhuizen 
Dr G. De Vries 
Mr N. Arfman 
University of Groningen 
University of Groningen 
University of Groningen 
University of Groningen 
The Netherlands 
Professor O.M. Neijssel 
Dr M.J. Teixeira de Mattos 
University of Amsterdam 
University of Amsterdam 
Professor D.W. Tempest 
Dr M.M. Attwood 
Dr A.G. Brooke 
Dr R. Burke 
Dr A. Moir 
Miss J. Pennock 
Miss L. Watling 
Mr P. Mallinder 
University of Sheffield U.K. 
University of Sheffield 
University of Sheffield 
University of Sheffield 
University of Sheffield 
University of Sheffield 
University of Sheffield 
University of Sheffield 
Dr T. Egli 
Mr N. Al-Awadhi 
ETH Zurich 
ETH Zurich 
Switzerland 
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Working Seminar of the ELWW in the field of: Mitochondrial Genetics in 
Relation to Crop Improvement 
The discussions in this workshop held at the John Innes Institute, 
Norwich, UK on September 18, 1987 were centered on three topics; 
structure and function of the mitochondrial genome; mitochondrial 
transformation; organelle transfer. In the first of these discussion 
sessions Dr. C. Thomas of the John Innes described his work on the 
mitochondrial plasmids of sugarbeet and in particular the information 
acquired on their sequences and transcripts. Certain common sequences 
among the plasmids were observed which might indicate a role as 
replication origins. Two transcripts have been detected from one of 
the plasmids, one transcript from another and several from a third. 
Putative promoter sequences are highly conserved on all three plasmids. 
It is hoped that the determination of sequences which promote 
replication and transcription will be useful in the development of 
vectors for transforming mitochondria. Of particular interest in the 
report of the work of the Orsay group provided by Professor Quetier was 
that of an analysis of the changes induced in the mitochondrial genome 
of two varieties of wheat during culture of callus derived from 
immature embryos. The changes observed in non embryogénie callus 
differed consistently from those observed in embryogénie callus and the 
implications of these observations are indeed far reaching. From this 
same laboratory Dr. Lejeune described his observations on a region of 
chloroplast DNA found in wheat mitochondrial DNA; this has been highly 
conserved during the evolution of wheat, being present in the 
progenitors of this crop. The possible mechanisms of mitochondrial 
recombination are being investigated and initial experiments aimed at 
studying this process were described. Recent work in the laboratory 
of Professor Briquet at Louvain-le-Neuve has included studies of a 
variant polypeptide -unique to cytoplasmic male sterile strains of Vicia 
faba. In this same species mitochondrial plasmids have been sequenced 
and transcripts detected from them. Origin of replication like 
sequences are also observed in two of these plasmids. The origin of 
cytoplasmic male sterility in sugarbeet has always been a paradox; 
evidence from the Dijon laboratory described by Dr. Berville suggested 
that the Owen form of cms may have arisen from a hybrid of garden beet 
and sugarbeet. This hypothesis is based on the observations of the 
chloroplast DNA of the two forms; garden beet has a similar chloroplast 
DNA to cms forms of sugarbeet whereas the fertile forms of sugarbeet 
have a different chloroplast DNA. Of particular interest was the 
observation from this same laboratory that in maize the information 
coding for susceptibility to the T-toxin of Helminthosporium maydis can 
be separated from the information coding for cytoplasmic male 
sterility. 
The second section of the meeting dealt with mitochondrial 
transformation and clearly this work is at a very early stage. Dr. de 
Haas from the laboratory of the Free University in Amsterdam described 
a strategy for isolating replication origins from chloroplast and 
mitochondria. Their ability to act as autonomously replicating 
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sequences (ARS) in yeast is a part of the strategy for their 
recognition. Chloroplast sequences isolated from Nicotiana tabacum, 
Petunia hybrida and Euglena gracilis show considerable homology to ARS 
sequences. Candidate ARS sequences from mitochondria have also been 
identified and a putative origin of replication from P. hybrida 
mitochondria shows many similarities to mitochondrial replication 
origins from Saccharomyces cerevlsiae. In addition they exhibit 
similar secondary structures to yeast replication origins and highly 
conserved sequences on sugarbeet minicircle DNAs. The problems of 
transforming mitochondria were also discussed by Mr. Moore from 
Edinburgh University. Vector constructs incorporating selectable 
markers and putative promoters were described with the particular 
problem being highlighted of the difficulty of selecting markers which 
will be expressed in mitochondria and not in the nucleus or 
chloroplast. To aid integration, homologous sequences from mitochondria 
were being incorporated into the construct. Dr. Vassarotti from 
Louvain-la-Neuve described an essentially similar approach being 
undertaken in their laboratory to produce suitable constructs for 
mitochondrial transformation; problems of copy number, transfer, 
delivery and of selection procedures were highlighted by all the 
participants in this section. 
In the final section on organelle transfer Dr. Lawrence of the John 
Innes Institute described her work to develop a system for 
mitochondrial transfer in sugarbeet. Suitable procedures have been 
devised to allow microinjection of mitochondria and the indications are 
that a successful regeneration of callus from microinjected protoplasts 
can now be obtained. The implications of the successful application of 
this technology are very significant in terms of the genetic analysis 
of mitochondria and also in terms of crop improvement of those species 
in which cytoplasmic male sterility is an important component of the 
production of new varieties. Mrs. Jensen of the Free University, 
Amsterdam is attempting to transfer organelles by protoplast fusion. 
Suitable donor or recipient strains with appropriate markers are being 
constructed and methods of inactivating the nuclei prior to fusion are 
being developed. 
The success of a meeting of this kind ultimately depends on the 
readiness with which participants exchange information; in these terms 
the workshop was outstandingly successful and at the end a joint 
decision was taken to circulate preprints amongst participants, to 
encourage exchange of students and research workers between 
laboratories, to identify the specialised techniques which each 
laboratory has and which might be of value to the others, to exchange 
clones wherever possible and to undertake joint experiments in all 
instances where benefits could accrue from this. The network of 
existing collaborations among the participants is already very 
substantial indeed and is indicative of the value of the concept of the 
European laboratory at large. 
Professor D. R. Davies. 
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ELWW meeting on "Hairy root and plant cell differentiation". 
Università "La Sapienza", Dip. Genetica e Biologia Molecolare, 
Rome, Sept. 15-16/1987. 
Tue, Sept. 15 
9.00-11.00 Session I. State of the art of hairy root research. 
Updating on: 
-Ri plasmids: types, maps, functions, homologies 
with Ti 
-Opines 
ll.00-li.00 Session I, cont.d 
-T-DNA: structure, homologies with Ti, various Ri 
DNAs, CT-DNA, genetic loci, ORFs, ORF cloning, tran-
scription 
-Hairy root tissues and plants: in vitro cultures, 
regeneration, hairy root phenotypes of cultures and 
plants, transgenic plants 
13-.D0-15.00 Lunch 
15.00-17.00 Session I, cont.d 
Role of hormones in hairy root induction. 
17.00-17.20 Coffee break 
17.20-19.00 Session II. Current research trends on hairy root. 
Short presentations of ongoing hairy root research 
in the various laboratories. 
Wed, Sept. 16 
9.00-11.00 Session III. 
Discussion on research perspectives based on hairy 
roots. 
11.00-11.20 Coffee break 
11.20-13.00 Definition of collaborative projects between parti-
cipating laboratories. Establishment of the ELWW. 
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-ELWW meeting on "Hairy root and plant cell 
d i f f erent i at i on" . 
-Meeting report. 
On September 15-16/1787 an ELWW working seminar on "Hairy 
root and plant cell differentiation" was held in Roma, 
Dipartimento di Genetica e Biologia Molecolare, Università 
"La Sapienza", with the participation of several european 
laboratories currently involved in hairy root research (see 
list of participants) . 
Scope of the meeting was to discuss state of the art 
research on hairy roots, define collaborative projects 
between the participating laboratories and establish an 
ELWW. 
After a thorough updating on what achieved so far on the 
various aspects of this biological system and a totally out-
spoken description of the projects and approaches currently 
underway in the different laboratories (see the scientific 
programme of the meeting) , a very fruitful discussion has 
taken place on the involvement of plant hormones in the 
hairy root syndrome. From the data presented by various 
groups and the above mentioned discussion it stood clear to 
all participants -including molecular biologists, 
microbiologists, biochemists, plant physiologists, cell 
biologists and morphologists- that the hairy root system 
bears enormous potentialities for the study of the molecular 
events underlying plant root differentiation. In'particul ar, 
the role of just a very limited number of Ri plasmid T-DNA 
genes in conferring to plant cells the competence to respond 
to the plant hormone auxin was pinpointed. These genes, 
capable of controlling root differentiation and other plant 
morphological traits, have been already cloned in expression 
vectors and transgenic plants obtained, providing unique 
biological material to approach complex problems of plant 
developmental biology. 
All participants agreed that the greatest interest of hairy 
root research lays on the unique tools it provides to get 
into the molecular physiology of root development. 
It has therefore been unanimously decided that the area of 
common interest to be covered by the ELWW should be defined 
in broader terms as "The genetic control of root 
differentiation"; within this cultural framework, 
approaches, projects and transnational collaborations not 
necessarily limited to hairy root work should be included in 
the envisaged ELWW. On the other hand, hairy root work not 
oriented towards or reí atable to the understanding of basic 
problems of plant developmental biology should be regarded 
as outside the scope of this ELWW. 
-Proposal for the estabiishment of the ELWW on "The genetic 
control of root development". 
The participants to the meeting on "Hairy root and plant 
cell differentiation", held in Rome, Sept. 15-16/1987, 
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unanimously welcome the opportunity to establish an ELWW 
according to the -following criteria: 
-The area covered by and the denomination of the ELWW should 
b e "The genetic control o-f root development" . 
-Two levels of participation to the ELWW are envisaged: 
a)ELWW membership. 
The member laboratories are not necessarily limited to 
those represented at the meeting in Rome (see 1 ist) . 
Members can be accepted provided their scientific level 
and interests meet the scope of the ELWW as judjed by 
an appropriate advisory board. 
Members of the ELWW agree on : 
i)Meeting at least once a year to exchange results and 
perspectives. 
i i)Exchanging papers at the latest when accepted for 
pubiication on the basis of an estabi ished mail ing 1 ist 
extended to all ELWW members. 
i i i)Exchanging clones, strains and other relevant mate-
rial at the latest when the work describing it is ac-
cepted for publication. 
iv)Exchanging personnel for training on new techniques 
according to the possibilities of the recipient labora-
tory . 
b)ELWW joint projects. 
Beyond the above described obiigations of the ELWW 
members, the recognised purpose of the ELWW is to foster 
transnational collaborations between member laboratories. 
These latter should, however, be free of collaborating 
individually with each other. Joint projects should 
therefore be established, within the framework of the 
ELWW, between any number of member laboratories. 
Collaborative .projects within the ELWW should be approved 
by an appropriate advisory board. 
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ELVA-/ meeting on 'Hairy root and plant cell differentiation' 
Rome Sept. 1 5/1 6/1 987-
Foreign participants: 
J. Schell, A. Spena 
Max-Planck-Institut für Züchtungsforschung, Köln, FRG 
F. Casse-Delbart, L. Jouanin, F. Vilaine 
Lab. Biologie Cellulaire, INRA, Versailles, France 
J. Tempe, A. Petit, J. Brevet 
Université de Paris-Sud, Orsay, France 
D. Chriqui 
Lab. Cytologie Végétale, Univ. P.et M. Curie, Paris 6, France 
J. Guern, C. Morel, H. Barbier 
Lab. Physiologie Végétale, CNRS, Gif-sur-Yvette, France 
J.H. Hoge 
Dept. Plant Mol. Biol., University of Leiden, The Netherlands 
G. Ooms 
Rothamsted Exp. S t a t i o n , Harpenden, UK 
Convener : 
■ P. Costantino 
Dip. Genetica e Biol.Mol., Università di Roma "La Sapienza", Italy 
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EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-013-D H. LÖRZ BAP-OW-F Y. DATTEE BAP-082-NL M.J. TEMPELAAR BAP-083-NL L.voN VLOTEN-DOTING BAP-084-I F. SALA BAP-085-F M, CABOCHE BAP-101-DK M.G.K. JONES BAP-111-B M. JACOBS 
In the field of 
CROP IMPROVEMENT THROUGH 
CELL BIOTECHNOLOGY 
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program BAP meeting Haren, the Netherlands, November '87: 
Presentations of contractants labs in EC sponsored ' Biotechnology Action 
Program ' no 165 : Genetic Manipulation and Regeneration of model and crop 
plants in vitro. 
Friday 6.11.'87 
(8.45 transport hotel-Biological Centre) 
MORNING: Biological Centre, green room. 
9.00-9*15 MJ Tempelaar (Haren, NL) 
Opening remarks 
9.15-9.45 B Junker/ E Kranz (Cologne, FRG) 
Strategies in cereal transformation 
9.45-10.15 M Jacobs/ I Negrutiu (Brussels, B) 
Gene tranfer experiments 
10.15 Coffee break, free discussion 
10.45-11.15 MGK Jones (Harpenden, UK) 
Production and characterization of somatic hybrid plants of 
potato. 
11.15-11.45 P Guerche/ Y Chupeau or C Bellini (Versailles, F) 
Direct gene transfer in Brassica and other crops 
11.45-12.15 Y Henri/ Y Dattee/ D Negri (Orsay, F) 
Relationship between mitochondrial genome organisation and 
regeneration ability in long term wheat somatic tissue culture 
12.15-12.45 M Sala 
Lunch 
AFTERNOON, Eiological Centre, orange room 
Lectures on projects in the Cell and Plant Genetics group of the Genetics 
Department of the Biological Faculty of the University of Groningen. 
13.30-14.00 WJ Feenstra (Head of Genetics Dept and CP group): Overview 
14.00-14.30 LP Pijnacker: Chromosome research in potato 
14.30-15.00 E Jacobsen: Different classes of pea mutants with an altered 
symbiotic interaction. 
15.00 tea break, subsequently opportunity for informal discussions, 
visit of the lab and contact with members from various re-
search groups 
18.15 Joint dinner, Informal discussions etc 
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Saturday 7-ll-'S7 
MORNING, conference room at the hotel 
9.00-9.30 HA Verhoeven/ HCPM van der Valk (Wageningen, NL) 
Flou cytometric analysis and sorting of metaphase chromosomes 
and micronuclei from N. plumbaginifolia. 
9.30-10.00 H Jones (Harpenden, UK) 
Direct gene transfer into potato protoplasts by electropora-
tion 
10.00-10.30 G vd Steege (Haren, NL) 
characteristics of protoplasts in electric fields : uptake 
of molecules and fusion 
10.30 Concluding discussion: 
coffee & meal 
departure 
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REPORT OF BAP MEETING OF PROJECT #165, NOVEMBER 6/7 IN HAREN, NL 
The second 1987 meeting of EC-sponsored BAP project #165 has been 
held in Haren, NL on November 6 and 7. 
Now comprising 8 groups, this ELWW meeting had each lab contributing 
with presentations on their present projects. Progress had been made on 
various fronts, such as crop plants obtained from electrofusion (potato) 
and electroporation (rape), more insight in electrical conditions and mem-
brane events in electric field manipulations for fusion and DNA uptake, 
large-scale preparation of purified plant chromosomes for transformation 
and analysis. In some instances, the first results from joint experiments 
could be presented. 
In addition, one afternoon was devoted to lectures dealing with 
topics worked on in the host lab (chromosomes -and mutants of pea and po-
tato) and to visits and exchanges in various parts of the lab. 
In the informal parts of the meeting, scientific discussions were 
held, joint experiments were evaluated and future collaborative work was 
planned. 
Finally, decisions were taken on the following points: 
- Location and date of the next ELWW meeting:., 'SS The next meeting will be held on June 2 and 3 in a suitable location in 
Italy, to be selected by local organizer Dr. F. Sala. Extra funds from the 
EC might be made available for this occasion (see previous reports), and 
Dr. Sala will look into this possibility. 
- Participation of industrial representatives: 
The main topic of discussion has been on. how to communicate with industrial 
representatives. It was decided, that a special once-a-year meeting of 
the group leaders with representatives from industry (with present or fu-
ture interests) would be the best way of interaction. This is thought to 
be preferable to changing the format of the present informal and small 
ELWW meetings. In addition, the proposed conferences could have a wider 
scope than the project-bound scientific meetings. 
These procedures could start form the 2nd meeting in 1988 onwards 
and participants could then invite their sponsors to take part. 
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LIST OF PARTICIPATING SCIENTISTS BAP MEETING NOVEMBER 1987, HAREN, NL 
B. Junker and E. Kranz, 
Max-Planck-Institut für Züchtungsforschung, 
Abt.Genetische Grundlagen der Pflanzenzüchtung, 
Egelspfad, 
D-5000 KÖLN 30, 
W-Germany. 
M. Jacobs, I. Negrutiu and T. Wichai, 
Laboratorium voor Plantengenetica, 
Vrije Universiteit Brussel, 
Paardenstraat 65, 
B-1640 SINT-GENESIUS-RODE, 
Belgium. 
M.G.K. Jones and H. Jones, 
Biochemistry Dept., 
Rothamsted Experimental Station, 
Harpenden, Herts, 
England, AL5 2JQ. 
L. van Vloten-Doting, H.A. Verhoeven and H.C.P.M. van der Valk, 
ITAL, 
Postbus 48, 
6700 AA WAGENINGEN, 
The Netherlands. 
F. Sala, 
University of Pavia, 
Dept. of Genetics and Microbiology, 
Via S. Epifanio, 
1-27100 PAVIA, 
Italy. 
P. Guerche and C. Bellini, 
INRA, 
Route de Saint Cyr, 
F-7800 VERSAILLES, 
France. 
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Y. Dattee, Y. Henri and N. Negri, 
Université Paris-Sud, 
Lab d'Amélioration des Plantes, 
Bat. 360, 
F-91405 ORSAY CEDEX, 
France. 
M.J. Tempelaar, G. van der Steege and W.J. Feenstra, 
Department of Genetics, 
Centre of Biological Sciences, 
University of Groningen, 
Kerklaan 30, 
9751 NN HAREN, 
The Netherlands. 
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Friday June 3 
Morning 
9.00 M. VALDEZ: 
STOLARTZ •-
M. VICENTE: 
10.30 Break 
10.45 C. TONELLI: 
H. LORTZ: 
M. JONES: 
Afternoon 
CAMOGLI 2-4 JUNE 1988 
E.L.W.W. MEETING 
PROGRAMME 
"Protoplast isolation from calli of the wild rice 
Oryza longistaminata" 
"Cell and protoplast culture of tri-ticale" 
••implementation of biotechnological techniques in 
a Mediterranean crop: the olive tree" 
"Analysis of somaclonal variants in tomato" 
"In vitro culture and transformation studies in 
barley" 
"Further characterization of somatic hybrids of 
S.tuberosum and S. brevidens (chromosomes, 
nuclear and chloroplast DNA contributions)" 
16.00 H. VERHOEVEN - "Isolation and characterization of micro 
protoplasts" 
H. van der VALK- "Towards chromosome mediated gene transfer. Vital 
staining and regeneration of immobilized 
protoplasts" 
I. NEGRUTIU: - "Transient expression: observations and 
speculations" 
17.30 Break 
17.50 R. CELLA: 
M. JACOBS: 
H. JONES: 
Saturaday, JUNE 4 
Morning 
9.00 M.J. TEMPELAAR 
"Intracellular localization of dihydrofolate 
reductase (DHFR-TS) in carrot cells resistant to 
methotrexate" 
"More facts about gamma-fusion" 
"Application of electroporation for stable 
integration and transient gene expression studies 
in potato protoplasts" 
"Progress in genome transfer into potato 
protoplasts" 
H. VAUCHERET: - "Improvement of electroporation by the use of 
Lambda recombinant DNA" 
W.J. FEENSTRA: - "Genetic analysis of starch biosynthesis in 
potato" 
10.30 Break 
10.45 E. NIELSEN: - "The valine-resistance of Nicotiana 
M. TERZI: 
11.45 
plumbaginifolia cell line as a tool to study 
regulation of branched-chain amino acid pathway" 
"Developmental mutant in somaţi embryogenesis" 
Discussion on the future of the C.E.C, programme 
in the BRIDGE perspectives 
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REPORT OF THE MEETING OF THE BAP GROUP : 
"Genetic manipulation and regeneration in model and crop plants in vitro", 
CAMOGLI (Italy), 2-4 June 1988. 
Research teams : 
M.G.K. Jones, Biochemistry Department, Rothamsted Experimental 
Station, U.K. ; 
M. Tempelaar, Genetics Department, University of Groningen, 
The Netherlands ; 
L. van Vloten-Doting, ITAL, Wageningen, The Netherlands ; 
M. Jacobs, Molecular Biology Department, Free University of 
Brussels, Belgium ; 
F. Sala, Genetics and Microbiology Department, University of 
Pavia, Italy ; 
M. Caboche, INRA, Cell Biology Laboratory, Versailles, France; 
H. Lorz¿ Max-Planck-Institute, Köln, FRG ; Y. Dattee, University of Orsay, France. 
Our research teams meet at six-month intervals to transfer 
information and technology and to plan joint experiments. 
The fifth meeting has been organized by the Italian group 
(University of Pavia) and held at Camogli (Genova) on June 2-
4. 
Twenty-seven participants coming from the eight laboratories 
presented data on the progress of their research. Dr. Miguel 
Vicente was a guest scientist and took actively part in the 
scientific discussion, also in view of his application to 
join, with his "Centro de Investigaciones Biológicas" 
(Madrid), our BAP research group. 
Progress has been made in different fronts. The Köln group 
presented data on efficient and reproducible methods for 
induction of somatic embryogenesis in Triticosecale. The Pavia 
group greatly extended their genetic and molecular analysis of 
somaclonal variants in tomato, showing their usefullness in 
plant breeding, demonstrated that the in vitro culture can 
lead to extensive nuclear DNA amplification in rice and 
performed a biochemical characterization of valine-resistant 
mutant plant cell lines. Encouraging data have been obtained 
at Köln on the culture of barley protoplasts and on their 
genetic transformation, while at Rothamsted further somatic 
hybrids between Solanum tuberosum and S^ brevidens have been 
obtained and characterized and a second field experiment is in 
progress. Asymmetric hybrids have been obtained at Sint 
Genesius Rode and demonstrations has been given that gamma-
irradiation of one of the two partner protoplasts can lead to 
the transfer of a few genetic components. 
102 -
Gene transfer is being pursued at ITAL where the development 
of chromosome transfer by micronuclei has been advanced up to 
the fusion stage, while (in a collaborative research between 
Rothamsted and Groningen) detailed work has been carried out 
on electroporation with potato protoplasts. Electroporation is 
also being utilized at Versailles where lambda recombinant DNA 
has come out as a most effective gene vector. Sint Genesius 
Rode produced data intended to elucidate the patterns of 
integration and expression of foreign genes following direct 
gene transfer into protoplasts of two Nicotiana species. 
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PARTECIPANTS 
Camogli 2 4 J u n e 1 9 8 8 
E . L . W . W . M e e t i n g 
PAVIA Francesco SALA 
Erik NIELSEN 
Giuseppe FORLANI 
Stefano CASTIGLIONE 
Rino CELLA 
Paola MIRANDA 
Maria Luisa MARCHESI 
Giuseppe GAVAZZI 
Chiara' TONELLI 
Mario TERZI 
KÖLN STOLARTZ 
STOLARTZ 
H. LORTZ 
ORSAY Marta VALDEZ 
D. NEGRI 
MADRID Miguel VICENTE 
HARPENDEN Michael G.K. JONES 
Hedduryn JONES 
GRONINGEN G. Van der STEEGE 
M.J. TEMPELAAR 
W.J. FEENSTRA 
WAGENINGEN Henry Van der VALK 
Harrie VERHOEVEN 
Van VLOTEN-DOTING 
SAINT GENESIUS RODE M. JACOBS 
loan NEGRUTIU 
VERSAILLES Catherine BELLINI 
Hervé VAUCHERET 
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EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-079-F P. BOISTARD 
BAP-080-IRL M. O'CONNELL 
BAP-081-D A. PÜHLER 
BAP-100-UK P.R. HIRSCH 
In the field of 
SYMBIOTIC GENES IN RHIZOBIUM : 
CONSTRUCTION OF IMPROVED STRAINS 
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Comparison of late symbiotic genes in Rhizobium species and construction 
of improved strains. 
Pierre Boistard, CNRS-INRA, Toulouse, France 
Penelope Hirsch, Rothamstead, Harpenden, U.K. 
Michael O'Connell, NIHE, Dublin, Ireland 
Alfred Puhler, Bielefeld, West Germany 
Participants in the above contract met in Dublin on October 15th and 16th 
1987. The meeting was attended by P. Boistard, D. Kahn, J. Batut, M. 
David (Toulouse), P. Hirsch (Rothamstead), A. Puhler, U. Priefer, 
(Bielefeld), M. O'Connell, M. Hynes, G. Reigh and D. Donnelly (Dublin). 
The Toulouse group reported on the genetic analysis of a cluster of 
nitrogen fixation genes located on the symbiotic megaplasmid of Rhizobium 
meiiloti. The role of fixL fix J genes as positive regulators of nitrogen 
fixation was determined using lac fusions and the expression of fixN, a 
gene belonging to the cluster was found to be regulated by oxygen. 
At Rothamsted experiments were carried out with R. leguminosarum biovar 
viceae to assess the influence of different chromosomal backgrounds and 
different symbiotic plasmids on the efficiency of the symbiosis. Strains 
with different chromosomal backgrounds but the same symbiotic plasmid 
varied in the onset of nitrogenase activity while strains with different 
plasmids in the same background varied in final yields as measured by 
plant dry weight. Chromosomal substitutions were made for comparison, 
using the plasmid R68.45 as a vector. 
The Bielefeld group reported the cloning of genes involved in lipopoly-
saccharide production in R. 1eguminosarum biovar viceae and genetic _ 
mapping of the regions involved. Lipopolysaccharide mutants have a fix 
phenotype and are non motile. 
The Dublin group reported the isolation of a Fix mutant of R. 
leguminosarum biovar viceae which is altered in exopolysaccharide 
production. Also, siderophore production was found in different species 
of Rhizobium as a strain specific phenomenon. 
The following transnational collaborations were planned during the 
meeting. Arrangements were made to accommodate visiting scientists at 
Toulouse for both long and short periods. Joint experiments were planned, 
specifically aimed at locating genes in R. 1egumino sarum biovar viceae 
corresponding to the fix regulatory genes L and J of R. meliloti. 
Exchange of clones and mutants between Dublin and Bielefeld was arranged 
to facilitate a comparative analysis of the mutants isolated. Increased 
industrial participation in the contract was planned. Finally, it was 
agreed that the four laboratories remain open to expansion of the 
collaboration to include other groups, in particular any interested 
Spanish or Portuguese groups. 
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EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-202-NL J.L. VAN WENT 
BAP-203-F CH. DUMAS 
BAP-204-I M. CREŞTI 
In the field of 
POLLEN BIOTECHNOLOGY 
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POLLEN BIOTECHNOLOGY - ELYY ACTIVITY BAP - 0202 NL 
- 0203 F 
- 0204 I 
(CREŞTI, Siena- DUMAS. Lyon - WILMS. Wageningen) 
This 3rd workshop held in Lyon (Istand 2nd of februardy 1988) followed 
those previously organized in Lyon (19-20 may 1987) and Wageningen (august 1987). 
This workshop was organized in 3 parts. 
- 1- Main data obtained in 1987 
- 2- Scientific exchanges planed during the 1st semester of 1988 
-3-Prospects for 1988. 
I- MAIN DATA OBTAINED DURING 1987 
Different subjects were presented during the 1st day through several talks 
followed by informal discussion. In addition to the activity of this ELWW several 
additionnai talks from invited speakers belonging to Lyon's group. 
- Pollen quality (Dr. C. DIGONNET-KERHOAS and P. ROECKEL, Lyon) 
-Stierm cell (SO 
. Isolation 
- Corn (Dr. E. MATTHYS-ROCHON, Lyon) 
- Spinach (K. THEUNIS, Wageningen ) 
- Brassica ( Dr.E.MATTHYS-ROCHON, S. DETECHEPARE, Lyon) 
Quality 
- Corn (P. ROECKELV. WAGNER, Lyon) 
- Male programme 
- Bmssica ( S. DETECHEPARE, Lyon) 
-Wheat (P. VERGNE, Lyon) 
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- Cytoskeleton 
- Nicotiana (A.TIEZZI.Síena) 
- Invited speakers 
- Molecular biology of the male programme in Brassica (CM. 
GUILLY. and P. HEIZMANN, Lyon) 
- Use of M. abs in self-incompatibility in Brassica (T. GAUDE, 
Lyon ) 
Publications; A book and several papers in preparation. 
II- SCIENTIFIC EXCHANGES 
a)- Between BAP participants, 2 nd semester 1987 workshops not included. 
Wageningen A.Tiezzi 
M. Murgia 
Siena 
Lyon A, Moscatelli (to test Mabs on SC, cytoskeleton ) 
Siena H. Wilms 
Wageningen 
Lyon K. Theunis (to learn SC isolation) 
b)- Lyon > Wageningen E. Matthys-Rochon (2nd workshop) 
c)- Participants to the 3rd workshop in Lyon: 
Siena (M.Creşti,A.Tiezzi) 
Wageningen ( K. Theunis, J. Van Went, H. Wilms) 
Lyon (S. Detchepare, C Dumas. I. Dupuis, T. Gaude, CM Guilly, P. Heizmann, N. Jnoud, 
C Kerhoas-Digonnet, E. Matthys-Rochon, P. Roeckel, P. Vergne, V. Wagner). 
Invitated and excused' ORSAN (Jarry). ICI (Schuch). DGXII Staff (Magnien, 
Nettancourt de). 
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I l l - PROSPECTS FOR 1988 
a)- To solve technical problems met in 1987 on. 
- pollen quality 
- SC isolation 
- MGU characterization 
b)- To improve SC characterization, and storage 
c)- To elucidate MGU formation (EM studies. Mabs) 
d)- Exchnages between scientists 
e)- Meeting in Siena (June 1988) 
- Organization of a common poster on "Pollen Biotechnology" (BAP 
participants) 
- Workshop n*4 - Monday 30th may (morning session for BAP 
participants) 
- BAP dinner (30th evening) with invited presons. 
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OGGETTO: Meeting BAP-Siena 27 - 28 maggio 1988. 
PARTECIPANTI 
Siena: Creşti M., Tiezzi A., Ciampolini F., Murgia M., Moscatelli A. 
Lione: Matthys-Rochon E., Dupuis F., Said C , Roeckel P. 
Wageningen : Van Went J.L., Willemse M.T.M., Wilms H.J., Theunis C.H., 
Keijzer C.J.. 
Hanno partecipato alla riunione anche i Proff. Risueño M.C. 
(Spagna) e Pais M.S.S. (Portogallo). 
Sono state invitate anche le seguenti Ditte: 
Soporcel: Ferreira G., Santos I. 
I.C.I.: Schuch W., Greenland A. 
Nunhem's Zaden B.V.: De Wit J.P.C. 
Royal Sluis: Wilms H. 
Nella riunione ufficiale alla quale hanno partecipato i titolari 
dei contratti e collaboratori sono stati presi in esame i risultati 
conseguiti negli ultimi sei mesi del 1988. Vengono inoltre riassunti da 
ciascun relatore le comunicazioni che verranno presentate al Simposio 
Sexual Reproduction in Higher Plants che si è tenuto dopo il meeting 
BAP. 
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Le comunicazioni riguardanti il progetto BAP che sono state 
presentate al Simposio sono le seguenti: 
- MOSCATELLI A., TIEZZI A., VIGNANI R. and CREŞTI M. 
Presence of kinesin in the pollen tube of Nicotiana. 
- TIEZZI A., MOSCATELLI A., CIAMPOLINI F., MILANESI C , MURGIA M. and 
CREŞTI M. 
The cytoskeletal apparatus of the generative cell in several 
Angiosperm species. 
- THEUNIS C.H., VAN WENT J.L. and H.J. WILMS 
A technique to isolate sperm cells of mature spinach pollen. 
- KEIJZER C.J. 
Artificial fertilization in Torrenia. 
- MATTHIS-ROCHON E., DETCHEPARE S., WAGNER V., ROEKEL P. and DUMAS C. 
Isolation and characterization of viable sperm cells from tricellular 
pollen species. 
- SONG Y., WAGNER V., MATTHYS-ROCHON E. and DUMAS C. 
Observations on isolated embryo sacs of corn. 
Dei tre gruppi sono inoltre state presentate delle dimostrazioni 
poster. Un poster sul progetto BAP è stato allestito. 
Si è discusso inoltre con i Proff. Pais M.S.S. e Risueño M.C. del 
loro probabile inserimento nel progretto BAP. 
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Al termine della discussione si è convenuto che i due nuovi 
Ricercatori invieranno a ciascuno dei tre laboratori (Siena, Lione, 
Wageningen) il programma inviato alla CE.E. per una visione completa. 
Successivamente qualora le nuove proposte vengano accettate dalla 
CE.E. verrà convocata una nuova riunione per programmare la ricerca 
dell'ultimo anno. 
Al Simposio•che ha seguito questo meeting .hanno partecipato anche 
le Industrie sopra citate. 
Prof. Mauro Creşti 
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EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-076-NL R BAP-090-D H BAP-091-DK D BAP-099-UK M BAP-106-UK R BAP-106-F P BAP-213-D W BAP-2M-I n 
.A, SCHILPEROORT .G, SARX 
, VON WETTSTEIN , KREIS .B, FLAVELL , JOUDRIER . ROHDE . MOTTO 
In the field of 
EXPRESSION OF 
PROTEIN 
CEREAL 
GENES 
SEED 
19E 
EXPRESSION OF CEREAL PROTEIN GENES 
WORKSHOP SEMINAR HELD AT MONTPELLIER (FRANCE) 
38-29 JANUARY 1988 
The scope of this two days workshop was to convene, for 
the first time, the contractants working in the field of 
molecular biology of cereal seed protein genes. 
In addition of the contractant laboratories : 
Cambridge : FBI, Prof. FLAVELL, England 
Rothamsted : Harpenden Station, Dr. KREIS, England 
Copenhagen : Carlsberg Res. Lab., Dr. BRANDT, Denmark 
Leiden : Drs. HENSGENS, de PATER, The Netherlands 
Andernach : MALZFABRIK, M. K. BRENNER, BRD 
Kein : Max Planck I., Dr. THOMPSON, BRD 
Bergamo : I. Sper. Cerealicoltura, Dr. MOTTO, Italy 
Montpellier : INRA, Drs M.F. GAUTIER, P. JOUDRIER, France 
other laboratories were invited because of their interest 
and works in this area of research : 
Milano : CNR, Dr. VIOTTI, Italy 
Barcelona : I. biologia CSIC, Dr. PUIGDOMENECH, Spain 
Madrid : ETS Ing. Agrónomos, Dr. GARCIA-OLMEDO, Spain 
Perpignan : University, Dr. M. DELSENY, France 
The aim of the workshop was to initiate and create an 
European Laboratory Without Wall (ELWW) in the field defined 
previously. 
The workshop was divided in three sessions : 
— The first one was a presentation of the research 
intentions of each participating laboratory for the next few 
years. 
— The second one dealed with current researches 
undertaken in each laboratory. 
— The third one was a general discussion about the ELWW. 
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It would be too long to relate all the objectives and 
programmes of each laboratory, it is why we are going to 
present the main themes emerging from all research teams. 
Several research themes are concerned with the 
research activity of all laboratories such as : 
+ Structure, expression and regulation of plant 
nuclear genome with storage protein genes as a model for 
these studies. 
+ Protein structure and functionality. 
- others are rather specific of.the activities of 
laboratories such as : 
+ Isolation and characterization of genes encoding 
proteins or enzymes involved in technological quality of 
cereal products : — malting and brewing quality 
(Carlsberg Research laboratory, Malz Fabrik). 
— pasta and breadmaking quality 
(PBI, INRA-Montpellier, Rothamsted). 
+ Cell structure analysis (PBI, Carlsberg, Leiden, 
Barcelona). 
+ Embryogenesis (Leiden, Barcelona, Rothamsted). 
(All these informations a.re gathered in table 1 and 8) 
In the second session, current works • have been 
presented. Most of them are concerned with the isolation and 
characterization of genes encoding storage proteins or 
enzymes in order to have a better knowledge on the 
expression and regulation mechanisms of these genes, (cf. 
list of scientific talks). 
On maize, research are under progress concerning a 
better understanding of the 02 locus (MOTTO, THOMPSON) and 
on the characterization of organ-specific genes (embryo) 
during germination. VIOTTI's group is studying the 
expression and regulation of zein genes in yeast and also 
the methylation of zein genes in connexion with MOTTO's and 
SHEWRY's groups. 
On wheat, the characterization of clones belonging to 
different classes (gliadin and glutenin) of storage proteins 
is under way (GAUTIER), and works are done on the expression 
of these clones after transfer into tobacco (FLAVELL). This 
strategy is used to determine what specific sequences are 
important for the expression of these genes. 
GARCIA-OLMEDO's group is working on wheat sucrose 
synthase genes and at . a lesser extend on barley and 
agropyron in order to study light influence, tissue 
specificity (coleoptile and roots) and growth conditions on 
sucrose synthase gene expression. 
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On barley, studies of regulation and expression of 
barley seed protein genes are the main objectives of the 
research conducted either by the group of KREIS or BRANDT. 
Their results underlined the importance of sequence 
regions located upstream the coding region of a gene. 
On rice» researches are concerned with tissue specific 
expressed genes (HENSGENS, De PATER). 
Third session : general discussion about the ELWW. 
After the agreement of all participants to constitute 
an ELWW, a discussion took place about what the group would 
1 ike to do. 
This ELWW will gather laboratories working on seeds 
(small grain cereals, maize) and wish to enlarge the group 
to laboratories working on legumes or oilseeds. 
Research will focuse on quality problems such as 
baking quality, malting and brewing quality, nutritional 
qual i ty. 
It was also decided to write a pamphlet describing the 
research teams involved in this preliminary ELWW, the aim, 
the areas of research of overlapping interest and then to 
illustrate the research in progress by several demonstrative 
example. 
Tables 1 and E list the different research themes, 
techniques used and expertises for each laboratory. 
Although plant transformation techniques (with plasmid 
Ti) are used with success by several laboratories, there is 
no equivalent monocot transformation system. 
However, considerable efforts to circumvent this 
problem are under progress. 
It is an important limitation for research programmes 
which aims are to transfer genes to cereals crops in order 
to improve them. 
All participants agreed to have another meeting, at 
the end of 1989. 
Last, but not least, we acknowledge the generous help 
from the CEC which made the meeting possible. 
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SCIENTIFIC PROGRAM OF THE ELWW WORKING SEMINAR 
"EXPRESSION OF CEREAL PROTEIN GENES" 
First Session : Research intentions of each participating 
laboratory 
A. BRANDT : CARLSBERG RESEARCH LABORATORY 
COPENHAGEN, DENMARK. 
K. BRENNER : WEISSHEIMER MALZ 
ANDERNACH, GERMANY. 
M. DELSENY : UNIVERSITE DE PERPIGNAN 
PERPIGNAN, FRANCE. 
R. FLAVELL : INSTITUTE OF PLANT SCIENCE 
RESEARCH. CAMBRIDGE, ENGLAND. 
F. GARCIA-OLMEDO : E.T.S. INGENIEROS 
AGRÓNOMOS. MADRID, SPAIN. 
L. HENSGENS : MOLBAS RESEARCH GROUP 
LEIDEN, THE NETHERLANDS. 
P. JOUDRIER : LABORATOIRE DE TECHNOLOGIE DES 
CEREALES. MONTPELLIER, FRANCE. 
M. KREIS : ROTHAMSTED EXPERIMENTAL STATION 
HARPENDEN, ENGLAND.. 
M. MOTTO : ISTITUTO SPERIMENTALE PER LA 
CEREALICOLTURA, BERGAMO, ITALY 
P. PUIGDOMENECH : CENTRO DE INVESTIGACIÓN Y 
DESARROLLO. BARCELONA, SPAIN. 
R. THOMPSON : MAX PLANCK INSTITUT FÜR 
ZÜCHUNGSFORSCHUNG, KÖLN, BRD. 
A. VIOTTI : INSTITUTE OF PLANT BIOSYNTHESIS 
C.N.R. MILANO, ITALY. 
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Second Session : Scientific talks : 
1) MAIZE : 
M. MOTTO - Molecular studies of the high lysine 
genes opaque—E. 
R. THOMPSON - The opaque-2 locus of maize. 
P. PUIGDOMENECH - Characterization of organ-specific genes 
in mai ze. 
A. VIOTTI — The zein gene of maize : expression and 
regulation in endosperm cell and in the 
yeast S. cerevisiae. 
H) WHEAT : 
R. FLAVELL — Control of wheat storage protein 
expression. 
M.F. GAUTIER - Cloning of wheat storage protein genes. 
F. GARCIA-OLMEDO - Mapping and differential expression of 
linked sucrose synthase genes in wheat, 
barley and agropyron. 
3) BARLEY : 
M. KREIS — Regulation and expression of barley seed 
protein genes. 
A. BRANDT - Structure and expression of B, C and 
gamma—hordein genes. 
4) RICE : 
S. de PATER - Tissue specific expressed genes in rice. 
Third Session : GENERAL DISCUSSION ABOUT THE ELWW. 
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TABLE 1 
techniques/expert i se 
DNA Cloning 
DNA Sequencing 
Protein Sequencing 
Plant Transformation 
Brewing 
Breadmak ing 
Immunology 
Protein Purification 
Plant Breeding 
(formal genetics) 
Cell structure analysis 
Tissue culture 
Heterologous expression 
of proteins. 
1 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
a 
+ 
+ 
+ 
+ 
+ 
3 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
if 
+ 
+ 
+ 
+ 
+ 
5 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
6 7 8 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
9 
-f-
+ 
+ 
+ 
+ 
+ 
10 
+ 
+ 
+ 
+ 
+ 
+ 
11 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
12 
+ 
+ 
+ 
+ 
+ 
1 
E 
3 
i* 
5 
6 
7 
8 
9 
10 
11 
12 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
BERGAMO 
MILANO 
CAMBRIDGE 
MONTPELLIER 
COPENHAGEN 
LEIDEN 
ANDERNACH 
PERPIGNAN 
BARCELONA 
MADRID 
HARPENDEN 
KÖLN 
ISTITUTO PER LA CERALICOLTURA, Dr MOTTO 
ISTITUTO BIOSYNTHESI VEGETALI, Dr VIOTTI 
INSTITUTE OF PLANT SCIENCE RESEARCH, PROF. FLAVELL 
INRA, LAB. TECHNOLOGIE DES CEREALES, Dr GAUTIER, JOUDRIER 
CARLSBERG LABORATORY, Dr BRANDT 
MOLBAS RESEARCH GROUP, Dr HENSGENS, DE PATER 
WEISSHEIMER MALZ, K. BRENNER 
UNIVERSITE, LAB. PHYSIOLOGIE VEGETALE, Dr DELSENY 
INSTITUTO DE BIOLOGIA, CSIC, Dr PUIGDOMENECH 
ETS INGENIEROS AGRÓNOMOS, Dr GARCÍA-OLMEDO 
ROTHAMSTED EXPERIMENTAL STATION, Dr KREIS 
MAX PLANCK INSTITUTE, Dr THOMPSON 
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TABLE 2 
THEME/ TEAM 
Protein functionality 
Enzymes seed formation 
seed germination 
Embryogenesis 
Duality related : 
nutritional 
starch structure 
protein structure 
brewing quality 
breadmaking quality 
1 
+ 
+ 
+ 
+ 
E 
+ 
+ 
3 
+ 
+ 
+ 
+ 
+ 
^ 
+ 
+ 
+ 
5 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
6 
+ 
+ 
+ 
7 
+ 
+ 
+ 
+ 
+ 
+ 
B 
+ 
+ 
+ 
9 
+ 
+ 
+ 
+ 
10 
+ 
+ 
+ 
+ 
+ 
11 
+ 
+ 
+ 
+ 
+ 
+ 
IE 
+ 
+ 
+ 
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EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-0205-UK M.A. VENIS 
BAP-0206-NL K.R. LIBBENGA 
BAP-0207-D D. KLAMBT 
BAP-0208-UK M.A. HALL 
BAP-0209-I A. BALLIO 
In the field of 
PLANT HORMONE RECEPTORS 
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Short report on the working seminar on "Plant Hormone Receptors" held from 
11th to the 14th of April 1988 at the Physik Zentrum in Bad Honnef, FRG. 
Thirty participants from the five working groups of this joint project acti-
vely discussed the reported results on auxin-, ethylene- and fusicoccin-re-
ceptors. Three guests, two from BASF, Limburger Hof, and Bayer, Monheim, and 
one from Jeff Schell's group at the MPI für Züchtungsforschung, Köln, joint 
us. 
The most progressive report was on the isolation of cDNA clones of the maize 
membrane associated auxin binding protein from a Agt 10 library. After a period 
of two years of frustrating research Thomas Hesse could report on a successful 
isolation of these clones using oligonucleotide probes. These were constructed 
from sequenced N terminal region and several tryptic peptides of the purified 
assumed auxin receptor. These clones will help to elucidate the structure and 
functions of the auxin receptor related to cell elongation. 
There are many data for the existence of a soluble, cytoplasmic auxin recep-
tor related to cell division. Direct evidences are still missing. Bert van der 
Zaal selected cDNA clones from 2,4D treates tobacco cell suspension cultures 
which do not cross hybridize with cDNA from auxin free tobacco cells. Seven 
of these are characterized further. The mRNA of one of these are induced very 
rapid within 15 min and also by the use of IAA instead of 2,4D. Although the 
nucleotide sequence is known, the gene could not identified yet. It is ex-
pected that this gene should be auxin-dependent regulated. 
There were reports on the solubilization and further characterization of a 
ethylene binding protein which seems to be an integral membrane protein and 
of a fusicoccin binding protein, which may be only associated to the membrane. 
Investigations were started to search for endogenous ligands for the fusi-
coccin binding protein and for the N-1-naphthylphtalamic acid binding protein 
as well by immuno affinity chromatography. 
The transnational contacts and cooperations are well developped and will be 
increased within the next year. 
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EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-0077-DK R, RAJA60PAL 
BAP-0078-DK P, OLESEN 
BAP-0093-NL S.C. DE VRIES 
BAP-0098-UK K. ROBERTS 
In the field of 
E M B R Y O G E N E S I S 
I N P L A N T T I S S U E C U L T U R E 
- 205 -
M I N I S Y M P O S I U M 
EMBRYOGENESIS IN PLANT TISSUE CULTURE 
A/S DE DANSKE SUKKERFABRIKKER, BIOTECHNOLOGY SECTION, 
THURSDAY, NOVEMBER 5, 1987 - 13:15 O'CLOCK 
PROGRAMME 
13:15 - 13:45: Louise Jannick, DDS/Biotechnology Section: 
"Identification and purification of embryogénie 
cells from cellsuspension of carrot." 
14:45 - 14:30: Sacco de Vries, Agricultural University of 
Wageningen, Holland: 
"Carrot somatic embryogenesis depends on the 
phytohormone controlled presence of correctly 
glycosylated extracellular proteins." 
14:30 - 15:15: Morten Jørsboe, DDS/Biotechnology Section: 
"Peroxidases as a marker for early event in 
somatic embryogenesis." 
15:15 - 15:30: Break 
15:30 - 16:15: Roger Pennell, John Innes Institute, UK: 
"The potential of an anti-AGP monoclonal antibody in 
the molecular analysis of plant cell plasma membranes" 
16:15 - 17:00 Ole Schou, Riso Research Laboratories: 
"Detection of embryo specific marker in the plasma 
membrane by means of monoclonal antibodies." 
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EUROPEAN LABORATORY 
BAP-013-D 
BAP-OW-F 
BAP-076-NL 
BAP-078-DK 
BAP-083-NL 
BAP-085-F 
BAP-088-I 
BAP-092-I 
W I T H O U T w 
BAP-093-NL 
BAP-098-UK 
BAP-099-UK 
BAP-101-UK 
BAP-103-UK 
BAP-111-B 
BAP-205-UK 
BAP-206-NL 
In the field of 
FUNDAMENTAL ASPECTS OF 
PLANT CELL REGENERATION 
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BAP workshop on fundamental aspects of 
Plant Regeneration 
***** 
De Danske Sukkerfabrikker, Copenhagen 
24 and 25 March 1988 
Significance of the topic : 
Plant regeneration from somatic cells is only the happy end of a long 
process of cell development and differentiation with many unpredictable 
traps. This process is far from being understood, but it can be controlled 
in a limited number of species, and even in a few fortuitous genotypes of 
otherwise recalcitrant species, by disrupting iri vitro the cell 
communication channels and by applying massive hormonal doses exogenously. 
However, irrespective of the fact that some well-known regenerating systems 
have successfully been applied on a large scale (among the Solanaceae in 
particular), most research approaches failed over the last decade to 
achieve any significant progress in controlling regeneration at will. 
This is because research in this field, has been too empirical and was 
barely given the means to elucidate the switch mechanisms and molecular 
mediators which, in the intimates of plant cells, govern the activation or 
repression of developmental sequences. Plant regeneration is nothing but 
the emerged side of an iceberg built on the hidden principles of plant 
development. 
Potential users of plant regeneration in agriculture and industry attribute 
a top priority to basic research designed at controlling the underlying 
processes. This priority is based on the fact that genetic engineering has 
made tremendous progress, which often cannot be applied until any 
manipulated cell is given a chance of reproducing itself into a fully 
reconstituted and fertile organism. The first bottlenecks have been, in the 
early 80's the lack of transformation methods applicable to new species of 
interest : this has now been largely overcome (J. Schell, pers. commun.). 
In the mid-eighties, the bottlenecks have been shortages of useful genes to 
engineer plants with : this is still an important question, but no more the 
actual limiting factor, considering the number of cloned genes that await 
further uses until proper recipient systems can be designed (1987 report of 
calgene for example mentions over 60 genes and a dozen of promotors already 
cloned or licensed). 
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Potential users of plant genetic engineering therefore recommend that 
s.-gnificant means be given to public research in the area of plant cell 
regeneration (see reports to the Commission of IRDAC, of GIBiP, of CEFIC, 
etc.). While stressing the urgency of the task, they are not in a position 
to suggest what the right approaches would be. Although it is clear that 
plant regeneration is just an aspect of plant developmental biology, there 
is not a programme with time limitations which could reasonably embark on 
developmental biology in a broad sense. The purpose of this meeting, 
therefore, was to identify sharp priorities for research on very early 
"signals" that trigger cell differentiation and morphogenesis. 
Current effort in the BAP programme 
The first meeting day was an occasion to review work under way in 
contracting laboratories. The programme is appended as annex 1. 
Contributors were from 11 different laboratories, distributed as follows : 
4 labs from the ELWW (European Laboratory Without Walls) on 
"Genetics and molecular biology of somatic embryogenesis" ; 
3 labs from the ELWW on "Cell biotechnology for crop improvement" ; 
2 labs from the ELWW on "Plant hormon receptors" ; 
1 lab from the ELWW on "Hairy root and plant cell differentiation" ; 
1 lab from the ELWW on "Proteins in seed development". 
None of these ELWWs established under BAP adequately cover the topic of 
plant cell regeneration, although all of them have significant 
contributions towards the same goal. 
- From a genetic point of view : 
Isolation and characterization of temperature sensitive developmental 
mutants in carrot. 
- From a molecular biology point of view : 
Isolation and characterization of genes induced in tobacco by growth 
promoting signals (auxins, cytokinins, . . . ) , or specifically expressed 
with the early steps of either somatic embryogenesis in carrot and sugar 
beet or seed development in barley. Further isolation of transacting 
factors controlling their specific expression. 
- From a biochemical/physiological point of view : 
Identification of hormon receptors and elucidation of transducing 
sequences in maize and tobacco. 
- From a cell engineering point of view : 
Cell markers of regenerative potential, cell/tissue fractionation, in 
vitro selection of "competent" cells, etc. 
All these approaches are the different facettes of plant cell regeneration 
research. They do not constitute yet a plant cell regeneration programme. 
This would require more focus and further rationalization. 
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A plant cell regeneration programme for BRIDGE 
The second meeting day (annex 1) brought the scientific debate under the 
BRIDGE perspective. A number of conclusions have been reached as follows : 
- Experimental species : to profit from multidisciplinarity, complementary 
approaches should apply to the same experimental species. Twenty-eight 
different experimental species such as in BAP presently cannot be 
afforded any more. As there are no E. coli or Drosophila-like plant 
models whatsoever, a unique experimental species cannot be easily chosen. 
Rather than a total exclusion of alternative models, the advise would be 
to use, for each particular scientific objective, the experimental 
species which is best adapted. Carrot, tomato, potato, Brassica, maize, 
alfalfa are frequently quoted, each with a particular advantage. 
- Industrial needs : These were reviewed by the responsible scientist for 
plant biotechnology in the seed company Zaadunie (Dr. A.J. Kool). He 
stressed the objective of regeneration could not be isolated from that of 
stability and homogeneity of products. The interference of regenerative 
procedures with genetic stability will have to be taken into account. He 
mentioned embryogenesis (somatic or zygotic) as a more reliable procedure 
than in vitro organogenesis, with the implication that basic research 
could concentrate on embryogenesis. He also advocated the choice of 
experimental species best adapted to each particular type of 
investigation. These could preferably be crop species, but not a priori 
crop species. The choice of crop species in principle, without looking at 
the needs of research, could be both a scientific and a political error. 
- Genetic background : Preference should go to systems with proper and 
accessible genetic controls. Small genomes, mutants available or easily 
inducible, rapidly cycling populations, amenability to jLn vitro 
manipulation and transformation, etc. 
- Functional analysis : Many genes expressed during gametogenesis or 
embryogenesis, or triggered by external stimuli, will be cloned by the 
time BRIDGE starts. Any new programme in this field should already make 
provisions for an increased emphasis on the products of these genes and 
on the higher levels of "trans-"regulation. 
- Plant cell interfaces : The above requirement leads immediately to the 
plant plasmalemma and to the cell wall. Many of the genes mentioned, 
related to development and differentiation, either direct their product 
to the membrane/wall, are switched by transductional chains initiated 
from membrane/wall, or both. As brilliantly described by S. Fry, the cell 
wall metabolism, at the crossroads of differentiation and plant-microbe 
interactions, will appear to be the site of primary events that control 
major developmental routes : an obvious target for BRIDGE. 
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In conclusion, the organizers of the meeting reached the following 
decisions : 
1. With regard to their activity in BAP, a special ELWW on "Fundamental 
aspects of plant cell regeneration" will be established, with 
cross-representations of the other ELWWs listed above. It will hold an 
annual meeting, the one in 1989 being hosted by K. Roberts at John Innes 
Institute. 
2. With regard to the preparation of BRIDGE, S. de Vries will draft a 
scientific report to cover promising research areas as discussed here. 
His draft, being amended by all participants in this meeting, eventually 
will be transmitted by Commission services to three target groups for 
final improvement and criticism if necessary. 
. Individual experts 
. CGC brainstorming group in plant biotechnology 
. GIBiP industrial platform 
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EEC-BAP workshop on fundamental aspects of plant 
regeneration 
to be held at De Danske Sukkerfabrikker, Copenhagen, Denmark 
Program for Thursday March 24 
Chair: P. Olesen, Copenhagen, Denmark / S.C. de Vries, Wageningen, Netherlands 
09.00-09.10 P. Olesen, Copenhagen, Denmark 
Welcome to participants 
09.10-09.40 M.G.K. Jones, Rothamstead, UK 
Events involved in plant regeneration in vitro and some culture systems for 
their study 
09.50-10.20 DJ. James, East Mailing, UK 
Severe reduction in regeneration ability In regeneration-competent 
genotypes after transformation of apple and strawberry plants with 
disarmed Ti binary vectors 
10.30-11.00 Coffee 
11.00-11.30 M. Terzi, Naples, Italy 
Developmental mutants for studying plant development 
11.40-12.10 S.C. de Vries, Wageningen, Netherlands 
Extracellular proteins and carrot somatic embryogenesis 
12.20-13.30 Lunch (courtesy of DDS) 
13.30-14.00 J.H.C. Hoge, Leiden, Netherlands 
Plant genes regulated by auxin and cytokinln 
14.10-14.40 P. Olesen / J. Mollerup Andersen, DDS, Denmark 
Detection of regenerative potential 
14.50-15.20 Thea 
15.20-15.50 M. Kreis, Rothamstead, UK 
Molecular analysis of early events In barley embryo and endosperm 
differentiation and development 
16.00-16.30 P. Lazzeri, MPI Cologne, BRD 
Somatic embryogenesis In barley and other cereals 
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Program for Thursday March 24 (continued) 
17.00-20.00 Dinner 
20.00-22.00 Round table discussion on regeneration. 
- Dr. Pennell, John Innes Inst., UK will present some of his recent data on 
sugarbeet regeneration. 
- Dr. Lazzeri. MPI, Cologne will summarize the in-house workshop on 
"Somatic embryogenesis in crop plants" held at the MPI on 22-24 February 
1988 
- Further topics to be discussed will be prepared by the chairmen 
BRIDGE expert meeting on "Control of d i f fe ren t ia t ion and 
morphogenesis in plants" 
to be held at De Danske Sukkerfabrikker. Copenhagen, Denmark 
Program for Friday March 25 
Chair: S.C. de Vries, Wageningen, Netherlands 
09.00-09.30 E. Magnien, EEC, Brussels 
The importance of this meeting for the preparatory work of the EEC-BRIDGE 
program 
09.30-10.15 Report by the chairmen of the previous day on priority areas selected and 
conclusions arrived at during the round table discussion 
10.15-10.45 Coffee 
10.45-11.45 View of experts ( C. Lloyd and K. Roberts, J.I.I., Norwich, UK; S. Fry, 
Edinburgh, UK; M. Jacobs, Belgium ) contacted for this meeting on research 
areas to be developed in the field of plant cell differentiation and 
development 
11.45-12.15 A.J. Kool, Zaadunie, Netherlands 
The expectations and role of industry 
12.15-12.45 S.C. de Vries, Wageningen, Netherlands 
Tentative conclusion; future EEC-BAP meetings on fundamental aspects of 
regeneration; preparation of BRIDGE document in the area of "Control of 
development and differentiation in plants" 
12.45-13.30 Lunch and farewell 
213 
List of participants EEC workshop 2 4 - 2 5 March 1988, Copenhagen, Denmark 
1 . dr. M. Buiatti, Dip. dl Biol. Animale e Genetica, Vìa Romana 17, 50125 Firenze, Italia 
2 . dr. P. Constantino, Univ. di Roma c/o 1st. Fisiologia Generale, piazzale A. Moro 5,1-00185 
Roma, Italia 
3 . dr. S. Fry, Dept. of Botany, Univ. Edinburgh, King's buildings, Mayfleld Road, Edinburgh, EH9 
3JH, U.K. 
4 . dr. Ch.H.Hänisch ten Cate, I. T.A.L.,P.O.Box 48,6700 AA Wageningen, Netherlands 
5 . dr. J.H.C. Hoge, Dept. of Plant Mol. Biol., Univ. Leiden, Wassenaarseweg 64, 2333 AL Lelden, 
Netherlands 
6 . dr. J. Hollerup Andersen, Biotechnology Section DDS, 1 Langebrogade, P.O. Box 17, DK-101 
Copenhagen K, Denmark 
7 . dr. M. Jacobs, Inst. Mol. Biol., V.U. Brussel, Paardenstraat 65, B-1640 St. Genesius-Rode, 
Belgium 
8 . dr. DJ. James, East Mailing Res. Station, East Mailing. Maidstone, Kent ME 19 6BJ, U.K. 
9 . dr. M.G.K. Jones. Rothamstead, Harpenden AL5 2JQ, U.K. 
10. dr. M. Jullien, I.N.R.A., Route de St. Cyr, F78000 Versailles, France 
11. dr. A.J. Kool, Biotechnology Section, Zaadunie B.V., Westeinde 62, P.O. Box 26, 1600 AA 
Enkhuizen, Netherlands 
12. dr. M. Kreis, Rothamstead, Harpenden AL5 2JQ, U.K. 
13. dr. P. Lazzeri, M.P.I., 30 Vogelsang, den Egelspfad, D-5000 Köln. B.R.D. 
14. dr. C. Lloyd, J.I.I., Colney Lane, Norwich NR4 7UH, U.K. 
15. dr. A. Maan, Dept. of Plant Mol. Biol., Botanical Laboratory, Nonnensteeg 3. 2311 VJ Leiden, 
Netherlands 
16. dr. E. Magnlen, C.E.C. Dir. Biology, Div. Biotechnology, Rue de la Loi 200, B-1049 Brussels, 
Belgium 
17. dr. P. Olesen, Biotechnology Section DDS, 1 Langebrogade, P.O. Box 17, DK-101 Copenhagen K, 
Denmark 
18. dr. K. Pennell, J.I.I., Colney Lane, Norwich NR4 7UH, U.K. 
19. dr. P. Puidgomenech/Dept. Molecular Genetics, C.S.I.C., Jorge Girona Salgado 18-26, 08034 
Barcelona, Spain 
20. dr. E. Teoule, Lab. du d'amélioration des plantes, Univ. de Paris-Sud, Centre d'Orsay, F91405 
Orsay, France 
2 1 . dr. M. Terzi, Dept. of Genetics, Univ. degli Studi di Napoli, Via Mezzocannone 8, 80134 Napoli, 
Italia 
22. dr. S.C. de Vries, Dept. of Molecular Biology, Agricultural University Wageningen, De Dreijen 
11, 6703 BC Wageningen, Netherlands 
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EUROPEAN LABORATORY 
""" — 
BAP-0074-NL 
BAP-0088-I 
BAP-0103-UK 
BAP-0105-UK 
BAP-0209-I 
VVM 
m 
P. 
M. 
S. 
D. 
A. 
M U U r 
DE W I T 
BUIATTI 
FRY 
INGRAM 
BALL I O 
In the field of 
MOLECULAR PLANT PATHOLOGY 
- 215 -
PROGRAMME OF THE SEMINAR 
A May .Morning (9 -12 ) 
Factors involved in fungal pathogenicity/compatibility including fungal 
transformation 
Chairman: D.S.Ingram 
Speakers: J.Johnstone: Towards a molecular biological analysis of the 
pethogenicity of Pyrenopeziza brassicae; R.Oliver: Transformation and 
molecular aspects of pathogenicity of the tomato pathogen Fulvia fulva: 
C.Caten: Molecular analysis of the pathogenicity of Septoria nodorum to 
wheat; M.S.Wolfe: Population genetics of powdery mildews; Ingram D.S.: 
Sexual reproduction in pathogenic fungi. 
General discussion 
4 May, Afternoon (14.30 -18) 
Response of the host with emphasis on changes at protein and mRNA and 
protein level 
Chairman: P.DeWit 
Speakers: P.DeWit: Elicitors and basic compatibility factors in the host 
fungus interaction Cladosporium fulvum-tomato: J.F.Bol: Structure and 
function of virus inducible plant genes; J.Friend: The role of 
lignification as a defense mechanism; P.Ricci: Elicitors of plant defense 
reactions in Phytophtora diseases of tobacco and carnation; 
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S.Kauffmann: Isolation,characterization and biological functions of 
PR-proteins 
General discussion 
5 May .Morning (9-12) 
Plant receptors for fungal toxins and elicitors 
Chairman: A.Bailio 
Speakers: A.Bailio: Fusicoccin binding sites; J.Ebel: Soybean-membrane 
receptors for glucan elicitors from the fungus P.megasperma f.sp.glycinea: 
S.Green: Apoplastic enzymes as markers of early pathogenesis in the 
host-fungus interaction 
General discussion on proposed models of plant-pathogen interactions 
5 May .Afternoon (14.30-18) 
In vitro manipulation and selection for resistance: 
Chairman: M.Buiatti 
Speakers: M.Buiatti: In vitro markers of resistance and their use in 
selection programmes; B.Foroughi-Wehr:.In vitro selection for resistance in 
potatoes and cereals; J.Grisvard: Strategy to study the interaction between 
Phaseolus vulgaris and Colletothricum lindemuthianum using RFLP; 
General discussion on the feasibility of practical applications of present 
knowledge on plant-pathogen interactions 
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6 May .Morning (9-12) 
Round table with industries on the applications of concepts and methods 
discussed in other sessions. The round table will be chaired by E.Magnien 
and introduced by the four chairmen of earlier sessions with a summary 
of their contents. The discussion will then be open particularly to firm 
representatives. 
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This was a meeting with two purposes. In the first place, it was 
the occasion for all BAP contractors working in molecular plant 
pathology to meet together and develop further their 
transnational links. The two first days were dedicated to this 
workshop activity, and to reviewing current progress in the field 
within Europe. The last day was left for a different purpose : 
taking advantage of the participation of 13 industrial 
representatives from 6 different Member State origins, 
preliminary views on future BRIDGE research were exposed, and 
experts invited to assess possibilities for strengthening this 
specific field in the light of industrial expectations. 
1. BAP workshop (4-5 May 1988) : 
1.1. Attendance 
Five BAP contractors have been the initial nucleus for 
the organization of the workshop. Contrary to other 
research areas in BAP, this one could not be 
sufficiently funded and suffers from the non 
participation of key European experts. Still, it was a 
priority, as the area was considered by industry one of 
high significance and one where biotechnology 
breakthrough could lead to qualitative research leaps. 
Next to the five contracting participants were also 
invited 9 other recognized European experts, as well as 
the industrial scientists mentioned above, to reach the 
critical mass which would be needed if the topic was to 
receive a decisive impetus in the framework of BRIDGE. 
In this case, therefore, the Commission is not dealing 
with a BAP-ELWW (European Laboratory Without Walls), 
but with a ELWW rooted in BAP and open to many non-
contracting participants. 
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1.2. Host-pathogen relations under present focus 
As indicated in the following table : 
Solanaceae 
Legumes 
Cereals 
Ornementais 
Trees 
Plant side 
Tomato 
Tomato 
Tomato 
Tomato 
Potato 
Potato 
Tobacco 
Tobacco 
Tobacco 
_Pepper 
Participant Microbial side 
Fusarium oxysporum 
Cladosporium fulvum 
Cladosporium fulvum 
Cladosporium fulvum 
Fusarium, Helmin-
thosporium, Phytoph-
thora 
Phytophthora infestans Friend 
Tobacco Mosaic Virus 
Tobacco Mosaic Virus 
Phytophthora spp. 
Phytophthora spp. 
tSoybean Phytophthora megasperma Ebel French bean Colletothricum lindemu-
[ 
Others 
I Almond tree 
Brassica 
BAP 
Buiatti 
de Wit 
Green 
Oliver 
Foroughi-
Wehr 
Bol 
Kauffmann 
Ricci 
Ricci 
Contract 
YES 
YES 
YES 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
Barley 
Barley 
Carnation 
Carnation 
Peach, 
thianum 
Erysiphe graminis 
(mildew) 
Fusarium, Helmint-
hosporium 
Fusarium oxysporum 
Phytophthora spp. 
Fusicoccum amygdali 
Grisvard 
Wolfe 
Foroughi-
Wehr 
Buiatti 
Ricci 
Bailio 
NO 
NO 
NO 
YES 
NO 
YES 
Pyrenopeziza brassicae Ingram YES 
1.3. Major research lines : 
Five lines received attention (see also the scientific 
programme in annex 1). 
Applications of Restriction Fragment Length 
Polymorphisms (RFLP) 
The possibility to pinpoint, with specific DNA 
probes, variable sequences revealed on 
electrophoretic patterns of digested fragments from 
the total genome. A systematic study of this DNA 
polymorphism can be conducted parallel to 
segregation analyses of breeding lines tested for a 
specific resistance trait. 
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The close correlation of the expression of this 
trait with unique sets of variable sequences in the 
DNA will give access to loci in the genome which 
may contain genes controlling resistance. Prior to 
any gene identification, the DNA probes, thus 
associated to a defined genetic character, can find 
powerful applications as diagnostic tools in 
breeding, to sharply orient selection. 
Transformation methods for pathogenic frungi. 
A presentation by Oliver of newly developed methods 
to transform Cladosporium fulvum reminds us that, 
dealing. with an interaction between host and 
pathogen, the definition of resistance is always 
relative to recognition and virulance genes on the 
fungal side, implying molecular tools to study 
these genes in the pathogen and how they function. 
Transformation methods in combination with the 
analysis of non-pathogenic mutant strains will make 
this study possible. 
Population genetics in relation to fungal 
resistance to chemicals. 
This is an essential part of crop protection 
strategy; it concerns an interaction which is not 
between host and pathogen as above, but between 
populations of this pathogen and defined chemicals 
used to control them. From a strictly scientific 
point of view, this is out of the scope of the 
meeting although not irrelevant. 
In vitro selection for resistance. 
The selection of plant cells can be either for 
survival under exposure to a purified fungal toxin, 
or for the expression of biochemical features 
normally associated to resistance reactions 
(phytoalexin production, endoglucanases, 
lignin,...) This is very empirical science, as 
potentially resistant cell lines may result so for 
completely unknown reasons, and may also fail to 
express the desired level of resistance when 
selected cells are regenerated into plants grown in 
the field. The position of industrial firms was 
quite clear on this type of work : some simply do 
not believe in it, others do think good breeding 
material could occasionally come out of it but, in 
this latter case, consider _in vitro screening as 
their own development work which is not in the 
domain of public research. 
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Recognition steps and activation of plant defences. 
This point is listed here as the last one because 
of its overwhelming importance. It occupied 2/3 of 
the discussion time in the meeting, appeared to be 
the most rewarding one from a scientific point of 
view and the one attracting the highest interest 
from industry. Dominating speakers were de Wit, 
Green, Kauffmann, Ebel, Boi, Ricci and Bailio. 
Three of them (underlined) are presently BAP 
contractors. The attention of these groups is 
focused on specific and rare signal molecules which 
can be traced at very early stages of both 
compatible and incompatible interactions. Plant 
genes and/or products characteristic of these 2 
types of interactions are described, mainly in two 
classes : the phytoalexins which are secondary 
metabolites, and PR (pathogenesis-related) proteins 
which belong to 4 immunological groups and appear 
to be hydrolases. An immense interest is 
concentrated on the plant wall where the initial 
events may take place and which was shown to 
release oligosaccharides with an eliciting power. 
The plant cell wall/membranes have already been 
identified as important targets in the coming 
BRIDGE programme. 
BRIDGE round table with industry (6 May 1988). 
The list of participating industrial scientists is provided 
as annex 2. 
Three major questions were debated : 
- Where to focus collaborative research ? 
Is concentration on few experimental species 
recommended ? 
What sort of involvement in Community research is 
industry expecting ? 
In conclusion, and with some oversimplification may be, industry 
in this BAP workshop urges again the Commission to support 
international cooperation. 
Their expectations in basic research is that 
the Commission prepares BRIDGE with new objectives, but relying on 
implementation methods mainly inherited from BAP. The situation 
would be totally different with a programme of product-oriented 
research, like ECLAIR or EUREKA, where industry would easily step 
in and be prepared to take leadership. The message of these 13 
industrial representives in Florence was essentially that both 
types of programmes are equally important from their point of 
view, but should not be mixed up as far as implementation 
mechanisms are concerned. 
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MOLECULAR PLANT PATHOLOGY 
Florence, 4-6 May, 1988 
List of industrial participants 
B.C. Baldwin 
G. Biasini 
T.K. Bradshaw 
A. Burggraaf 
M. Dubois 
G. Freyssinet 
B. Grezes-Besset 
L. Martinelli 
F. Massardo 
R. Pontzen 
R. Shields 
P. Van den Elzen 
F. Vecchio 
J. Wall 
ICI Seeds 
Montedison 
SHELL Research Ltd. 
Phytotec 
SANOFI-Elf 
Rhône-Poulenc Agrochimie 
SANOFI-Elf 
Montedison 
Montedison 
BAYER AG 
UNILEVER 
MOGEN International 
ORIS/SIPCAM 
Agricultural Genetic 
Company 
Bracknell (UK) 
Massa (I) 
Sittingbourne (UK) 
Louvain-la-Neuve (B) 
Labège (F) 
Lyon (F) 
Labège (F) 
Massa (I) 
Milano (I) 
Monheim (D) 
Sharnbrook (UK) 
Leiden (NL) 
Milano (I) 
Cambridge (UK) 
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BIOTECHNOLOGY OF ANIMALS 

EUROPEAN LABORATORY 
WITHOUT WALLS 
B A P - 1 2 7 - F 
B A P - 1 2 8 - F 
B A P - 1 2 9 - F 
B A P - 1 3 0 - D 
B A P - 1 3 2 - D 
HACHE 
ENGASSER 
NABET 
LEHMANN 
SCHÜGERL 
In the field of 
BIOCHEMICAL-PHYSICAL KNOWLEDGE, CONTROL 
OPTIMISATION OF ANIMAL CELL CULTURES IN 
BIOREACTORS 
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ELWW - meeting in the field of 
Biochemical-physical knowledge, control, optimization 
of animal cell cultures in bioreactors 
NANCY, 30 - 31 May 1988 
List of participants: 
K. Schiigerl, D. Wentz, G. Kretzmer, H. Graf 
Universität Hannover 
Institut für Technische Chemie 
Callinstr. 3 
D-3000 Hannover 
J. Lehmann, H. BÜntemeyer 
Lehrstuhl - Biotechnik tierischer Zellen 
Universität Bielefeld 
D-4800 Bielefeld 1 
B. Roder, J. Vorlop 
G.B.F. 
Mascheroderweg 1 
D-3300 Braunschweig 
D. Duval, C. Demangel 
Bertin et Cie 
Chemical and Biochemical Engineering Division 
F-78373 Plaisir Cedex 
P. Nabet, J.-M. Bour, D. Carbonell, D. Marsic, J. Capiaumont, 
F. Derouiche, C. Legrand 
Universite de Nancy 
INSERIR 
Faculté de Médecine 
F-54505 Vandoeuvre-les-Nancy Cedex 
J.-M. Engasser*, A. Marc, L. Heibert, V. Geaugey, A. Martial, 
E. Mailly, J.-L. Goergen 
Institut National Polytechnique 
de Lorraine 
E.N.S.A.I.A. 
2, Avenue de la Forêt de Haye 
F-54505 Vandoeuvre-Les-Nancy 
* Local organizer 
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Scientific presentations 
J. Vorlop 
H. BÜntemeyer 
B. Roder 
C. Demangel 
H. Graf 
D. Wentz 
J.-M. Bour 
L. Helbert 
V. Geaugey 
: Oxygen transfer and carrier mixing in the 
100 1 membrane stirrer cell culture reactor 
: Arnino-acid estimation in mammalian cell 
culture media 
: Nutrient requirements of BHK 21 cells 
: Influence of ultrasonic treatment on 
hybridoma growth and monoclonal antibodies 
production 
: Development of the influence of physical 
stress on mammalian cells 
: Determination of biological parameters 
by on-line methods 
: Use of whey as a substitute for FCS in 
culture media - New biochemical markers 
for cell proliferation and death - Design 
and assay with a reactor in which cells are 
entrapped inside a foam 
: Kinetics and modelling of BHK cell growth 
on microcarriers 
: Nutrient requirements of hybridoma cells 
and membrane bioreactor assays (ultra and 
microfiltration) 
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EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-121-B Rommelaere 
BAP-122-I Riva 
BAP-236-I Donini 
BAP-237-UK Bostock 
BAP-256-D Lipps 
E Azor in 
P Costa 
In the field of 
MAMMALIAN MINICHROMOSOMES 
AND LINEAR VECTORS 
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European laboratory Without Walls 
in the field of Genetic Engineering for Animal Husbandry 
Area of research: Mammalian minichromosomes and linear vectors 
First meeting: May 19-20, Université Libre de Bruxelles and 
Solvay Co., 
Brussels, Belgium 
1. PARTICIPANTS 
Animal Virus Research 
ASCENZIONI, Università 
Genetica, 
C.J. BOSTOCK and A. SHERVINGTON, 
Institute, Pirbright, UK 
P. DOMINI, A.M. GUERRINI and F. 
di Roma, Italy 
S. RIVA and G. BIAMONTI, Istituto di 
Biochimica ed Evoluzionistica del CNR, Pavia, Italy 
WEFES, Universität Tübingen, FRG 
F. GRUMMT, Universität Würzburg, FRG 
J. VANCONCELOS-COSTAS, Instituto Gulbenkian de 
Oeiras, Portugal 
F. AZERINE, Escuella Tecnica Superior de 
Industriales, Barcelona, Spain 
Ph. d'OULTREMDNT, Solvay Co, Bruxelles, Belgium 
J. ROMMELAERE, A. BRANDENBURGER, P. CAILLET-FAUQUET, F. 
DUPONT and P. SEGELAERE, Université Libre de Bruxelles, 
Belgium 
Ciencia, 
Ingenieras 
2. AIM 
The group developed from a common commitment in the 
construction of linear vectors which could be used as 
artificial ininichromosomes for the transfer and maintenance 
of foreign genes in animal cells. 
Minimal requirements for such constructs consist of an 
origin of replication, telomeres and a centromere allowing 
the initiation and completion of DNA replication and the 
proper segregation of the vector, respectively. Given our 
poor present knowledge of these 3 components of mammalian 
chromosomes, the different teams are using homologous 
elements from lower eukaryotes or animal viruses, hoping 
that they will be functional in mammalian cells after 
cloning in an appropriate vector. 
The participating teams therefore share a common goal and 
use similar biotechnologies, yet they study different model 
systems. The groups therefore decided to join together, in 
order to profit by their unity at the technical level and 
their complementarity at the biological material level. 
3. SYNERGISTIC RESEARCH ACTIVITIES OF THE DIFFERENT GROUPS 
This ELWW makes it its ambition to deliver recommendations 
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state of the art still requires one to assess a variety of candidate 
DNA sequences from different sources, as putative components of animal 
minichromosomes. This diversity was apparent from the progress reports 
but does not mean a lack of coordination of different activities. 
Actually, research programmes are concerted at three levels: 
a) The work is distributed among participants so that unnecessary 
duplications are avoided, complementary lines of investigation 
are followed and a variety of biological systems (ranging from 
viruses to mammalian cells) are screened. Research in the ELWW 
encompasses work on the three essential elements of artificial 
minichromosomes mentioned above, i.e. origins of DNA. replication, 
chromosomal telomeres and centromeres. Different model systems 
are used to clone and test candidate DNA. sequences for these 3 
components. The distribution of work on these systems is as 
follows: 
vector constituents 
Teams Telomeres Origins of Centromeres 
replication 
Others Systems from which vector 
constituents are derived 
Pirbright 
Roma 
Tubingen 
Pavia 
Brussels 
Oeiras 
Barcelona 
x 
x 
Bovine papilloma virus: 
Capriopoxvirus; Tetra-
hymena, Yeast 
Bovine papilloma virus; 
Tetrahymena; Plasmodium; 
Yeast, Mammalian cells 
Bovine papilloma virus; 
Tetrahymena; Yeast 
Mammalian cells 
Parvoviruses 
African swine fever virus 
Simian virus 40; 
Mammalian cells 
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b) In addition, scientists and biological materials are 
exchanged between different teams in order to perform joint 
experiments which aim, in particular, at combining some of 
these DNA elements on a single vector. For example, 
recombinants comprising putative origins of DNA. replication 
from mammalian cells and genomic telomeres of animal 
parvoviruses, respectively cloned in Pavia and Brussels, are 
in the process of construction and testing. Several other 
examples of cooperations of this sort were given in the 
progress reports. 
c) Another area of cooperation is methodology, since 
technical problems to be faced are often similar, 
irrespective of the system studied. As an example, the 
Pirbright's group discussed during this meeting the 
conditions of filed inversion gel electrophoretic methods 
suitable for measuring the sizes and analyzing the 
structures of larger constructs. 
THE INDUSTRIALIST'S POINT OF VIEW 
P. d'Oultremont 
Why industrial companies should participate to BAP or later 
on BRIDGE, ECLATR ... EEC research programmes. 
As far as SOLVAY is concerned these are some reasons of 
which we want to indicate the most important ones. 
1) By definition industry is not performing basic but 
applied research in order to transform scientific 
discoveries in useful products. It is therefore 
essential to stay in close contact with Universities 
and Scientists. 
2) It seems important to indicate to the scientific 
community how industry sees the future needs in some 
market segments and thus in which direction Scientists 
should concentrate their efforts. 
As a resume SOLVAY will always be prepared to participate to 
such kind of action provided we can work with first class 
research teams and provided the programmes fit with our 
product lines. 
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EUROPEAN LABORATORY 
WITHOUT WALLS 
BAP-272-UK MILLER 
BAP-284-UK GILLHAM 
BAP-285-F KORDON 
In the field of 
CELLULAR NEUROIMMUNOLOGY 
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PROCEEDINGS OF THE MEETING 
"PERSPECTIVES IN CELLULAR NEHROIMMUNCIßGY" 
Held in Paris on June 17 and 18 1988 
JLNTRODOCTICN 
'Thirty scientists representing eighteen academic and four 
industrial laboratories from eight countries of the European 
Economic Community met on June 17 and 18 1988 in Paris. They 
reviewed current trends and work in progress in their own 
laboratories within the field of neuroimmunoloyg. 
The analysis of common properties of interactions between the 
nervous, the endocrine and the inmune systems is developing very 
rapidly. It requires multi-disciplinary approaches, and is likely 
to yield important clinical applications in particular a better 
understanding of 
1) immunological processes underlying aging, 
2) mechanisms involved in natural or drug induced 
irnmunomodulation, 
3) the relationship between coping behaviour and immune 
disorders, including autoimmune diseases and facilitation of 
tumoral growth, 
4) the transfer to the brain of feedback information 
concerning challenges to the immune system, and 
5) use by viruses or bacteria of signal molecules involved 
in communication within the nervous of the immune system, 
and which may thus mediate infection of neural or immune 
cells. 
In addition, neuroimmunological research is also of potential 
biotechnological interest. It includes definition of new cellular 
models useful for toxicology, in particular immunotoxicology, as 
well as for the design of new drugs (immunomodulators; substances 
acting directly on postreceptor transduction levels, but also 
molecules which may affect access of toxins or infectious vectors 
to the nervous system. 
Most data generated in this area over the last two years 
originate from North-American laboratories, and have mostly 
raised interest so far from US pharmaceutical companies. The 
participants to the meeting agreed however that, taken as a 
whole, the European research potential is far from négligeable; 
its efficiency could be significantly increased by procedures 
aimed at facilitating cooperation between teams developing 
complementary approaches, and by closer contacts between those 
laboratories and European companies. 
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MAJOR ORIENTATIONS OF PROSPECTIVE INTEREST 
Four major orientations were reviewed during the meeting: 
1. General aspects of neuroimmune communication 
Data accumulated over recent years show that discrete lesions of 
the nervous system, changes in the activity of determined neural 
networks or behavioral parameters can affect immune responses. 
More recently, those data were substantiated by observations 
indicating that neuropeptides can affect directly various 
functions, such as the rate of mitosis or of gene expression of T 
or B lymphocytes and conversely, that interleukins can have a 
direct impact on hypothalamic or hypophyseal structures 
responsible for neuroendocrine regulation. 
Those discoveries are important, because they provide the first 
cellular and molecular correlates likely to account for 
interactions between the brain and the immune system. A certain 
number of observations however require further confirmation. In 
particular, actions of lymphokines on the brain or the endocrine 
system do not necessarily involve transfer of information from 
the immune system; they could be produced locally, or involve 
direct communication between lymphocytes and non immune tissue 
under particular homing conditions only. Mapping of brain 
circuits involved in neuroimmune regulation has never been 
attempted with modern neuroanatomicai methods. Characterization 
of neuronal networks involved in either neuroendocrine mediated 
or direct (via the peripheral innervation of lymphoid organs) 
effects on the immune system should thus be encouraged. Finally, 
improvement of immune parameters used for studying immunological 
correlates of copying would yield further insight into the 
mechanisms involved, and provide models for studying some of its 
important practical of theoretical aspects, as the hemispheric 
dependence of immune disorders. 
2. Expression of neuropeptide genes and receptors by lymphocytes 
Among receptors expressed by lymphocytes, several correspond to 
peptide or transmitters released by nerve or epithelial cells 
within the thymus or other lymphoid organs. These signalling 
systems; as well as tight junctions present in the thymus, have 
been shown to play an important role in lymphocyte 
differentiation. This process could be an important level of 
neurogenic effects on immune cells. For instance, immunodeficient 
states could be due to inadequate migration of nursing cells; 
tumoral cells have been shown to secrete immunomodulators 
interfering with thymic maturation of lymphocytes; tachykinins 
are likely involved in the pathogeny of rheumatoid diseases; 
antidromic release of neuropeptides in the thymus has been 
reported to occur under the influence of nociceptive stimuli, and 
thymocytes have been reported to undergo suicide processes when 
exposed to excess levels of corticosteroids. In addition, 
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different antigens or toxins can induce expression of specific 
hormone genes. Differentiated lymphocytes are also sensitive to 
circulating peptide hormones as Beta-endorphin, ACTH, prolactin 
and several others. Beta-endorphin for instance influences the 
expression of the T3 complex by a differential action on its 
subunits, an action which parallels that of the hormone on 
lymphocyte proliferation; the process might involve changes in 
the recognition capacity of antigens by T cells. 
Several of those aspects await further investigation. In 
particular, the types of Beta-endorphin receptors underlying 
effects of the hormone on lymphocytes are not satisfactorily 
characterized; some of them are not naloxone dependent, 
suggesting mediation by a possible non opiate receptor. Formal 
characterization of prolactin receptors is still pending. Those 
questions will have to be answered before the relevance of 
effects mentioned above can be assessed. 
3. Membrane transduction of lymphocyte signals 
Postreceptor coupling mechanisms and transduction signals have 
been less extensively studied in the immune system than in 
several other tissues, as for instance the nervous or the 
endocrine systems. They are likely to provide interesting 
endpoints for analyzing the mechanisms involved in sequential 
stimulation or double check of immunocompetent cells, in 
immunomodulation, or in the onset of refractory periods following 
discrete patterns of stimulation. In addition, they could provide 
new tools for immunotoxicology or the design of immunomodulatory 
drugs. 
So far, a few data suggest that antibodies direct against CD3 
receptors or interleukin 2 may affect phospholipase C and 
generate phosphoinositide and diacylglycerol signals which, in 
turn, end up in protein kinase C activation. Preliminary data 
suggest that some of those processes might depend upon GTP 
binding proteins, in particular since they appear affected by 
pertussis or by cholera toxins. In parallel, these or other 
signals affecting lymphocytes modulate the activity of calcium 
channels. Systematic studies of the nature and the possible 
specificity of G proteins subunits expressed by lymphocytes and 
on the potentialisation or the reciprocal inhibition of second 
messengers upon exposure to combined signals are still lacking. 
Complete characterization of second messengers could provide 
early signals to analyze the impact of natural or artificial 
immunomodulators, as for instance Beta-endorphin, prolactin, 
steroid hormones or immunosuppressors. 
4. Cytokine actions on non immune tissue 
Actions of cytokines on the brain raises several unanswered 
problems. The inventory of ILI or neuroleukin effects on neurons 
or glial cells in culture, or on the brain itself, must now be 
approached in a more systematic manner. Questions to be asked 
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concern for instance: the possibility that ILI could be produced 
within neural or glial cells themselves, a hypothesis which could 
be approached by biochemical or in situ hybridization techniques; 
characterization of ILI receptors and receptor expression in the 
brain by appropriate molecular probes and their localization 
within brain structures; the possible function of sequence 
homologies between neuroleukin and viral or bacterial agents able 
to infect the nervous system. Similar questions can be addressed 
to other tissues which receive lymphocyte information, as 
neutrophils, platelets or erythrocytes. 
PROPOSALS 
1. As a conclusion ot the scientific discussion, the 
participants to the meeting identified topics ("burning 
questions") which could be immediately and efficiently 
addressed on the basis of discrete cooperative projects 
between members of the panel. Those are: 
Pharmacological characterization of peptide or 
transmitter receptors on lymphocytes and assessment of 
their identity to corresponding neuronal receptors. 
Pharmacological characterization of lymphokine 
receptors in the nervous system. 
Regulation of the expression of cytokin receptors in 
non immune tissue or neuropeptide receptors in 
lymphocytes. 
Characterization of coupling mechanisms involved in 
lymphocyte signalling. 
Inventory and role of lymphocyte (and thymocyte) G 
proteins. 
Mechanism of action of peripheral hormones (Beta-
endorphin, prolactin, steroid hormones) on lymphocytes. 
Regulation of the production of neuropeptides by 
lymphocytes. 
Functional neuroanatomy of neuroimmunological circuits 
and of thymic innervation. 
Characterization of signalling processes in homing 
models or during pregnancy. 
2. On those topics, rapidly developing short term cooperations 
could be initiated by light procedures. A limited number of 
initial cooperative studies between members of the panel are 
already under way; the project coordinators listed below 
have committed themselves to propose further pilot studies 
before the end of 1988. Generation of preliminary data would 
greatly benefit from support of a few investigator exchanges 
or postdoctoral fellowships. 
3. At a later stage, cooperative research within European teams 
could be greatly enhanced by developing three distinct 
subprogrammes within the general area of cellular 
neuroimmunology. Each of those subprogrammes or networks 
would associate a more restricted number of participating 
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laboratories and approach the field at a distinct level: 
a. Selection of appropriate models; analysis of 
immunomodulatory effects of antigens, antibodies, 
cytokines, neuropeptides and hormones on thymocytes and 
lymphocytes; characterization of receptors and 
expression of the corresponding genes, coupling 
proteins, second messengers, protein kinases and ionic 
channels; discriminative approach of the coupling 
mechanisms involved respectively in cell proliferation 
and expression of specific genes. 
Proposed coordinator: P. GIERSCHIK, assisted by A. 
ENJALBERT and G. FUJJQN. 
Participating laboratories*: 
1. (Characterization of vasopressin and oxytocin 
receptors, of their coupling properties and their 
effect on T lymphocytes). 
2. (G proteins technology). 
3. (Measurement of second messengers after discrete 
sequences of T cell stimulation). 
4. 9, 11. (Models of CDE2, CD3, IL2 receptor 
stimulation). 
5. (Gamma interferon messengers). 
7. (Neuropeptide expression). 
8. (Pharmacology of 5HT 1 and 2 and of prolactin 
receptors). 
14. (Selection of cell lines). 
16. (cDNA probes for receptors and oncogenes). 
17. (Role of polyamines and ionic channels). 
b. Characterization of biosynthesis, the distribution and 
the receptors of lymphokines in the nervous system, by 
both in vivo (quantitative autoradiography, in situ 
hybridization) and in vitro (primary cultures of 
nervous and glial cells). Analysis of their effects on 
neuronal growth and differentiation, on 
neurotransmitter secretion and release and on the 
hypothalamo-hypophyseal unit. Neurotransmitter 
regulation of cytokine secretion in the nervous system. 
Proposed coordinator: C. KORDON, assisted by J. MARJAN. 
Participating laboratories: 
3. (Neurons and glial cells in primary culture). 
8. (In situ hybridization techniques). 
10. (Mutant models, glial cell lines). 
15. (Perifusion of hypothalamic slices). 
laboratory number refers to the list of participants 
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c. Improvement of in vivo models available for the study 
of neuroimmune interactions. Mapping of neuronal 
circuits controlling hormone mediated immunomodulation 
or affection the extrinsic peripheral innervation of 
immune tissues, immunological correlates of behavioral 
patterns or coping and non coping situations, effect of 
cytokine on higher neural functions. 
Proposed coordinator: R. DANTZER, assisted by K. MILLER 
Participating laboratories: 
1. (Human cytokine radioimmunassays, thymus 
inmunc»cytochemistry). 
3, 8. (Receptor autoradiography). 
5. (Role of hormones and transmitters in 
autoimmunity). 
10. (Genetic models). 
12, 15, 18. (Neuroanatomicai techniques in humans and 
rodents). 
14. (Brain immune relationships after specific immune 
suppression by viruses, bacteria and parasites). 
16. (Pharmacology of the thymus). 
Industrial laboratories will be associated to the development of 
each topic. 
Each of those subprogrammes could be coordinated separately; a 
general meeting of the three programmes should be organized every 
year or every second year to review work in progress in the whole 
area and adjust the objectives of the action. 
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IN CELLULAR NEUROIMMUNOLOGY 
List of p a r t i c i p a n t s 
Academic l a b o r a t o r i e s 
1. Mr. GEENEN 
Université de Liège, B - 4020 LIEGE 
2. Mr. P. GIERSCHI]K 
University of Heidelberg, D - 6900 HEIDLEBERG 
3. Mr. C. KORDON, Mr. A. ENJALBERT 
U. 159 INSERM, F - 75014 PARIS 
4. Prof. L. DEGOS, Mr. A. BENSUSSAN 
U. 93 INSERM, F - 75010 PARIS 
5. Mrs. J. CHARRIERE 
U. 283 INSERM, F - 75674 PARIS CEDEX 14 
6. Mr. R. DANTZER 
U. 259 INSERM, F - 33077 BORDEAUX 
7. Mr. J.C. AMEISEN, Mr. D. MONTE 
INSERM-Institut Pasteur, F - 59019 LILLE 
8. Mr. G. FILLION, Mrs. F. HAOUR 
Institut Pasteur, F - 75015 PARIS 
9. Mr. S. CHOUAIB 
Institut G. Roussy, CNRS, F - 94800 VILLEJUIF 
10. Mr. J. MARIANI 
Université de Paris VI, F - 75005 PARIS 
11. Mrs. C. HEIJNEN 
Dept. of Clinical Immunology, University Hospital, 
NL - 3500 CG UTRECHT 
12. Mr. K. SCHUURMAN 
University Hospital, NL - 3500 GG UTRECHT 
13. Mrs. R. ZWIJSIN 
A g r i c u l t u r a l U n i v e r s i t y , NL - 6703 BC WAGENINGEN 
14. Prof. M.A. CHAVEZ 
Institute of Biomedical Sciences, P - PORTO 
15. Prof. J. BORRELL, Mr. N. RUBIO 
Instituto Ramo y Cajal, E - 21006 MADRID 
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16. Mr. R. BARRASS, Mrs. K. MILLER, Mr. S. VQLSQN 
British Imperial Biological Research Ass. 
UK - CHARSHALTON, SURREY SM5 4DS 
17. Mr. B. GILLHAM 
United Medical and Dental Schools, UK - LONDON SEI 7EH 
18. Mrs. M. KENDALL 
United Medical and Dental Schools, UK - LONDON SEI 7EH 
Industrial Laboratories 
19. Mr. G. FLOCH, 
Rhône Poulenc, F - 94403 VITRY S/S 
20. Mr. P. CESSELAS 
SANOFI, F - 34082 MONTPELLIER 
21. Mr. L. VAN ROOIJEN 
TROPON Pharmaceuticals, D - 5000 KÖLN 
Secretariat of the EEC 
22. Mr. A. KLEPSCH 
EEC - DG XII/F/2, B - 1049 BRUSSELS 
* * * * * 
* * * 
* 
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In the field of 
GENETIC ENGINEERING OF 
FOOD- AND-MOUTH DISEASE VIRUS ANTIGEN 
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Report on working seminar of ELWW entitled 
"Genetic Engineering of Foot-and-Mouth Disease Virus Antigen" held at 
Rhenen, NL, February 28 - March 1, 1988 
PARTICIPANTS: 
Name 
Brown, F. 
Clarke, B.E. 
Parry, N.R. 
King, A.M.Q. 
Belsham, G.J. 
Ryan, M. 
Pouwels, P.H. 
Enger-Valk, R.E. 
Caspars, M. 
Vlak, J.M. 
Roosien, J. 
Beck, E. 
Domingo, E. 
Meloen, R. 
Address 
Wellcome Biotech, 
Langley Court, 
Beckenham, Kent, BR3 3BS, U.K. 
Institute for Animal Health, 
Pirbright Laboratory, 
Pirbright, Woking, GU24 ONF, U.K. 
TNO Medical Biological Laboratory, 
PO Box 45, 2280 AA Rijswijk, 
The Netherlands. 
Department Virology, 
Agricultural University, 
6700 EM Wageningen, 
The Netherlands. 
Zentrum fur Molekulare Biologie, 
Universität Heidieberg, 
Im Neuenheimer Feld 282, 
D-6900 Heidelberg 1, Feberal Republic Germany. 
Centro de Biologia Molecular, 
Facultad de Ciencias, 
Universidad Autonoma de Madrid, Canto Bianco, 
Madrid 34, Spain. 
Centraal Diergeneeskundig Institut, 
Postbus 65, 
8200 RA Lelystad, 
The Netherlands. 
Marquardt, 0. 
Klepsch, A. 
DAY 1. RESEARCH REPORTS 
Bundersforschungsanstalt fur 
Virusskrankheiten Tiere, 
PO Box 1149, Paul Ehrlich Strasse 28, 
D-7400 Tubingen, Federal Republic Germany. 
CEC observer. 
The field was divided into the five subject areas, listed below. This 
programme attracted a total of 21 contributions. Each was followed by a 
period of discussion. Main highlights were as follows. 
1) Synthesis, processing and assembly of capsid proteins in heterologous 
expression systems. Virion proteins can be made in a cell-free transla-
tion system, processed, and assembled into structures resembling capsids, 
although the products appear to be unstable. N-terminal myristoylation 
of VP0 was not necessary for assembly. Much attention was paid to finding 
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how much of the nonstructural protein coding region of the genome must be 
included to ensure proper processing. Two virus-coded proteolytic 
activities (L and 3C) were characterised, and a third (presumably 2A) 
implicated. Unfortunately, these activities are extremely fastidious; 
even a minor alteration to the substrate, or to a protein encoded next to 
the putative enzyme, can inhibit processing. 
The use of recombinant DNA. viruses (vaccinia virus or baculovirus) to 
express the complete capsid protein region in animal cells was described. 
Synthesis of the capsid precursor, and limited proteolytic processing, was 
demonstrated using both vectors. However, it has so far proved impossible 
to make recombinants of either vector containing the L protease gene, 
implying that its product is toxic. Moreover, we are a long way from 
achieving the high level of expression that was planned with baculoviruses. 
Ways of solving both problems were discussed. 
As an alternative to expressing whole capsids, the immunogenic region of 
VPl, residues 140-160, was inserted into the pre-S2 sequence attached to 
hepatitis B virus surface antigen, and expressed in yeast. The immuno-
genicity of the product has still to be determined. 
2) Engineering live virus. A method for recovering live virus from cDNA 
clones of foot-and-mouth disease virus continues to elude us. Two groups 
are currently working on this important problem, following quite different 
approaches; both described encouraging recent progress. 
3) Virion structure and sequence alignments. We can expect the complete 
atomic structure of foot-and-mouth disease virus shortly; 80% of the x-ray 
reflections, which are of exceptional quality, have already been measured. 
Currently, the information available is still sketchy, although we are told 
that the deep cleft in the virion surface, and the elevated 5-fold axis of 
symmetry which it surrounds, are less pronounced than in rhinovirus. This 
was confirmed independently by model building. On sequence alignments, 
much molecular epidemiological data, and a mathematical model of evolution-
ary changes, were described. 
4) Antigenic structure. The five speakers in this section described the 
use of monoclonal antibodies for studying variation among natural virus 
isolates and mapping neutralizable epitopes. Interestingly, variation 
among a group of type C viruses occurred at epitopes recognised by neutral-
ising antibodies, but not nonneutralisable epitopes, a good illustration of 
the driving force of antibody selection in nature. Four Groups had tried 
to locate antigenic sites by mapping antibody-escape mutations. All agreed 
that there are several, maybe five, independent sites but only one site, 
the 140-160 region of VPl, was identified unequivocally as an antibody-
binding site. There was also evidence for a site at residues 43-48, and a 
third in VP2. Conflict was noted between the results of this genetic 
method of mapping antigenic sites, which has been well authenticated with 
other picornaviruses, and those obtained by peptide competition studies. 
It is hoped that these conflicts will be resolved when we know the 
structure of the virus. 
5) Host immune response. There is now a wealth of detailed information on 
the immune response of model animal species (mice and guinea pigs) to one 
particular epitope, viz the 140-160 region of VPl. It is estimated that 
10-40% of the neutralising antibodies in cattle sera are directed against 
this site. Increasing the molecular size of the peptide-containing immuno-
gen generally increases potency but may decrease coverage. Recent work 
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showing that the ability to respond to the peptide depends on inclusion of 
an epitope recognised by the host's helper T-cells was reviewed. The most 
potent peptide vaccine yet developed consists of residues 140-160 of VPl 
fused to the amino terminus of hepatitis B virus core antigen. 
DAY 2 (am) DECISIONS 
The local organiser introduced the proceedings by commending not only the 
excellence of the work that had been described the previous day, but also 
the candour with it was reported. He noted that there is a long and happy 
tradition of cooperation in the international fight against foot-and-mouth 
disease. A considerable amount of collaborative research already occurs 
outside formal CEC contracts. A good example, which members of the ELWW 
would do well to follow, is the epitope mapping work, described by 
G Belsham, which is to be published with an authorship drawn from five 
different countries. The main conclusions of the meeting were as follows: 
1) The need for a vaccine. Foot-and-mouth disease is still enzootic in 
parts of the European Community, and poses a threat to Europe's eastern 
border. For the foreseeable future it will be imperative to maintain an 
ability to vaccinate. For this purpose, and for the eventual control of 
the disease worldwide, a safe and stable vaccine is needed. 
2) Current status of research. Research into new vaccines had been 
following two strategies, one aimed at expressing the entire virus capsid, 
the other, individual epitopes. The first was proving difficult owing to 
the functional complexities of the virus genome, toxicity of one gene 
product, and disappointing levels of expression. Nevertheless, these 
projects were at a very early stage, and encouraging progress had already 
been made. The second approach, with many more years' work behind it, had 
made great progress, with at least one potentially marketable product on 
the horizon. Here, the main problem is that few of the data on peptide 
immunogenicity, or- antigenic sites, relate to the animal species we wish 
to protect, the cow and the pig. The meeting concluded that there is an 
urgent need for more basic immunology in these ungulates. 
3) Future cooperation between members of the ELWW. The following 
decisions were taken: 
a) Expert advice/assistance will be sought from bovine/porcine 
immunologists. Action: F. Brown 
b) A monthly foot-and-mouth disease virus bibliography will be made 
available to ELWW members by the IAH library at Pirbright. 
Action: A. King 
c) The computer database of foot-and-mouth disease virus nucleic acid 
sequences, set up by Mr. N.J. Knowles, World Reference Laboratory, IAH, 
Pirbright, will be made available to members. Action: A. King 
d) It was agreed to convene a second meeting of the ELWW, with the same 
number of participants, in one year's time. Action: E. Domingo 
A.M.Q. KING 
Local Organiser 
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Cheruy 2-191 
B i o r e a c t o r 
E n g a s s e r 3-907 
P e r r e t 2-207 
Bioreactors 
B a s t i n 2-199 
de F l o r a 2-479 
Biosequences 
S a l l a n t i n 2-155 
Biotechnological process 
Cheruy 2-191 
B i o t e c h n o l o g i c a l p r o c e s s e s 
Rozz i 2-213 
Biotechnology 
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Biotechnology risk assessment 
Leaver 4- 7 
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Bovine 
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Ingram 3-471 
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Broadbean 
P ü h l e r 3-557 
B r u c e l l a 
Dubray 3-759 
Limet 3-765 
Bubble free oxygenation 
Lehman 3-893 
C-reactive protein 
C i l i b e r t o 3-703 
Cancer chemotherapy 
Clynes 4-117 
Roberfroid 4-129 
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Lehman 3-893 
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B r u n s t e d t 3-453 
C a t a l a s e 
R o u x h e t 2-423 
C a t a l o g u e ( i n t e g r a t e d ) 
d e Br a b a n d e r e 2-131 
C a t t l e 
Gannon 3-727 
CDNA 
Cohen 3-665 
L i b b e n g a 3-323 
S i l e n g o 2-487 
CDNA c l o n e s 
P u n i e r 3-557 
Cell adhesion 
C o m o g l i o 3-879 
C e l l b a n k 
D o y l e 2-295 
G a l j a a r d 2-301 
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Dubertret 4-69 
Lapiere 4-77 
Cell culture 
Bach 4-53 
Regan 4-103 
Schousboe 4-109 
Stolte 4-61 
Cell density 
M i l a n d e 2-219 
Raymond 2-219 
Cell differentiation 
Whalen 2-33 
Cell engineering 
Witholt 3-153 
Cell organell replication origin 
Ni j kamp 3-615 
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PÜhler/Priefer 3-545 
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Fry 3-483 
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Krieg 4-85 
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F i s h e r 3-887 
C e l l u l a s e 
C h a m b o s t 3-521 
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Demarly 3-281 
Lörz 3-275 
Charged membranes 
Kulbe 2-403 
Chimeric genes 
Schell/Schreier 3-579 
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de Bont 2-375 
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Schell/Schreier 3-579 
Chloroplast transformation 
Schell/Schreier 3-579 
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Bailio 3-301 
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Chromosome transfer 
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Chromosomes 
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C l a r k e 2-119 
Downs 2-103 
Linnemans 2 - 9 9 
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C a r c a s s o n n e 4-123 
H e n n e b e r t 2-847 
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C u l t u r e 
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Dicarboxylic acids 
Meussdoer f f e r . 2-505 
Digital 
Bateman 2-53 
Direct blotting electrophoresis 
Pohl 2-47 
Direct gene transfer 
J a c o b s 3-245 
DNA 
Bateman 2 - 5 3 
Tempelaa r 3-239 
DNA homology 
Hirsch 4-31 
DNA methylation 
Hernalsteens 3-419 
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Nabet 3-919 
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S c h u g e r l 2-451,3-913 
Enzyme k i n e t i c s 
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Enzymes 
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Garwes 3-841 
Gascon 3-S49 
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E n t w i s t l e 4 - 3 7 
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Moura 2-673 
Epstein Barr Virus 
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Erwinia chrysanthemi 
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Ethanol production 
D r a i n a s 3-127 
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Eukaryotic vectors 
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Exonuclease III 
Pohl 2-47 
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E x p r e s s i o n v e c t o r 
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Faba bean 
B r i q u e t 3-573 
Fami ly s t u d i e s 
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F a t t y a c i d s 
Meussdoer f f e r 2-505 
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Maerkl 2-225 
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Germain 3-227 
Ferredoxin 
Minton 3-173 
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Moura 2-673 
F e r r i t i n 
A r o s i o 2-551 
C e s a r e n i 2-559 
H a r r i s o n 2-565 
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Greaves 4-91 
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Krieg 4-85 
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Fiers 3-119 
K i n g h o r n 3-107 
P o u w e l s 3-113 
F i n e c h e m i c a l s 
Bückmann 2-339 
S r e e n a n 3-715 
F i x g e n e s 
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F l a v o n o i d g e n e s 
Mol 3-441 
Flavonoid synthesis 
Geräts 3-427 
F l o w c y t o m e t r y 
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FMDV 
Brown 3-791 
M u r r a y 3-787 
P o u w e l s 3-793 
F o l d i n g 
J a e n i c k e 2-523 
P a i n 2-531 
S c h u m a c h e r 2-537 
Foot-and-mouth disease 
McCahon 3-781 
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V l a k 3-775 
FORTRAN 77 
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F u s i c o c c i n 
B a i l i o 3-301 
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S i l e n g o 2-487 
Fusion Proteins 
Gascon 3-849 
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P a r m e g g i a n i 2-611 
y $ - g a l a c t o s i d a s e 
R o s s i 2-437 
G a l l u s 
Nigon 3-753 
GALT 
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S t o k e s 3-867 
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Wilms 3-643 
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J a c o b s 3-245 
Gene 
F l a v e l l 3-385 
Gene cloning 
Grenson 3-221 
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O ' C o n n e l l 3-539 
Gene cloning systems 
Venerna 3-37 
Gene expression 
C o r t e s e 3-709 
K r e i s 3-379 
van Montagu 3-563 
Gene r e g u l a t i o n 
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Gene Transfer 
Bos tock 3-825 
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Lörz 3-275 
S a l a 3-261 
Gene vectors 
F r o n t a l i 3 -45 
Genes 
Dubray 3-759 
H a r t l e y 3 - 9 3 
Limet 3-765 
276 
G e n e t i c 
Doyle 2-295 
Genetic disease 
Galjaard 2-301 
Genetic disorders 
Dunn 2-27 
Genetic engineering 
Petersen 3-79 
Genetic manipulation 
Entwistle 4-37 
LÖrz 3-275 
Genetic stability 
Hill 2- 19,2-283 
Genetic studies 
Daly 3-7 
Gasson 3-15 
Genetic transfer 
Amarger 4-19 
Genetic transformation 
Leaver 3-567 
Genomic charting 
Beck 2-41 
Genomic marker sequence 
Entwistle 4-37 
Glia 
Regan 4-103 
^-glucanase 
Staudenbauer 3-181 
Glucanase gene 
Sarx 3-400 
von Wettstein 3-399 
Glucerate-3-phosphate dehydrogenase 
Jaenicke 2-523 
Glucoamylase 
Fiers 3-119 
Glucocorticoids 
G i l l h a m 4-135 
G l u c o n i c a c i d 
Kulbe 2-403 
Glucose regulation 
McConnell 3-87 
G l u t a m i n e s y n t h e t a s e 
K r e i s 3-379 
Glutamine uptake 
Typas 3-133 
Gluten enteropaty 
F e r r a r a 2-325 
G l u t e n i n 
F l a v e l l 3-385 
Glycolysis 
Zimmermann 3-81 
Glycolysis regulation 
Hartley 3-93 
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Glycoprotein gene 
Flamand 3-637 
G l y c o p r o t e i n g l i 
Rz iha 3-799 
G l y c o p r o t e i n s 
K e i l 3-811 
Van O i r s c h o t 3-805 
G l y c o s y l h y d r o l a s e s 
Fry 3-483 
Gramineae 
Lörz 3-275 
Growth factors 
Comoglio 3-879 
Growth hormone 
Gannon 3-727 
Growths f a c t o r s 
F i s h e r 3-887 
GTP-b ind ing p r o t e i n s 
C l a r k 2-597 
H a b i t u a t i o n 
Olesen 3-335 
Haloaromatics 
de Bont 2-375 
Maule 2-383 
Hardware interface 
Perret 2-207 
Helices extremities 
Wodak 2-251,2-619 
H e l p e r 
Nigon 3-753 
H e p a t i t i s 
Brown " 3-791 
Murray 3-787 
Hepatoma cells 
B a b i n e t 3-695 
Heptad p a t t e r n 
C e s a r e n i 2-559 
Herpes s u i d 1 
Rz iha 3-799 
H e r p e s v i r u s e s 
K e i l 3-811 
Heteroclitic antibodies 
Bricogne 2-77 
Poljak 2-65 
Heterologous expression 
Kinghorn 3-107 
Heterologous gene expression 
Fiers 3-119 
Hexokinase 
S i l e n g o 2-487 
High cell density 
Maerkl 2-225 
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H i g h d e n s i t y 
H a c h e 3-901 
H i g h l y s i n e g e n e 
M o t t o 3-407 
High-level expression 
Vlak 3-775 
High-lysine 
Thompson 3-413 
Higher plants 
Q u é t i e r 3-623 
H i s t o l o g y 
O l e s e n 3-335 
HLA associated diseases 
G r o s s e - W i l d e 2-319 
HLA homozygous lines 
G r o s s e - W i l d e 2-319 
HLA linked diseases 
G r o s s e - W i l d e 2-319 
HLA-homozygous lines 
F e r r a r a 2-325 
Homologies 
S a l l a n t i n 2-155 
Homology s e a r c h e s 
S h a r p 2-163 
H o r d e i n 
K r e i s 3-379 
H o r d e i n g e n e s 
S a r x 3-400 
v o n W e t t s t e i n 3-399 
H o r m o n e s 
O l e s e n 3-335 
Host strains 
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Doyle 2-295 
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Galjaard 2-301 
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C l y n e s 4-117 
Human proteins 
Dunn 2 - 2 7 
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H a c h e 3-901 
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L e s p i n a t 2-691 
Moura 2-673 
Hydrogénation reactions 
L e s p i n a t 2-691 
Hydrophobie interactions 
K o k k i n i d i s 2-571 
4 - h y d r o x y b e n z o a t e 
de Bont 2-375 
Hydroxylase 
Witholt 3-153 
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de Bont 2-375 
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P a r a f 3-861 
S t o k e s 3-867 
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Bertero 2-95 
Brakenhoff 2-83 
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Downs 2-103 
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P i k e 2 - 8 9 
Schade 2-113 
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Massen 2 - 5 9 
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Garwes 3-841 
Immunoabsorption 
R a j a g o p a l 3-349 
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Immunomodulators 
Vecchi 4-153 
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Roberfroid 4-129 
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Inducible promoter hepatocyte stimulating factors 
Ciliberto 3-703 
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Croy 3-459 
Insertion mutagenesis 
Hernalsteens 3-419 
Insulin 
Dodson 2-653 
Integration 
Guérineau 3-101 
Interfacial forces 
Schügerl 2-451,3-913 
Interleukin 
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L-ascorbic acid 
Kulbé 2-403 
L - s o r b o s e 
Kulbe 2-403 
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The biotechnology action programme (BAP) was adopted on 12 March 1985 for a 
period of five years and led to the conclusion, throughout the year 1986 and early in 
1987, of a total of 262 research contracts. The purpose of this action is to allow the 
continuation of a previous biomolecular engineering programme (BEP) and its 
extension to new areas considered as essential for the development of biotechnol-
ogy in the Community. Further supported have been the sectors on second 
generation bioreactors, on genetic engineering — covering the whole range of 
methods applying to animal husbandry, veterinary medicine, plant improvement, 
crop protection, beneficial soil micro-organisms — and on risk assessment. New 
domains, which BAP now also addresses, include contextual measures for the 
pooling and improvement of infrastructures for R&D (storage and treatment of 
biological data, collections of biotic materials), as well as specific projects for protein 
design, the applications of genetic engineering to industrial micro-organisms, the 
development and upscaling of novel methods for in vitro cell cultures. A special 
effort is also being initiated in the area of in vitro systems for the screening and 
assessment of pharmacological properties and toxicological effects of new mol-
ecules. 
A. This is the second of a series of four progress reports, to cover on a yearly basis 
the period 1985-89 of the execution of the BAP programme. The first of this series, 
published last year, only presented two thirds of the activities foreseen by the 
programme, at a very preliminary stage of implementation. Due to a stepwise start 
of contracts, it is only with this second publication that all contributions of the 262 
scientific contractors who participate in BAP can be reviewed in detail. One striking 
development, resulting from gradual integration of research in the framework of 93 
transnational projects, certainly is the constitution of multipartner European 
Laboratories Without Walls (ELWWs), with provisions for exchanges and with 
division of tasks. This is how the Community hopes to be able to circumvent some of 
the academic and geographical barriers which obstruct this multidisciplinary field. 
B. The programme will be revised by Council before the end of 1988, and may 
then expand further by an increase of activities in selected areas and by the entry of 
Portuguese and Spanish participants. In addition to this research programme, a 
training programme is run in parallel with a capacity of 60 grants a year covering all 
biotechnology related fields. Reports on the training programme are issued 
separately on a periodical basis. 
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